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1
Summary
This thesis investigates the potential for monitoring current and historic blood serum con-
centrations of amino acids via transdermal extraction using phenylalanine as a case study.
This work furthers the field of non-invasive monitoring of amino acid disorders which have
several advantages over invasive methods such as blood tests. In this thesis we derive mod-
els to simulate blood serum concentrations, the formation of the skin reservoir and, finally,
transdermal extraction of amino acids under an applied electric field.
Chapter 1 concerns itself with the biological background and sets up motivation of the thesis
by discussing amino acids, associated amino acid disorders, the overarching clinical problem,
skin structure and transdermal extraction methods. Chapter 2 then considers mathematical
techniques utilised throughout the thesis.
Chapter 3 formulates a model for the distribution of phenylalanine in blood serum. One
compartment and two compartment approaches are considered in both a fasting state and a
non-fasting state. We consider if these have a noticeable effect on the blood serum concen-
tration of phenylalanine.
Having obtained a model for the distribution of phenylalanine in blood serum, chapter 4
models the formation of reservoirs of amino acids in the skin. Prior work has identified
the existence of such a reservoir, but its formation has not been addressed. The models
developed consider the effect of the removal of outer layers of skin, the stratum disjunctum,
and production of amino acids in the skin. Unknown parameters are estimated by comparing
the model to in vivo and in vitro data.
Chapter 5 and 6 are concerned with transdermal extraction under an applied electric field.
Chapter 5 formulates the velocity induced by applying an electric field across a charged
interface. Chapter 6 utilises these results for modelling extraction of compounds through the




1.1 Amino Acids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
1.1.1 Phenylalanine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.2 Amino Acid Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
1.2.1 Phenylketonuria (PKU) . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.3 The Clinical Problem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
1.4 The Skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
1.4.1 Overall structure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
1.4.2 Epidermis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
1.5 Physiologically Based Pharmacokinetic Modelling . . . . . . . . . . . . . . . . 15
1.6 Dermal Extraction Routes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
1.7 Extraction Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
1.7.1 Passive Diffusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
1.7.2 Reverse iontophoresis . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
1.8 Thesis Structure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
2 Mathematical Techniques 21
2.1 Steady State Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.1.1 Stability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.1.2 Resilience . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2.1.3 Reactivity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
2.1.4 Amplification envelope . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
2.2 Parameter estimation - Gauss-Newton Algorithm . . . . . . . . . . . . . . . . 27
2.2.1 Goodness of Fit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
2.3 Propagation of Error . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
2.4 Continuity Equations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
2.5 Diffusion Partial Differential Equation . . . . . . . . . . . . . . . . . . . . . . 30
2.6 Advection-Diffusion Partial Differential Equation . . . . . . . . . . . . . . . . 30
2.6.1 Generalised Integral Transform Technique . . . . . . . . . . . . . . . . 32
3
2.6.2 Numerical Solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.7 Laplace Transform . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
2.8 Bessel Functions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.9 Chapter Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
3 Systemic Profile of Phenylalanine 42
3.1 Chapter Objective . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
3.2 Parameter Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
3.3 Background Biology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
3.3.1 Enzyme Kinetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
3.3.2 Bateman Model for Food Intake . . . . . . . . . . . . . . . . . . . . . 49
3.3.3 The Human Body . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
3.3.4 Phenylalanine in Skeletal Muscle . . . . . . . . . . . . . . . . . . . . . 52
3.4 Fasting State Model for Phenylalanine . . . . . . . . . . . . . . . . . . . . . . 52
3.4.1 Single compartment model . . . . . . . . . . . . . . . . . . . . . . . . 53
3.4.2 Analysis of the single compartment model . . . . . . . . . . . . . . . . 54
3.4.3 Two-compartment model . . . . . . . . . . . . . . . . . . . . . . . . . 62
3.4.4 Comparison of the one and two compartment systemic model . . . . . 71
3.5 Intake of food into the systemic model . . . . . . . . . . . . . . . . . . . . . . 71
3.5.1 Previous food intake model using the Bateman function for food intake 73
3.5.2 Food intake systemic model - Single compartment . . . . . . . . . . . 74
3.5.3 Food intake model - Two compartment . . . . . . . . . . . . . . . . . 76
3.5.4 Varying food intake . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
3.6 Chapter Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
4 Stratum Corneum Profile of Phenylalanine 82
4.1 Chapter Objective . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
4.2 Parameter Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
4.3 Background Biology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
4.3.1 Stratum Corneum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
4.3.2 Stratum Disjunctum . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
4.3.3 Viable Epidermis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
4.3.4 Potts and Guy Model . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
4.3.5 In Vivo Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
4.4 Model Formation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
4.4.1 Phenylalanine in the Blood . . . . . . . . . . . . . . . . . . . . . . . . 98
4.4.2 Corneocyte Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
4.4.3 Intercellular Space Model . . . . . . . . . . . . . . . . . . . . . . . . . 100
4.4.4 Total Concentration Model . . . . . . . . . . . . . . . . . . . . . . . . 102
4.5 Model analysis - Time Dependent and Steady State Solutions . . . . . . . . . 103
4
4.5.1 Corneocyte Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
4.5.2 Intercellular Space Model . . . . . . . . . . . . . . . . . . . . . . . . . 106
4.6 Model Analysis - Parameter estimation . . . . . . . . . . . . . . . . . . . . . . 111
4.6.1 Zero Cell Production . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
4.6.2 Tape Stripping only Assesses the Intercellular Space . . . . . . . . . . 115
4.7 Comparison without the Stratum Disjunctum . . . . . . . . . . . . . . . . . . 117
4.8 Comparison with Tyrosine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
4.9 Effect of Parameter Variation on Total Amount in the Skin . . . . . . . . . . 122
4.9.1 Varying Stratum Corneum Depth . . . . . . . . . . . . . . . . . . . . . 124
4.9.2 Varying Stratum Disjunctum Depth . . . . . . . . . . . . . . . . . . . 124
4.9.3 Varying Production in Corneocytes and the Intercellular Space . . . . 124
4.9.4 Varying Stratum Disjunctum Decay Rate in the Intercellular Space . . 126
4.10 Model analysis - Non-fasting state . . . . . . . . . . . . . . . . . . . . . . . . 127
4.11 Model Analysis - In Vitro Porcine Skin . . . . . . . . . . . . . . . . . . . . . 128
4.12 Chapter Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
5 Electro-osmotic Flow Dynamics 132
5.1 Chapter Objective . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
5.2 Parameters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
5.3 Introduction to Electro-Osmotic Flow . . . . . . . . . . . . . . . . . . . . . . 137
5.4 Navier-Stoke Equations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
5.5 Poisson-Boltzmann Equation . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
5.6 Boundary Behaviour . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
5.6.1 Zeta Potential . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
5.6.2 Surface Charge Density . . . . . . . . . . . . . . . . . . . . . . . . . . 143
5.6.3 Debye Length . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144
5.6.4 Streaming Potential . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144
5.6.5 Stern Theory . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145
5.7 Application . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
5.7.1 Assumptions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147
5.7.2 Parallel Plate Approach . . . . . . . . . . . . . . . . . . . . . . . . . . 148
5.7.3 Cylindrical Approach . . . . . . . . . . . . . . . . . . . . . . . . . . . 155
5.8 Surface Charge Density Calculation . . . . . . . . . . . . . . . . . . . . . . . . 162
5.8.1 Average Charge Concentration in the Fluid . . . . . . . . . . . . . . . 163
5.8.2 Modifications to Surface Charge Modelling . . . . . . . . . . . . . . . 167
5.9 Chapter Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
6 Reverse Iontophoresis 174
6.1 Chapter Objective . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
6.2 Parameters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
5
6.3 Background Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 178
6.3.1 Reverse Iontophoresis . . . . . . . . . . . . . . . . . . . . . . . . . . . 178
6.3.2 Hair Follicles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 179
6.3.3 Hindrance Modelling . . . . . . . . . . . . . . . . . . . . . . . . . . . . 180
6.4 Initial Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 182
6.4.1 Model Formation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185
6.4.2 Model Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 188
6.4.3 Application to Experimental Work . . . . . . . . . . . . . . . . . . . . 191
6.4.4 Summary of Initial Model Findings . . . . . . . . . . . . . . . . . . . . 197
6.5 Model Adaptation Including Hindrance Effects . . . . . . . . . . . . . . . . . 200
6.5.1 Model Alterations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 200
6.5.2 Steady State Solution . . . . . . . . . . . . . . . . . . . . . . . . . . . 201
6.5.3 In Vivo time dependent . . . . . . . . . . . . . . . . . . . . . . . . . . 202
6.5.4 Summary for Hindrance Model . . . . . . . . . . . . . . . . . . . . . . 213
6.6 Chapter Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 214
6.6.1 Variable Resistance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 215
7 Summary and Future Work 218




The aim of this chapter is to introduce the key biological concepts behind the thesis. We begin
by introducing amino acids and associated amino acids disorders, focusing on the amino acid
phenylalanine and the associated amino acid disorder, phenylketonuria. Having considered
amino acid disorders, we then discuss the current clinical problems associated with monitoring
these disorders. The main clinical problem revolves around having to use invasive methods,
such as blood tests, to monitor such conditions. Due to problems associated with invasive
sampling methods, prior work has proposed that an alternative to invasive sampling is non-
invasive sampling through the skin, called transdermal extraction [1, 2]. Mathematically
modelling transdermal extraction is the primary goal of this thesis, hence, once the clinical
problem has been discussed, the skin and the transdermal extraction methods, such as passive
diffusion and reverse iontophoresis, are considered.
The chapter is concluded with an overview of the structure of the thesis.
1.1 Amino Acids
The primary function of amino acids in the body is to form proteins. Proteins are polymer
chains comprised of over 50 amino acids linked by peptide chains [3]. Proteins are incredibly
important in the human body and perform a variety of tasks essential to life, such as being
the building blocks of body tissue, forming antibodies that help prevent disease and infection
as well as being a major source of energy [4]. Due to the multitude of roles proteins play in
the body, the human body is approximately 20% protein by weight [4].
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Forming proteins is not the only biologically important role amino acids play in the body.
Amino acids also perform other roles such as acting as chemical messengers, either as neuro-
transmitters or hormones, and playing an essential role in metabolism [3].
1.1.1 Phenylalanine
Phenylalanine is an example of an amino acid [5]. From the structure of phenylalanine shown
in Figure 1-1 it is clear that phenylalanine has an aromatic ring, which allows it to absorb
UV radiation. Due to this, phenylalanine is useful in skin protection and an important
part of the natural moisturising factor (NMF) that controls skin hydration [5]. Additionally,
phenylalanine’s primary metabolite is tyrosine which is important in melanin synthesis [6];
melanin is important in protecting the body from UV radiation.
Figure 1-1: Structure of Phenylalanine. The chemical formula for this compound is
C9H11NO2 with an aromatic ring on the far left of the structure. Taken from [7].
Phenylalanine is taken into the body either by food intake, as it is present in meat, fish, dairy
products, nuts and aspartame, an artificial sweetener, or by the decomposition of proteins in
both the skin and general body muscle [8]. As an amino acid, phenylalanine is hydrophilic
and hence it is distributed evenly throughout total body water [9].
There are several ways that phenylalanine is eliminated from the body which can be broadly
split into metabolism and excretion. The metabolic pathways for phenylalanine are shown in
Figure 1-2. Route 1 represents hydroxylation of phenylalanine into tyrosine, a reaction that
is catalysed by the enzyme phenylalanine hydroxylase (PAH). This step is the rate limiting
part of the conversion of phenylalanine into carbon dioxide and water and is responsible for
approximately 75% of phenylalanine clearance [6] in the body.
The second route identified for metabolism is transamination into phenylpyruvate, which
is then metabolised into other compounds. Other metabolic routes exist, but these are
considered to be negligible in comparison to hydroxylation and transamination [10].
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Figure 1-2: Metabolic pathways of phenylalanine. Route 1 represents hydroxylation of
phenylalanine into tyrosine and responsible for approximately 75% of phenylalanine clear-
ance in the body. Route 2 represents transamination into phenylpyruvate which is another
important metabolic process, especially in patients with phenylketonuria. Taken from [10].
Removal of phenylalanine from the body also occurs via the formation of muscle. Correspond-
ingly, muscle degradation can also generate phenylalanine. Typically serum phenylalanine
concentration in a healthy patient in a fasting state is between 0.057-0.060mM [10], and is
expected to be higher than this if food intake is considered [11].
1.2 Amino Acid Disorders
Amino acids, such as phenylalanine, are very important in biological processes [3]. Metabolism
is a key process in biological systems either involved in building up new compounds, an-
abolism, or breaking down organic matter, catabolism. Enzymes are proteins that catalyse
metabolic reactions with almost all metabolic processes in the body requiring enzymes to
achieve rates fast enough to sustain life [12].
Modern biochemical genetics has shown how proteins with specific structural and metabolic
properties are synthesised from genetic information [13]. Genetic information is stored in
chromosomes in cell nuclei encoded in DNA. Mutations in DNA can alter the structure of
a protein which can have several effects on the protein formed. The exact effect can vary
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from affecting the function of the protein to the rate of synthesis depending upon the part of
the protein effected [13]. In enzymes, this can lead to reduced metabolism of an amino acid
which, depending on severity, can cause a variety of medical complications [13].
We consider the most frequent of amino acid disorders, phenylketonuria, which inhibits the
metabolism of phenylalanine.
1.2.1 Phenylketonuria (PKU)
Phenylketonuria (PKU) is the most frequent of inherited amino acid disorders and affects 1
in 10,000 people [14]. This particular disorder affects the PAH enzyme, limiting its ability
to metabolise phenylalanine and, depending on the severity of the condition, can lead to
a significant increase in blood serum concentration of phenylalanine. This is a problem as
phenylalanine is transported from the blood into the brain along with other large, neutral
amino acids (LNAAs) via LNAA type 1 transporter [15]. Phenylalanine has the highest
binding affinity to this transporter, thus will be selected for transport preferentially over
other compounds [15]. Hence, higher levels of phenylalanine increasingly limits the transport
of other LNAAs transported into the brain via LNAA type 1 transporter. Limiting the
transport of these compounds causes a decrease in cerebral protein synthesis (CPS) which
has been shown to be very important in cognitive development [15].
In short, phenylketonuria can cause mental health problems ranging from severe retardation
to minor IQ loss [15], hence it is important to begin treatment of this condition as soon as
possible. Due to this, in combination with its prevalence, phenylketonuria is tested for about
a week after birth via a blood test with the sample taken from the heel of the foot [16].
Phenylalanine levels and the ratio of phenylalanine/tyrosine are tested using this sample
and PKU is diagnosed if systemic levels of phenylalanine are above 0.12-0.13mM with a
phenylalanine:tyrosine ratio of 2 or greater [16].
One of the considerations while doing this test is that 2% of positive PKU tests are a result
of a BH4 metabolism disorder, which needs to be treated very differently from PKU. For this
reason, PKU confirmation tests are done after the initial blood sample [16].
Once PKU has been identified, phenylalanine levels are then monitored at intervals through-
out the patient’s life. Phenylalanine levels are also monitored closely in pregnant women as
elevated phenylalanine levels in the mother can damage the unborn child [8].
The severity of the condition can be identified via a tolerance test, which is repeated through-
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out childhood to get progressive measurements. This classification provides guidelines to the
amount of phenylalanine that should be in the patients diet. These different classifications
are detailed below and are relative to the bodyweight of the patient [16].
Classical PKU Phenylalanine tolerance less than 20mg/kg/day.
Moderate PKU Phenylalanine tolerance of 20-25mg/kg/day.
Mild PKU Phenylalanine tolerance of 25-50mg/kg/day.
Mild hyperphenylanemia (HPA) Phenylalanine tolerance of greater than 50mg/kg/day.
In this case a special diet is not required.
There has also been work into classifying PKU based on the results of genetic tests. Currently
over 500 different PAH mutations have been identified [16] and several databases exist which
predict the type of PKU a patient has based on their genotype combination. In this, different
allele mutations are given a mutation score of 1, 2, 4 or 8, with 1 being a severely inhibiting
mutation and 8 being a mildly inhibiting mutation [16]. The scores for the two relevant alleles
are then added together to give the assigned phenotypic effect of mutant PAH alleles score
(AV score) which can then be used to predict the severity of PKU [16].
There are some discrepancies in the genetic method, making tolerance tests still important
[17]. Additionally, recent papers have suggested that tolerance for adult patients is affected
by BMI and gender. A higher BMI results in a lower phenylalanine tolerance and women
typically have a lower tolerance than men [17]. This difference is likely due to BMI affecting
the volume of distribution for phenylalanine. Phenylalanine is hydrophilic [9] and hence
distributes itself throughout total body water. Total body water is normally considered to be
about 57% in a man at ideal body weight, but can decrease significantly, as low as 45%, with
higher BMIs. However, the reduction in tolerance has only been tested on a very small scale
[17], so follow up needs to be investigated before the effect of this result on phenylalanine
tolerance can be confirmed.
1.3 The Clinical Problem
Patients with amino acid disorders often have serum concentrations monitored via blood
samples which is an invasive procedure [10]. Invasive procedures have several drawbacks such
as risk of infection, patient discomfort and the requirement for trained personnel to administer
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[18]. Finding a non-invasive method, such as transdermal extraction, would eliminate all of
these problems and allow tests to be administered more conveniently.
Due to the prevalence of amino acid disorders, especially PKU, there has been research into
finding blood serum concentrations of amino acids, like phenylalanine, via transdermal extrac-
tion [1, 2]. In vivo research has indicated that there is a significant reservoir of phenylalanine
in the epidermis which takes over 4 hours to completely clear before systemic levels can be
measured [1]. This is due to phenylalanine being formed in the skin as part of the natural
moisturising factor (NMF) which is discussed in more detail in section 1.4.2. Mathematically
modelling how this skin reservoir is formed and extracted based on historic systemic levels
would potentially allow PKU severity to be assessed using a short sampling time on the skin.
The goal of this thesis is to attempt to form mathematical models for the formation and
extraction of skin reservoirs of amino acids using phenylalanine as a case study. In later
chapters we will extend the model to also consider other amino acids, such as tyrosine.
1.4 The Skin
Clearly, a critical element in transdermal extraction is the skin itself. In this section, we
detail the main properties of the skin, starting by considering the overall structure before
focusing on the epidermis as this layer is the main barrier to transport through the skin.
1.4.1 Overall structure
Although skin samples vary between patients and areas of the body - scalp skin has a greater
density of hair follicles than skin from the palm etc - the main features of the skin remain
the same. Figure 1-3 shows a cross section of human skin sub-divided into 3 distinct layers,
the epidermis, the dermis and subcutaneous tissue.
Subcutaneous tissue is a layer of fat and muscle that varies significantly between patients
and is primarily used for insulation from heat and shock [20].
The dermis is comprised of connective tissue between the subcutaneous tissue and the epider-
mis. The dermis is primarily concerned with regulating body temperature, supplying oxygen
and nutrients to the epidermis and removing toxins from the epidermis [18]. It is also helpful
in shielding the body from stress and strain [18].
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Figure 1-3: Cross section of human skin. Taken from [19].
The outermost layer is the epidermis which is comprised of several layers of keratinocytes
whose primary function is to provide a barrier between the body and invading pathogens
[18]. The outermost layer of the epidermis is called the stratum corneum and can range from
10-40µm thick in a brick and mortar type arrangement with keratinocytes in the final stage
of terminal differentiation, called cornoecytes, forming the bricks and a mixture of lipids
forming the mortar [18].
It has been previously shown that, due to this special architecture, for all but small, highly
lipophilic molecules, the stratum corneum is the rate-limiting layer for the transport of com-
pounds through the skin [21].
1.4.2 Epidermis
When examining chemical reservoirs in the stratum corneum, it is prudent to consider the
whole epidermis and the processes involved in forming the stratum corneum. This then allows
an understanding to be developed as to where these compounds come from. It is also worth
noting that there is no blood flow through the epidermis.
The structure of the epidermis is shown in Figure 1-4 [22]. The deepest layer is called the
stratum basale or basal layer and from here cells, known as keratinocytes, migrate upwards
through the layers undergoing a process called cornification [22] until they are eventually
shed from the surface of the skin by a process called desquamation [22]. The stratum basale
is a base layer of skin stem cells that generate other cells by asymmetric division [22]. The
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new cells cease to divide and start moving towards the surface of the skin.
Figure 1-4: Cross section of human epidermis. Taken from [22].
From the stratum basale, cells enter the stratum spinosum or spinous layer. In this layer,
the keratinocytes become connected by desmosomes [22]. Desmosomes are cell structures
specialised for cell to cell adhesion [23] and connect the cells in the stratum spinosum together,
giving rise to the name spinuous layer as the cells appear to be spiky and connected via small
tendrils.
Above the stratum spinosum lies the stratum granulosum or granular layer in which ker-
atinocytes begin to lose their nuclei and intracellular lipids are released into the extracellular
space to start forming the lipid matrix between cells [22]. This lipid matrix makes the stra-
tum corneum quite impermeable and could potentially trap materials, limiting the transport
of compounds both into out and out of the body.
In this layer, cells also start to become more rigid with intermediate keratinocyte rods re-
inforcing the cell structure [24]. This process culminates in the stratum corneum with cells
becoming very rigid and developing a cornified envelope, making transport between cells and
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the intercellular space difficult. In this, cells remain tightly linked by corneodesmosomes
which are desmosomes integrated into the cornified layer around cells [22]. Water content in
this layer is also reduced significantly [24] which could lead to an increase in concentration
of other compounds.
In the stratum corneum, or cornified layer, not only do cells become more rigid with a
very impermeable lipid matrix, but the natural moisturising factor (NMF) is also formed.
This is due to decomposition of a protein called filaggrin and corneodesmosomes between
cells into smaller amino acids which form the NMF [2, 22]. These amino acids keep the skin
hydrated despite exposure to external conditions by drawing in moisture from the surrounding
environment.
One of the amino acids formed in the NMF is phenylalanine, which is part of the reason that
skin reservoirs of phenylalanine are larger than would normally be expected [2].
The upper layer of the stratum corneum is sometimes split into a separate layer called the
stratum disjunctum [25]. This is a partially detached layer of the stratum corneum about to
be removed via desquamation.
1.5 Physiologically Based Pharmacokinetic Modelling
Pharmacokinetics is a branch of pharmacy that studies the movement of compounds in the
body. Physiologically based pharmacokinetic modelling (PBPK) is a sub-branch of pharma-
cokinetics that utilises mathematical modelling techniques such as enzyme kinetics [26]. This
is commonly used to describe the exact progression of drugs, toxins, nutrients and hormones
between different body areas. The body areas are usually split into different compartments
with movement of compounds between these compartments based on factors such as lipholic-
ity, molecule size and charge. For example, a highly lipophilic molecule will be found in
higher concentrations in fatty tissues than non-fatty tissues.
A prime example of a use of PBPK modelling comes when considering digoxin, a drug used
to treat heart failure [27]. Digoxin has been used for over 200 years, yet digitalis poisoning,
which is caused by toxic build up of digoxin, remains one of the most common causes of drug-
related hospitalisation [27]. This problem is an example of one that can severely reduced by
the application of PBPK modelling, which can identify if a dose, or series of doses, will cause
a toxic build up in the body.
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When considering amino acid reservoirs in the skin, it will be necessary to consider movement
of amino acids from the blood to the inner layers of the skin, the epidermis, and then into
the stratum corneum. This will require consideration of PBPK techniques, especially when
dealing with metabolism of amino acids in the body.
1.6 Dermal Extraction Routes
Movement of compounds through the skin can occur via several routes as demonstrated in
Figure 1-5. These routes can be broadly split into [28]:
Intercellular route - Transport through torturous pathways through the lipid matrix sur-
rounding corneocytes.
Intracellular route - Transport via penetration alternating through corneocytes and lipid
matrix.
Transappendageal route - Transport via appendages such as hair follicles.
Figure 1-5: Diagram of extraction routes through the stratum corneum. (a) represents the
appendageal route, (b) the intracellular route and (c) the intercellular route. Modified from
[29].
It is generally accepted that, due to the cornified envelope around cells in the stratum
corneum, the main route of transport for all but small, hydrophilic molecules, like water,
is the intercellular pathway [30]. Due to appendages covering approximately 0.1% of the
total skin surface area, this route is generally considered to be insignificant in transdermal
penetration [31]. However, recent work using scanning electrochemical microscopy and laser
scanning confocal microscopy has suggested that the appendageal pathway dominates trans-
port through the skin [32].
Prior work into flow through the skin has identified an empirically derived ‘reflection factor’
which decreases the flux of larger molecules through the skin [33]. An alternative approach
16
is to use the Potts and Guy equation [34]
log10(kpcms
−1) = −6.36(±0.18)− 6.0(±0.6)x10−3MW + 0.74(±0.07)log10kOW ,
which expresses the permeability coefficient, kp, of a compound in terms of its molecular
weight, MW , and its octanol-water partition coefficient, kOW . Higher permeability coeffi-
cients correspond to more transport through the stratum corneum and, from the expression,
larger molecules therefore have less transport through the stratum corneum. The Potts and
Guy equation also links transport rates to the hydrophilic nature of the compound consid-
ered with more hydrophilic compounds, corresponding to a lower kOW , also having slower
transport through the stratum corneum.
Work into hindered transport through capillaries in membranes also suggests that the larger
a molecule is in comparison to the tube, the more restricted its flow through that capillary
is [35]. This concept is investigated in more detail in chapter 6, but again suggests that the
flow of large compounds will be restricted through small tubes.
1.7 Extraction Methods
This section briefly discusses passive diffusion and reverse iontophoresis through the skin.
These concepts are more fully explored in later chapters.
1.7.1 Passive Diffusion
The simplest skin transport mechanism is passive diffusion, the movement of substance from
an area of high concentration to one of lower concentration down a concentration gradient.
This allows compounds to be either extracted or inserted into the skin.
To extract compounds transdermally via passive diffusion, areas of skin are cleaned before
being put into contact with a buffer solution either by dipping the skin in, in the case of a
finger, or attaching a chamber to the skin. The concentration gradient of amino acids and
other compounds between the skin and the buffer causes movement of these compounds from
within the skin to the buffer, for extraction, or vice-versa, for delivery.
When considering passive diffusion path length is an important factor, especially as the skin
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has a very complex organisation, and has been previously considered in transdermal drug
delivery [23]. As mentioned in section 1.6, there are also several different routes through the
skin each with different diffusion rates and path lengths.
Although passive diffusion is cheap and easy to use, it does have some drawbacks such as
speed with prior research into the extraction of amino acids suggesting it takes several hours
for a steady state to be reached [1, 2]. These issues make methods to enhance the amount
transported a current area of interest in drug delivery and non-invasive skin sampling [21].
1.7.2 Reverse iontophoresis
Iontophoresis is a method of transdermal drug delivery that works via application of a small
electric current to the skin [21]. This method has been used since the early 20th century [36]
in order to treat certain disorders of the eye [37] and skin [38]. Iontophoresis is now used
for treatment of Parkinsons disease and migraine pain [39] as well as having applications in
paediatric medicine [18] as problems with invasive methods, highlighted in section 1.3, are
often magnified in young children.
More recently, iontophoresis has been applied in reverse in order to extract compounds
through the skin; this technique is called reverse iontophoresis. Reverse iontophoresis is
the subject of current research [21] due to its potential to monitor compounds in the body
non-invasively. The GlucoWatch used reverse iontophoresis to continuously monitor blood
glucose levels in patients with diabetes and was trialled in the USA in 2002 [40]. Unfortu-
nately, this product did not make it to widespread distribution due to costs.
Although iontophoresis and reverse iontophoresis are effectively the same process applied in
opposite directions, prior research has shown that the flow rate for compounds into the skin
can be different to that of compounds out of the skin under an applied current [33]. This is
due to the skin being electrically asymmetric.
Reverse iontophoresis works by applying two oppositely charged electrodes to the skin and
putting a constant DC current between them. This enhances the transport of compounds
through the skin by two means. Firstly, ions move towards the oppositely charged electrode,
called electro-migration, and, secondly, bulk solvent flow through the skin carries both ions
and uncharged compounds through the skin, electro-osmosis. Under physiological conditions,
electro-osmosis occurs towards the cathode. Both mechanisms are well documented transport
phenomena [21, 33, 32, 41] and are displayed in Figure 1-6 [21].
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Figure 1-6: Reverse iontophoresis in diagrammatic form. Route (1) represents passive diffu-
sion which occurs in equal amounts to each compartment. Route (2) represents electro-
migration with positively charge compounds going towards the cathode and negatively
charged compounds towards the anode. Route (3) shows electro-migration into the cath-
ode compartment. Taken from [21].
In the case of phenylalanine, which is an uncharged molecule, we primarily focus on electro-
osmotic flow. Experimental work has also shown that phenylalanine is mostly collected in
the cathode compartment as would be expected from electro-osmotic flow [2].The role of
electro-osmostic flow in transdermal iontophoresis has been previously investigated [33].
1.8 Thesis Structure
The aim of this thesis is to model the skin and systemic disposition of amino acids and
investigate the potential for these compounds to be monitored via transdermal extraction
methods using phenylalanine as a case study. The thesis starts by introducing the core
mathematical techniques used through the thesis before moving on to model phenylalanine
distribution through the body.
Chapter 2 details the key mathematical techniques used throughout the thesis including
methods to solve and analyse ordinary and partial differential equations. This section also
details propagation of error, parameter estimation and Bessel functions.
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Chapters 3 to 6 each follow a similar structure. Firstly, the objective of the chapter is
introduced and a breakdown of key parameters is given as a reference for the rest of the
chapter. Having done this, key background concepts for the chapter will be introduced
before moving on to form appropriate models for that section and analyse them. Each of
these chapters is then completed with a summary.
Chapter 3 considers phenylalanine concentrations in the blood. Firstly prior serum models for
phenylalanine are assessed before presenting several new approaches for the systemic profile
of phenylalanine. A final model for use throughout the report is then chosen from these. This
chapter also considers the effect of food intake on serum concentrations of phenylalanine.
Chapter 4 moves on to consider time-dependent profiles of phenylalanine through the stratum
corneum based on the profiles found in chapter 3 in order to get an idea of the effect of blood
concentrations on the skin reservoir. Parameter estimations are obtained using in vivo data
[2].
Electro-osmotic flow is a complex topic which is critical to understanding the extraction of un-
charged compounds from the skin. Hence, chapter 5 gives detailed theory into electro-osmotic
flow dynamics using the Navier-Stokes equations, surface chemistry and micro-capillary the-
ories. This chapter aims to find the electro-osmotic flow velocity during reverse iontophoresis
in terms of known properties of the system.
Chapter 6 builds on the work presented in chapter 5 and forms a time-dependent system for
extraction of uncharged compounds from the skin using both passive diffusion and reverse
iontophoresis. Extraction is considered to occur through hair follicles and the intercellular
space separately. Results from in vitro extraction of mannitol [42, 43] are used to estimate
parameters such as the surface of the skin covered by pores. These results are then analysed
and the model changed accordingly to incorporate hindrance effects. Other potential changes,
including changes in skin resistance under an applied electric field, are also considered.
The final chapter then summarises the results presented in the thesis and suggests further
experimental work to validate the model structures presented and giving possible methods




In order to model the formation and extraction of chemical reservoirs from the skin, a variety
of mathematical techniques are used to analyse ordinary and partial differential equations,
estimate parameters and calculate error in calculated parameters. The objective of this
chapter is to detail these methods for use in later chapters and introduce the concept of
Bessel functions.
2.1 Steady State Analysis
2.1.1 Stability
For the n-dimensional system
dx
dt
= f(x) x ∈ Rn, f ∈ Rn, t ∈ R, n ∈ N,
the steady state, x∗ such that f(x∗) = 0, is said to be asymptotically stable if there exists
some ² > 0 such that if ||x(0)− x∗|| < ² then x(t) → x∗ as t → ∞. This occurs if all







i, j = 1, ..., n,
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where eigenvalues are roots of the characteristic polynomial
det|J − λI| = 0,
have negative real parts.
2.1.2 Resilience
Resilience measures the asymptotic rate of return to a stable steady state, or the asymptotic
rate of departure from an unstable steady state, after a small perturbation [44]. There are
several different methods for measuring resilience with the most frequently used being based
on the eigenvalues of the system near the steady state considered. In line with the problems
encountered in this thesis, we consider the case where eigenvalues are real and distinct. For
this case, consider the linear system/the linearisation of a non-linear system near the steady
state where J ∈ Rnxn, x ∈ Rn, n ∈ N and t ∈ R:
dx
dt
= Jx x(0) = x0. (2.1)
This system has an exact solution given by
x = x0eJt,
or
x = c1eλ1tv1 + c2eλ2tv2 + c3eλ2tv3 + ..., (2.2)
where λ1,...,n are real and distinct eigenvalues of J with corresponding eigenvectors v1,...,n.
Assuming, without loss of generality, that λ1 has the largest real part of all eigenvalues, then
the return time to x∗ after a perturbation is dominated by this component. This can be
shown by rearranging equation (2.2):
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e−λ1tx = c1v1 + c2e(λ2−λ1)tv2 + c3e(λ3−λ1)tv3 + ... (2.3)
λ1 has the largest real part of all the eigenvalues of A, hence ∀k ≤ n, k ∈ N, k 6= 1, λk−λ1 < 0.




hence for large time, the system’s decay rate will be approximately equal to λ1 and x will be
proportional to v1[44].
Considering the decay rate at large t, the time taken for x to reduce by a factor of 1/e is
−1/Re(λ1) and is known as the return time. The resilience of the system is defined as the
reciprocal of the return time:
Resilience = −Re(λ1).
For the system to be stable, the real part of all eigenvalues must be less than zero, hence
if resilience is less than zero then the system is unstable [44]. The larger the resilience, the
faster the system returns to the steady state after a perturbation. For complex or repeated
eigenvalues, there are alternative methods for calculating resilience discussed in [45, 46].
Resilience is used to measure the long term effect of a perturbation on the system, but ignores
short term transient behaviour.
2.1.3 Reactivity
Reactivity is a measure of instability and used to investigate the behaviour of the system
immediately after a perturbation [44].
If a system is reactive, then some small perturbations from the equilibrium will initially grow
in magnitude. If the system is not reactive then no small perturbations from the steady state
will initially grow in magnitude. This is demonstrated graphically in Figure 2-1.
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Figure 2-1: Demonstration of the difference between a reactive and an unreactive function.
The system described by A1 is unreactive and tends immediately to the steady state, whereas
the system described by A2 is reactive and increases in magnitude before tending back to the
steady state. Both systems start after a perturbation from a stable equilibrium. Modified
from [44].
Reactivity is a transient behaviour in the system; it is possible for a system to be both reactive
and stable.
Reactivity is defined as the maximum amplification rate, over all initial perturbations, im-
mediately following the perturbation [44]. Like resilience, considering the linear system or
linearisation of a non linear system
dx
dt













which is the maximum proportional increase in the system state.
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The expression on the right hand side of equation (2.6) is known as the Rayleigh quotient
and the maximum value of this term over all possible initial conditions, x0, will give the
reactivity of the system [44]. By Rayleigh’s principle [47] this expression is maximised when
x0 is equal to the eigenvector, v1, corresponding to the largest eigenvalue of H(J), λ1(H(J)).












Hence, reactivity is determined by the largest eigenvalue of the Hermitian matrix of A. As
the Hermitian matrix is real and symmetric by definition, the eigenvalues of H(A) will be
real with orthogonal eigenvectors.
If reactivity is greater than zero, then the system will be reactive and some perturbations
will initially increase in magnitude with higher reactivities causing a more pronounced effect
[44]. If the reactivity is less than zero, the system is unreactive and an inital perturbation
from the steady state will not increase in magnitude.
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2.1.4 Amplification envelope
Reactivity quantifies the initial response of the system to a perturbation from the steady
state and resilience the long-term asymptotic response. In a resilient and reactive system,
neither property quantifies the behaviour of the system between the initial perturbation and
behaviour as t → ∞. This is normally quantified by considering the amplification envelope
[44] and from this the maximal possible amplification of the perturbation and how long this
takes to occur.
The amplification envelope, ρ(t), is defined as the maximum possible amplification at time
t ≥ 0 after a perturbation, x(0) = x0, to the asymptotically stable equilibrium at x = 0 to











which is the definition of the Euclidean norm of the exponential matrix, eJt.
From this definition of the amplification envelope, it is possible to find the largest possible
amplification of a perturbation, ρmax, and the time at which maximum amplification is




and tmax being the time, t, at which this maximum is achieved.
We used the MATLAB function ‘expm()’ to find the exponential matrix via the Pade´ ap-
proximation and ‘norm()’ to find the largest singular value of the resulting matrix and hence
the matrix norm following [44].
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2.2 Parameter estimation - Gauss-Newton Algorithm
In mathematical modelling, it is not uncommon for some parameters to be completely un-
known. Regression analysis is a branch of statistics that can estimate the value of unknown
parameters. As most of the parameter estimation problems in this thesis involve non-linear
regression, it is necessary to consider an iterative approximation method to find the best
parameter estimate. In this case, we consider the Gauss-Newton method [48] in order to
find parameters that minimise the sum of squares between the predicted results and the
experimentally obtained data.
In general, the Gauss-Newton algorithm [48] takes m functions, often called residuals, r =
(r1, r2, ..., rm) and n variables β = (β1, β2, ...βn) with n ≤ m and iteratively selects β to











, i ∈ [1,m], j ∈ [1, n]
the method proceeds to estimate β iteratively using
βs+1 = βs − (JTJ)−1JT r(βs), (2.9)
where s is the iteration number.
In this thesis, the Gauss-Newton algorithm is used to find parameters for input into a model
function y = f(x,β) that minimises the sum of squares to data points (xi, yi). To do this,
the residuals are selected to be [48]:













, i ∈ [1,m], j ∈ [1, n],
the iterative formula in equation (2.9) can be rewritten in terms of the Jacobian of f with
respect to β, Jf :
βs+1 = βs + (JTf Jf )
−1JTf r(β
s).
Over iterations, βs should tend to some limit, β∞, resulting in an approximation of the
unknown parameter set that minimises the sum of squares given in equation (2.8).
2.2.1 Goodness of Fit
Having obtained parameter estimates using the Gauss-Newton algorithm, it is then prudent
to consider the goodness of fit of the predicted data to real data. In linear regression, it is
common to use a coefficient of determination, R2, test to see how well the model fits experi-
mental data. Prior work has shown that this approach is not appropriate when considering
non-linear regression [49]. As this thesis mainly deals with non-linear regression problems,
alternative methods were considered.






where yi is the predicted measurement and fi is the corresponding expected measurement
at data point i. N is the number of measurements considered [50]. The standard error
represents the average distance at that observed values are from the predicted line. Hence,
the lower the standard error the better the model fits the predicted results.
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2.3 Propagation of Error
In biological systems, there is usually a significant amount of variation between individuals.
Hence parameters for biological systems are usually expressed as a value ± the standard
deviation based on the spread of results. If we have some parameter, y, which is linked to
other parameters, xi, i ∈ [1, n] by
y = f(x), x = (x1, x2, ..., xn),
where each xi has corresponding standard deviation σi and f(x) is a linear or non-linear
function. In order to find the standard deviation in the calculated parameter y, σy, we











A continuity equation describes the movement of some quantity, for example energy, mass or
charge, through a system. These equations can deal with both quantities that are conserved
and quantities that are not conserved in a system. These equations are very useful in math-
ematical modelling and see frequent application in fluid dynamics, population dynamics and
biological systems. The general form of a conservation equation is
∂C(x, y, z, t)
∂t














where C(x, y, z, t) is the concentration of interest based on position, (x, y, z), and time, t.
f(x, y, z, t) represents the rate of formation and decay of the quantity of interest in the
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system and J(x, y, z, t) represents the flux. If the quantity considered is conserved in the
system, then f(x, y, z, t) is equal to zero.
Selection of the flux changes the behaviour of the system. In the next two sections we consider
the selection of flux to represent a diffusion and advection-diffusion based system.
2.5 Diffusion Partial Differential Equation
Mathematically, diffusion can be derived from the continuity equation, given in section 2.4,
combined with Fick’s first law, which states that materials move from a high concentration
to a lower concentration with a magnitude proportional to the concentration gradient [52].
Considering Fick’s first law, the flux in a diffusion only system is given by
J(x, y, z, t) = −D(x, y, z, t)∇C(x, y, z, t), (2.12)
where D(x, y, z, t) is the diffusion coefficient. Hence, using equation (2.11), diffusion is mod-
elled via:
∂C(x, y, z, t)
∂t
−∇.(D(x, y, z, t)∇C(x, y, z, t)) = f(x, y, z, t).
Considering the quantity of interest to be conserved in the system, f(x, y, z, t) = 0, with
constant diffusion coefficients, D(x, y, z, t) = (Dx, Dy, Dz)T , in one spatial dimension, x, as







2.6 Advection-Diffusion Partial Differential Equation
Advection-diffusion equations are commonly found partial differential equations that describe
the distribution of physical quantities, such as particles or energy, in a system where diffu-
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sion and advection are occurring. Flux due to advection and diffusion is usually considered
to be additive with advection flux being directly proportional to the velocity of advection,
v(x, y, z, t). Considering the continuity equation in equation (2.11), the flux in a diffusion
system given in equation (2.12) and the flux due to advection results in:
J(x, y, z, t) = −D(x, y, z, t)∇C(x, y, z, t) + v(x, y, z, t)C(x, y, z, t). (2.13)
Combining equations (2.11) and (2.13) hence results in the advection-diffusion equation:
∂C(x, y, z, t)
∂t
−∇.(D(x, y, z, t)∇C(x, y, z, t)− v(x, y, z, t)C(x, y, z, t)) = f(x, y, z, t).
Considering v(x, y, z, t) and D(x, y, z, t) to be constant in x, y and z directions
v = (vx, vy, vz)T , (2.14)
D = (Dx, Dy, Dz)T , (2.15)
the advection-diffusion equation in 3 spatial dimensions can be written as
∂C(x, y, z, t)
∂t
+ v.∇C(x, y, z, t) = ∇.(D∇C(x, y, z, t)) + f(x, y, z, t), (2.16)









+ f(x, t). (2.17)
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2.6.1 Generalised Integral Transform Technique
The Generalised Integral Transform Technique (GITT) is a method of exactly solving ad-
vection diffusion equations [53] of the form given in equation (2.16) with non-homogeneous
boundary conditions and initial condition:
C(x, y, z, 0) = C0(x, y, z). (2.18)
The method presented in [53] solves these equations via a series of steps:
1. Homogenise the boundary conditions.
2. Reduce the advection-diffusion equation to a diffusion equation via substitution.
3. Implement the GITT to solve the resulting diffusion equation.
4. Transform back to find the analytical solution for the original equation.
Homogenising Boundary Conditions
In order to homogenise the boundary conditions, we consider the substitution for C(x, y, z, t)
C(x, y, z, t) =M(x, y, z, t) + F (x, y, z, t), (2.19)
where F (x, y, z, t) is any function that satisfies the original boundary conditions of C(x, y, z, t)
and M(x, y, z, t) is the new variable of interest. Using this substitution, equation (2.16)
becomes
∂M(x, y, z, t)
∂t
+ v.∇M(x, y, z, t) = ∇.(D∇M(x, y, z, t)) +G(x, y, z, t), (2.20)
where G(x, y, z, t) combines f(x, y, z, t) and all terms containing F (x, y, z, t). For simplicity
when considering time-independent boundary conditions, F (x, y, z, t) is normally taken as
the steady state solution to equation (2.16) and hence G(x, y, z, t) contains no terms related
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to F (x, y, z, t). The new initial condition for M(x, y, z, t) is given by:
M(x, y, z, 0) = C0(x, y, z)− F (x, y, z, 0).
The boundary conditions for equation (2.20) are homogeneous as F (x, y, z, t) satisfies the
boundary conditions on equation (2.16).
Reducing to Diffusion Equation
We now have a diffusion advection equation with homogeneous boundary conditions. The
next stage in finding an exact solution for C(x, y, z, t) is to reduce the problem to a diffusion
equation which can then be solved using GITT.
Consider the substitution
M(x, y, z, t) = θ(x, y, z, t) exp(p1x+ p2y + p3z + t(q1 + q2 + q3)), (2.21)
where pi, qi, i ∈ [1, 3] are currently undefined constants. Using (2.20) this substitution results
in:
∂θ(x, y, z, t)
∂t
+ θ(x, y, z) [(q1 + q2 + q3)
+ p1(−Dxp1 + vx) + p2(−Dyp2 + vy) + p3(−Dzp3 + vz)]
+ (−2Dxp1 + vx)∂θ(x, y, z, t)
∂x
−Dx∂
2θ(x, y, z, t)
∂x2
+ (−2Dyp2 + vy)∂θ(x, y, z, t)
∂y
−Dy ∂
2θ(x, y, z, t)
∂y2
+ (−2Dzp3 + vz)∂θ(x, y, z, t)
∂z
−Dz ∂
2θ(x, y, z, t)
∂z2
=
G(x, y, z, t)
exp(p1x+ p2y + p3z + t(q1 + q2 + q3))
.
(2.22)























which reduces equation (2.22) to
∂θ(x, y, z, t)
∂t
= ∇.(D∇θ(x, y, z, t)) + G(x, y, z, t)
exp(p1x+ p2y + p3z + t(q1 + q2 + q3))
, (2.23)
with initial condition on θ(x, y, z, t)
θ(x, y, z, 0) =
C0(x, y, z)− F (x, y, z, 0)
exp(p1x+ p2y + p3z)
, (2.24)
and homogeneous boundary conditions.
GITT
The original partial differential equation for C(x, y, z, t) has now been reduced to the diffusion
equation presented in equation (2.23) with homogeneous boundary conditions and initial
condition given in equation (2.24). In order to find an exact solution for C(x, y, z, t), we
solve the diffusion equation given in equation (2.23) using GITT to find an exact solution for
θ(x, y, z, t).
To implement the GITT method, we select an eigenvalue problem












and the same type of boundary conditions as those found for θ(x, y, z, t). Solving this eigen-
value problem yields non-trivial solutions for certain values, eigenvalues, of µ = µi, i ∈ [1,∞)
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with corresponding normalised, linearly independent eigenvectors ψi(x, y, z).
Using the orthogonality property of eigenvectors, the integral-transform pair for GITT over




ψi(x, y, z)θ(x, y, z, t)dV, (Transform)
θ(x, y, z, t) =
∞∑
i=1
ψi(x, y, z)θ¯i(t). (Inverse)
Applying this transformation to equation (2.23) reduces the partial differential equation to
an infinite series of decoupled ordinary differential equations of the form:
dθ¯i
dt







exp(p1x+ p2y + p3z + t(q1 + q2 + q3))
dV,
with initial conditions:




C0(x, y, z)− F (x, y, z, 0)
exp(p1x+ p2y + p3z)
dV.
Hence the solution for θ¯i(t)








and use the inverse transform to obtain:
θ(x, y, z, t) =
∞∑
i=1









Using equations (2.19) and (2.21), we know that
C(x, y, z, t) = θ(x, y, z, t) exp(p1x+ p2y + p3z + t(q1 + q2 + q3)) + F (x, y, z, t),





















+ F (x, y, z, t),
(2.26)
hence we have obtained the solution to the diffusion advection equation presented in equation
(2.16) with a spatially dependent initial condition and non-homogeneous boundary conditions.
Solution in 1D
Most advection-diffusion equations through the skin are considered to only vary in one spatial
dimension, x, in domain Ω. The GITT can be applied to a one-dimensional advection diffusion









= f(x, t). (2.27)
under non-homogeneous boundary conditions and initial condition:
C(x, 0) = C0(x).
Using GITT, the resulting solution is




















































and F (x, t) is any function that solves the boundary conditions of equation (2.27). Finally,
µi and ψi(x) are determined by the eigenvalue problem formed during the GITT.
2.6.2 Numerical Solutions
In some cases, obtaining an exact solution to an advection diffusion equation, or indeed
most systems represented by partial differential equations, is very complex. Examples of
situations where this occurs can include a spatial or time dependent velocity or a non-constant
diffusion coefficient. When this occurs numerical solutions are often used to view non-steady
state behaviour. This section briefly runs through the method of lines for solving systems
represented by partial differential equations with one spatial dimension, x, and one time
dimension, t, numerically.
The main aim of the method of lines is to replace the spatial derivatives in the partial
differential equation with algebraic approximations [54]. Doing this will reduce the partial
differential equation to a series of time-dependent ordinary differential equations which can
then be solved using numerical methods such as the Runge-Kutta method [54].
To apply the method of lines, the 1D space the problem is considered over, [a, b] a < b,
is split into a grid with n points and spacing between points h = (b−a)/n. We then define
ui(t) = C(a+ ih, t), i ∈ [1, ..., N ] to be the value of the variable of interest at each grid point.

























≈ ui+1 − 2ui + ui−1
h2
. (2.30)
Higher order terms can be found in the same manner. Applying the approximations given in
equations (2.29) and (2.30) to a partial differential equation system will reduce the partial
differential equation to a system of ordinary differential equations. By construction, u0 and
un+1 will be outside the defined range [a, b]. This problem is solved by considering the
boundary conditions present at x = a, corresponding to u0, and x = b, corresponding to
un+1. This method generally allows u0 and un+1 to be expressed in terms of known grid
points and constants.
2.7 Laplace Transform
If f(t) is fully defined and locally integrable over t ∈ [0,∞), then the Laplace transform of





One of the key reasons for considering the Laplace transform is that it transforms linear inte-
gral and ordinary differential equations into polynomial equations [55]. Polynomial equations
are usually easier to solve and the resulting solution to the original system can be found by
applying the inverse transform. The inverse Laplace transform is complex to apply hence,
in practice, it is more convenient to decompose the function being inverse transformed into
functions with known inverse transforms. The inverse transform is then found by inspection
[55].
In the case of partial differential equations in one spatial dimension and time, applying
the Laplace transform can reduce the system to an ordinary differential equation, which is
generally easier to solve. The solution to the partial differential equation can then be obtained
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by inverse transforming the solution to the ordinary differential equation.
2.8 Bessel Functions







(x) + (x2 − n2)y(x) = 0, (2.32)
for arbitrary complex number n, also called the order of the function. Depending on the
properties of the initial condition, y(x = 0), and n, Bessel functions can have radically
different behaviour.
In this thesis, the Bessel functions encountered are modified Bessel functions of the first kind,







(x)− (x2 + n2)y(x) = 0, (2.33)
with no singularity at the origin, x = 0 [56]. Modified Bessel functions of the first kind are











where the contour integral encloses the origin and moves in an anticlockwise direction [56].
A sketch of the behaviour of these functions for the integers n = [0, 4] given in Figure 2-2
with In(x) → ∞ as x → ∞. Figure 2-3 considers In(x) exp(−x) over the same range of n.
From this, it is clear that In(x)/Im(x) → 1 as x→∞ for m,n ∈ N0.
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Figure 2-2: Behaviour of modified Bessel functions for x ∈ [0, 4].
2.9 Chapter Summary
This chapter has detailed several useful mathematical methods including steady state and
stability analysis, parameter estimation using the Gauss-Newton algorithm, propagation of
error, methods of evaluating advection diffusion equations and has defined Bessel functions.
These techniques will be used throughout the thesis. The next chapter moves on to consider
models of amino acids in the blood serum.
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Figure 2-3: Using the same line colours as Figure 2-2, this figure shows that modified Bessel




Systemic Profile of Phenylalanine
3.1 Chapter Objective
The objective of this chapter is to mathematically model the systemic distribution of phenylalanine
with food intake. To do this, we first consider the biological background for metabolism and
input of amino acids into the body before moving on to consider a fasting state model of
phenylalanine. Fasting state blood serum phenylalanine has been previously modelled as a
single compartment model [10] and does not consider that the metabolism of this compound
primarily occurs in the liver [57]. We consider both a single-compartment model and a two-
compartment model that includes the effect of liver only metabolism and compare the models
before incorporating food intake.
As art of the comparison between the single-compartment and two-compartment approach,
we consider resilience and reactivity, detailed in sections 2.1.2 and 2.1.3, in order to measure
the response of both systems to a perturbation. Differences in this behaviour may indicate
differences in system dynamics once food intake is introduced.
3.2 Parameter Summary
Table 3.1 summarises all the parameters and variables used in this chapter with their def-
initions and, where appropriate, values and standard deviations for reference through this
chapter. Due to the incredibly diverse nature of humans around the world, we consider a man
of average height at ideal body weight with a balanced diet to calculate phenylalanine dose
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into the body. Human diversity is considered later in this chapter. This table is designed to
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































When considering systemic disposition of amino acids, it is important to consider several
biological concepts. Firstly, one of the primary methods of removal of amino acids in the
body is via metabolism. Modelling metabolic processes, or enzyme kinetics, mathematically
has been researched extensively and we begin by considering this.
Many amino acids, like phenylalanine, are taken into the body via food intake, so the Bateman
function is then considered as a method of mathematically modelling the input of amino acids
into the body via food intake and how this then distributes through the body.
3.3.1 Enzyme Kinetics
Enzymes are large biological molecules whose sole purpose is to catalyse reactions [64]. En-
zyme kinetics deals with the rates of enzyme-catalysed reactions [64] and is important to
consider when trying to model phenylalanine concentrations in the body as metabolism of
phenylalanine into its metabolites is governed by enzymes.
The first general rate equation for reactions involving enzymes was developed by Henri in
1903 [64]. This method accounted for the rate of a reaction, v, being directly proportional
to the concentration of the reactant, referred to as substrate, but increasing in a non-linear
manner tending to a maximum rate as the concentration of substrate was increased.
The derivation of the Henri equation has several assumptions [64], namely that:
1. The enzyme is a catalyst, which means it remains unchanged after the reaction has
occurred.
2. The enzyme and substrate react rapidly to form an enzyme substrate complex.
3. Only a single substrate and single enzyme-substrate complex are involved and these
break down directly into one product and one enzyme.
4. The reaction from enzyme + substrate into enzyme-substrate complex is at equilibrium,
this is called the quasi-equilibrium assumption.
5. The substrate concentration is much greater than that of the enzyme, hence formation
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of the enzyme-substrate complex does not affect the substrate concentration.
6. The rate limiting part of the reaction is the breakdown of the enzyme-substrate complex
into enzyme and product.
7. The reverse reaction is considered to be insignificant.
These assumptions result in the chemical equation given in equation (3.1). In this, the
enzyme, E, and substrate, S, combine at rate k1 to form an enzyme substrate complex, ES,
which then either dissociates at rate k−1 back into enzyme and substrate, or reacts at rate






k2−→ E + Pr (3.1)
By consideration of the law of mass action and using the quasi-steady state assumption, it is





In the Michaelis-Menten equation, the rate of reaction, v, is given in terms of the maximum
rate of reaction, Vm, the concentration of the substrate, [S], and the dissociation constant
of the enzyme-substrate complex, KS , which is related to the rate of reactions given in the








This approach was used to consider the transamination pathway for phenylalanine metabolism
in the body. The metabolic pathways of phenylalanine are shown in section 1.1.1.
The Michaelis-Menten equation is a fundamental part of enzyme kinetics and the method of
formulating this equation can also be used to consider more complex problems.
Previous research has modelled the metabolism of phenylalanine into tyrosine via hydroxyla-
tion using a two-site ordered binding model [10, 64]. The base reaction for a two-site ordered
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binding model is shown in equation (3.2).
E + S
Ka
À SE + S
Km
À SES kp−→ E + Pr (3.2)
In this equation the dissociation constant of activation is given as Ka and the dissociation
constant of the substrate-catalytic site complex, SES, is given by Km. The two stage process
in equation (3.2) represents activation of the enzyme by the substrate by having one molecule
of the substrate bind to the enzyme first, which then produces a complex that acts as a
catalyst for the substrate to product reaction.
Using the same method as before [64], it can then be shown that
v =
Vm




which is used to show the rate of reaction in a two-site ordered binding model.
3.3.2 Bateman Model for Food Intake
The Bateman function has been previously used to model food absorption from the stomach
to systemic circulation [11]. It represents food intake, neglecting any clearance or metabolic
effects in the body. Considering a dose of amount a into the stomach, we assume that
1. Rate of uptake to the systemic circulation, k3, is constant over time, t.
2. The only removal of the compound from the stomach is into the systemic circulation.
3. The compound instantaneously distributes evenly throughout the volume of distribu-
tion, V , which in the case of phenylalanine is total body water.


































Figure 3-1: Behaviour of a Bateman function modelling the absorption of a single dose from
the stomach to the blood with the dose given at time zero.


















where N is the number of doses and H(t) is the Heaviside step function. The first dose is
considered to be at t = 0. Figure 3-2 shows the time dependent solution to the multiple dose
case for a fixed dose applied at three evenly spaced intervals.
Total body water
The Bateman function highlights the importance of volume of distribution in understanding
drug concentrations in the body. As discussed in section 1.1.1, phenylalanine is hydrophilic
and hence distributes itself throughout total body water (TBW) [11]. TBW percentage varies




















Figure 3-2: Expected behaviour of a sum of Bateman functions modelling the absorption of
three doses of equal amount and spacing from the stomach to the blood with the first dose
given at time zero.
has an estimated TBW percentage of 57% [59].
Obesity can reduce TBW percentage to as low as 45% [17]. Tolerance to phenylalanine is
measured in mg/kg of total body weight. As a consequence a large increase in weight from
a patient suffering from PKU would increase their bodyweight, but decrease their tolerance
relative to their bodyweight as their volume of distribution does not increase proportionately
to total weight [17]. Due to this, significant changes in a patient’s physiology can change the
treatment needed to manage a chronic illness. This suggests that phenylalanine tolerance
should be regularly assessed and should not rely on childhood data.
Blood composition
Blood circulates oxygen and other nutrients through the body as well as removing waste
compounds such as carbon dioxide. Blood is comprised of a yellowish liquid called plasma,
55% by volume, in which billions of cells are suspended [59]. Plasma is approximately 92%
water with the other 8% comprising a variety of substances vital to the body including the
clotting protein fibrinogen [59]. Blood serum is the blood plasma without fibrinogen and is
approximately 90% water by volume [59].
In a fasting state, blood serum concentration of phenylalanine is between 0.055-0.060mM in
a normal person, increasing in excess of 1.2mM in a patient with classical PKU [10].
51
3.3.3 The Human Body
The human body and dietary intake of phenylalanine is important to consider when calcu-
lating the increase in concentration of phenylalanine in blood serum.
Considering a range of prior studies amalgamated in [65] it is clear that body weight, height
and body mass index vary significantly between countries, ethnic backgrounds, gender and
age. Considering a trial person as a man at average height for the UK, 177.8cm [61], at ideal
body weight, calculated using the Miller Formula to be 70.5kg [62], resulting in a total body
water volume of 40L. Considering a balanced diet results in a daily phenylalanine intake of
approximately 137mg of phenylalanine per kg of body weight [58].
Variations in body weight and phenylalanine intake only contribute to serum concentration
in a non-fasting state. When considering the non-fasting state, we begin by considering this
trial person and then expand the results to consider a range.
3.3.4 Phenylalanine in Skeletal Muscle
In the human body, a major store of phenylalanine is in skeletal muscle [10, 66]. Hence
formation of this muscle removes phenylalanine from systemic circulation and its breakdown
releases phenylalanine back into systemic circulation [10].
In a fasting state, muscular breakdown in the body exceeds formation. This leads to the
release of phenylalanine into systemic circulation which has been previously considered to be
at a constant rate calculated from phenylalanine present in skeletal muscle [10].
3.4 Fasting State Model for Phenylalanine
A loading test in a pharmaceutical sense involves giving a patient a large dose of a compound
and observing the rate of decay of this compound over a period of time. PKU has been
previously identified and classified via loading tests of patients in a fasting state [16]. A
fasting state is used as phenylalanine is present in lots of foods, hence eating during the
loading test would introduce more phenylalanine into the system making it harder to classify
PKU. It has been previously suggested that the only significant factors that replenish the
plasma pool of phenylalanine are food intake and the breakdown of proteins in the body [10].
In a fasting state, delivery of phenylalanine via food intake can be ignored hence the only
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method of intake is via natural protein degradation.
In this section, we consider modelling phenylalanine concentration in a fasting state. First,
a single compartment model from previous literature [10] is considered before splitting this
model into two compartments to more realistically model the metabolism of phenylalanine
in the body as metabolism of this compound primarily occurs in the liver [67]. These two
models are then compared.
3.4.1 Single compartment model
Several mathematical models have been developed to explore underlying processes that im-
pact on systemic phenylalanine levels [10, 11]. The model presented in [10] considers systemic
phenylalanine levels of a patient in a fasting state via a single compartment model with rate
of change of phenylalanine concentration, P (t), in the blood given as a sum of the rate of
hydroxylation, vPAH , transamination, vTRANS , and natural protein degradation, vNPD:
dP
dt
= −vPAH − vTRANS + vNPD.
Hydroxylation is assumed to follow a two-site ordered binding process [10], transamination
a single site binding process and natural protein degradation is assumed to be at a constant












+ vNPD = f(P ), (3.3)
where constants are defined in table 3.2 and include parameter estimates based on experi-
mental work published for non-PKU suffering patients [10]. Based on the constants in table
3.2, P is in mM and t is in hours.
The concentrations predicted from this model, including steady state and half life, were
found to be comparable to experimental data [10]. PKU suffering patients were investigated
by changing V Pm , effectively limiting the maximum rate of phenylalanine metabolism in the
body. The result of this over a ten hour period is shown in Figure 3-3.
Consideration of the B route in Figure 3-3 also showed that transamination has a very small
effect compared to hydroxylation. However, as shown by case D and previous research [9], the
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Table 3.2: Table of constants in systemic phenylalanine model obtained from [10]. Standard
deviation is given for KT but was not available for other parameters.
Constant Symbol Value
Maximum rate of hydroxylation V Pm 0.90mMh
-1
Maximum rate of transamination V Tm 0.063mM
-1h-1
Natural protein degradation vNPD 0.012mM-1h-1
Kinetic constant for PAH activation Ka 0.54mM
Dissociation constant for PAH Km 0.51mM
Dissociation constant for transamination KT 1.37±0.14mM
Figure 3-3: Model for blood phenylalanine levels over a 10 hour period. A represents a healthy
patient, B represents the effect of removing the transamination pathway, C represents a 50%
effective PAH enzyme and D represents a 0% effective PAH enzyme. Taken from [10].
transamination pathway is important in patients with classic PKU and needs to be considered
in tests that measure phenylalanine levels in response to treatments such as BH4 response
tests [9]. Beyond confirming the steady states were consistent with experimentally obtained
results, previous published work did not analyse the model in detail [10].
3.4.2 Analysis of the single compartment model
Figure 3-4 reproduces data from [10], shown in Figure 3-3, but additionally considers the
impact of activation of phenylalanine hydroxylase on phenylalanine concentrations. Without
activation, Ka = 0, the hydroxylation term in equation (3.3) reduces from a two-site ordered













Figure 3-4 shows that the effect of this is that stable levels of phenylalanine are significantly
lowered, which suggests that activation is an important component in phenylalanine dynam-
ics; in some previous studies it has been omitted [11].































Figure 3-4: Plot of blood phenylalanine levels over time in a fasting state. Initial
phenylalanine concentrations are set at 1mM to simulate a loading test and be in line with
the previous model [10]. The red line represents classical PKU, the green line moderate PKU,
the blue line a normal person, the black line a normal person with no transamination pathway
and purple the effect of the activation term in the activity of PAH.
Steady state analysis of equation (3.3)
Under physiological conditions, all parameters and variables given in equation (3.3) must be
greater than 0. Hence under physiological conditions:
f ′(P ) = − V
P
mPKm (P + 2Ka)
2




2 < 0. (3.5)
As f ′(P ) < 0, this means that f(P ) is a decreasing function on [0,∞) with f(0) = vNPD > 0
and f(P )→ vNPD − V Tm − V Pm as P →∞.
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Hence equation (3.3) has a globally asymptotically stable positive steady state P ∗ if V Tm +
V Pm > vNPD, which is biologically realistic regardless of severity of PKU, while f(P ) > 0 and
P (t)→∞ as t→∞ if V Tm + V Pm < vNPD, which is not.
In order to find the globally asymptotic steady state, we consider











which can be re-arranged to create the cubic
α1P
∗3 + β1P ∗2 + γ1P ∗ + δ1 = 0, (3.6)
with coefficients:
α1 = vNPD − V Pm − V Tm ,
β1 = [Km +KT ]vNPD −KTV Pm −KmV Tm ,
γ1 = [KmKT +KmKa]vNPD −KmKaV Tm ,
δ1 = KmKaKT vNPD > 0.


















∆0 = β21 − 3α1γ1,
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∆1 = 2β31 − 9α1β1γ1 + 27α21δ,
and


















with one positive steady state, P ∗1 , as expected. Figure 3-5 demonstrates that decreasing V Pm ,
corresponding to increasing severity of PKU, causes P ∗1 to increase, as expected.
In Figure 3-6 we show the dependence of P ∗1 on V Pm and vNPD with other parameters fixed
from table 3.2.
Beyond considering the existence and stability of the steady states in the model, it is also
interesting to examine the rate at which the steady state is approached and the nature of that
approach. To do this we employ the following measures: resilience which measures the rate
of return to the steady state following a small perturbation; and reactivity which measures
if the initial perturbation grows in magnitude. The methods for calculating these measures
are discussed in sections 2.1.2 and 2.1.3 respectively.
Resilience The single compartment model linearises using




= f ′(P ∗1 )p.
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Figure 3-5: Using the parameters for all but V Pm given in table 3.2, the effect of PKU on the
steady state P ∗1 is shown. Severity of PKU is represented by changing V Pm with more severe
cases being reflected by this parameter decreasing.
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Figure 3-6: The shaded area on the plot shows the conditions under which a positive, stable
steady state exists. For the parameters considered in table 3.2, all patients are in the shaded
area.
Hence, for the single compartment model:





(P ∗21 +KmP ∗1 +KmKa)2
+
V TmKT
(P ∗1 +KT )2
,
> 0 ∀P ∗1 ≥ 0. (3.7)
In Figure 3-7 we show how resilience depends upon V Pm . For low values of V
P
m , which corre-
spond to a severe PKU scenario, resilience increases non-linearly with V Pm as demonstrated
by Figure 3-8. The initial non-linearity is likely due to metabolism via transamination, rep-
resented by the transamination term in equation (3.7), dominating overall metabolism and
hence the return to the steady state at low values of V Pm . In the real world, this means that,
as patients with PKU have a lower V Pm compared to the rest of the population, patients with
PKU will take longer to return to a steady state concentration of phenylalanine after a per-
turbation than a normal patient. This is especially concerning when considering food intake
and raises the question as to whether it is better to have a large dose of phenylalanine once
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a day or a continuous infusion and whether this preference changes with severity of PKU.
Figure 3-7: Graph showing the effect of V Pm on the resilience of the fasting state model. The
dotted line represents V Pm in a non-PKU suffering patient.
Figure 3-9 considers the rate of change of resilience with respect to V Pm ,
∂R/∂V Pm . As expected,
this function started with a non-linear increase with V Pm and tended to a constant as V
P
m →∞.
This would result in the non-linear to linear behaviour demonstrated by resilience in Figures
3-7 and 3-8.
Figure 3-9 also suggests that a small increase in V Pm close to 0 can have a large effect on
resilience. Hence strategies to improve V Pm by a small amount in PKU suffering patients
would be very effective.
Reactivity For a single compartment model,
Reactivity = −Resilience < 0,
and we will not observe a reactive system. This means that any small perturbation from the
steady state will return to that steady state monotonically.
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Figure 3-8: Zoomed in version of figure 3-7 to demonstrate the initial non-linearity. The
black line on the plot is linear for comparison.




In the single-compartment model, metabolism is considered to happen throughout the whole
blood serum compartment [10, 11]. In reality it has been shown that metabolism of phenylalanine
in humans occurs primarily in the liver [67] and so we extend the model to a two compartment
structure.
We split the single compartment model into systemic, where no metabolism occurs, and liver
compartments, where metabolism occurs, and compare the behaviour of this to the single
compartment model.
Model formation
Figure 3-10: Two compartment model diagram.
We split the body into two compartments, the systemic and liver compartment, as shown in
Figure 3-10. The systemic compartment has concentration of phenylalanine, PS(t), over a
fixed volume, VS , with intake via natural protein degradation at rate vNPD, influx from the
liver compartment at rate kOUT and outflow into the liver compartment at rate kIN .
The liver compartment has a concentration of phenylalanine, Pl(t), over a fixed volume, Vl,
with intake via natural protein degradation at rate vNPD, influx from the systemic compart-
ment at rate kIN and outflow into the systemic compartment at rate kOUT . Metabolism of
phenylalanine occurs in the liver via hydroxylation and transamination. The mechanisms
for transamination and hydroxylation are the same in both the one compartment and two
compartment models using adjusted model parameters described below.
Using the conservation principle, the rate of change of amount of phenylalanine in the sys-
temic, AS(t), and liver compartment, Al(t), with respect to time under constant volume
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assumption for both compartments is given by
dAs
dt
= −kINAS + kOUTAl + vNPDVS ,
dAl
dt









As the volumes of both compartments are assumed to be constant, this results in the following
system of differential equations for concentration of phenylalanine
dPs
dt























Most of the parameters for this model were found exactly from previous literature or adapted
from the one compartment systemic model.
Firstly, the dissociation constants of hydroxylation and transamination metabolism are prop-
erties of the enzyme and the same for both the one compartment and two compartment
model[10], hence:
Kml = Km = 0.51mM, Kal = Ka = 0.54mM, KTl = KT = 1.37± 0.14mM.
It is known that the average adult has 4.85±0.15L of blood in the body [59] of which 55% is
serum [59], hence there is 2.67±0.08L of serum in the body. As phenylalanine is measured in
blood serum this means that:
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VS + Vl = 2670± 80ml.
It is also known that, on average, the liver contains 12.5% [60] of the blood in the body, hence
VS = 2336.25± 66ml, Vl = 333.75± 10ml and α−1 = 7.
Blood flow into the liver is equal to blood flow out of the liver and is known to be 9.9±0.9x104mlh-1
[63]. Rate of influx and outflow of phenylalanine concentration in the liver was calculated









As natural protein degradation occurs in both compartments, vNPD remains unchanged from
the one compartment model at 0.012mMh-1. Published values for V Pm and V
T
m are obtained by
considering the initial rate of metabolism after a loading test based on metabolism occurring
throughout systemic circulation. When considering metabolism to occur in the liver, we











Using the volumes obtained earlier in the section, the maximum rate of metabolism for
hydroxylation and transamination in the liver compartment are 8 times higher than in the
single compartment model
V Tml = 0.504± 0.018mMh−1 and V Pml ∈ [0, 7.2]mMh−1,
where V Pml depends on the severity of PKU.
Using these parameters, the model behaviour for non-PKU, moderate PKU and classic PKU
patients is shown in Figure 3-11 for the two compartment model. This shows that both the
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systemic and liver concentrations decrease over time towards a steady state. The rate of
decrease is lower in patients with severe PKU compared to those without PKU. The systemic
and the liver compartment have very similar concentrations in each case with the systemic
concentration being slightly higher than the liver throughout.




































Figure 3-11: Two compartment model for blood serum phenylalanine concentration using
parameters obtained from the literature or adapted from the one compartment model.
Steady state analysis
At steady state, equations (3.8) and (3.9) become:
0 = −kINPS + αkOUTPl + vNPD (3.10)




















































vNPD − V Pml − V Tmaxl ,
β2 = (Kml +KTl)
(α+ 1)
α
vNPD −KTlV Pml −KmlV Tml ,
γ2 = (KmlKTl +KmlKal)
(α+ 1)
α





As with the single compartment model, since δ2 > 0 and provided α2 < 0, at least one
positive non-trivial steady state exists for Pl with:




Moreover, h(Pl) is monotonically decreasing for Pl ≥ 0 since:
h′(Pl) = −
V PmlPlKml(Pl + 2Kal)









Since h(0) > 0 and given that h(Pl) is monotonically decreasing for Pl ≥ 0, as all parameters
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in h′(Pl) are positive. This means that h′(Pl) < 0 ∀Pl ≥ 0. Considering that h(Pl) is



















vNPD − V Plml − V Tml
)
.
Then provided, as in the single compartment case, vNPD < V Pm + V
T
m the single non-trivial
steady state exists. Figure 3-12 demonstrates this behaviour using the parameters obtained
in section 3.4.3 for a normal patient.
Figure 3-12: Rate of change of Pl against Pl. One crossing point exists showing the location
of the steady state.
Using the parameters given in section 3.4.3 for a normal patient only one physiologically

















with the liver concentration being slightly lower than the systemic concentration. The sys-
temic concentration is comparable to that obtained experimentally [10]. For a patient with
classic PKU, V Pml = 0, only one physiologically realistic steady state exists at P
∗
s ≈ P ∗l =
0.32mM, which is also comparable to experimentally obtained results [10].
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Stability of the steady state As the system is two-dimensional, we use the Routh-















(KmlP ∗l +2KmlKal)P ∗l
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)2 < 0 for Pl ≥ 0,
and
det(J) = kINkOUT + kIN
V TmlKTl(
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)2 > 0 for Pl ≥ 0.
Hence the steady state is locally stable.
Resilience Resilience in the two compartment model is determined using the characteristic
equation
0 = det(J − λI),
= λ2 + β3λ+ γ3,
where J is the Jacobian matrix, λ is an eigenvalue with constants:
68
β3 = −trJ > 0,
γ3 = detJ > 0.
Resilience is defined by considering the eigenvalue of J with the largest real part, λ1(J). In
Figure 3-13 shows the resilience over the normally found range of V Pml .




patient without PKU is 7.2µmolml-1h-1.
The behaviour of resilience suggests that patients with classic PKU, corresponding to very
low V Pml , take longer to reach the steady state after a perturbation than normal patients.
This behaviour is the same as the single compartment model.
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with eigenvalues given by the characteristic equation
λ2 + β4λ+ γ4 = 0,
where
β4 = kIN + kOUT +
V TmlKTl(
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Figure 3-14 shows how these eigenvalues vary with V Pml and indicate that the two compartment
model is not reactive as the largest eigenvalue of the Hermitian matrix is negative.
Figure 3-14: Reactivity, calculated by considering the largest eigenvalue of the Hermitian
matrix of J .
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3.4.4 Comparison of the one and two compartment systemic model
The derivation of the relationship between V Pm and V
P
ml
ensures that both the single com-
partment and two compartment approach attain equivalent steady states as show in Figures
3-15 and 3-16. Figure 3-15 also shows that the behaviour of both models under loading tests
produce similar decay patterns. This is likely due to the transport between the stomach and
the systemic system in the two compartment model being rapid and hence well mirrored by
the single compartment system.
Both models also have the same conditions for a steady state to exist, namely:
V Pm + V
T
m > vNPD.
However, there are some noticeable differences between these two models. In the single
compartment model, resilience is linearly related to V Pm at large times whereas the two com-
partment model tends asymptotically to a limit. This effect is only noticeable at large values
of V Pm and is similar for both models over physiologically realistic ranges, so is unlikely to
have a clinical effect. Over the range of V Pm found in humans with and without PKU, the
single compartment model has much higher resilience. This means that the single compart-
ment model will return to the steady state faster after a small perturbation. From a clinical
standpoint, this means that considering metabolism throughout the body, rather than in the
just the liver, may lead to the model predicting faster declines of systemic phenylalanine
concentration than are actually observed.
Reactivity is not observed in either the one or two-compartment models. Hence, neither
model predicts that any perturbation will initially increase in magnitude before returning
the steady state.
3.5 Intake of food into the systemic model
The models presented up until this point have only considered patients in a fasting state to
allow comparisons to loading tests. Since we are interested in build up and maintenance of
phenylalanine levels over time, we extend the work to consider regular food intake.
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Figure 3-15: Comparison between the one and two compartment models.






























Figure 3-16: Comparison between the one and two compartment models.
72
3.5.1 Previous food intake model using the Bateman function for food
intake
Previous work [11] considered blood serum phenylalanine levels in patients not in a fasting
state using the Bateman function for food intake from the stomach. The structure of this
model is shown in Figure 3-17.
Figure 3-17: Structure of a systemic phenylalanine model that includes food intake of 3 meals
per day. Adapted from [11] by removing the model label and changing the parameter labels
to be consistent with this work.
The resulting differential equation governing concentration of phenylalanine in the blood,







−k3t − k4P (t)− k5
c
,
where the dose is considered to be evenly distributed throughout total body water calculated
using body weight, b, multiplied by percentage water, c. First order rate constants were used
to model rate of resorption from the stomach, k3, and rate of phenylalanine conversion into
tyrosine, k4, with rate of protein synthesis, k5, considered as a zero-order term. This has
exact solution [11]:
P (t) = P0e−k4t +
ak3











A constant input rate from the stomach, ac, was also considered for multiple doses resulting







− k4P (t)− k5
c
.
The solution in both cases exhibits non-oscillatory behaviour increasing monotonically to the
steady state, and an increase in the steady state blood concentration compared to a fasting
state model.
The model presented in [11] was able to mimic data from a selection of classic PKU sufferers
and presented a good method for dealing with food intake throughout the day. Moreover, it
raised the need to consider protein synthesis in a non-fasting state model as well as confirming
that the volume of distribution for phenylalanine was over total body water.
However, the model did not include the transamination and hydroxylation pathway seper-
ately, and considered both as a single stage process, ignoring the activation behaviour of the
hydroxylation pathway.
3.5.2 Food intake systemic model - Single compartment
To model phenylalanine concentration in blood serum in a non-fasting state, the single com-
partment fasting state model in section 3.4.2 was extended to include food intake via a
Bateman function. This is displayed diagrammatically in Figure 3-18. The volume of distri-
bution for phenylalanine, V , was considered to be total body water volume. This resulted in
the modified model equation:
Figure 3-18: Structure of single compartment systemic phenylalanine model that includes
food intake. The stomach compartment is listed but the concentration not modelled. This
is similar to the model given in Figure 3-17 [11], but additionally includes the activation























To demonstrate the model behaviour we assume that 3 meals are consumed equally spaced
over 24 hours. The first order absorption rate from the stomach was k3 = 1h−1 [11].
As discussed in section 3.3.3, we consider a European man at average height and ideal body
weight [58, 61, 62] initially and then extend this to a range later in this chapter. For an
individual of 70.5kg we take TBW=40L, and assume that 137mg of phenylalanine per kg of
bodyweight is consumed at each meal, corresponding to a total 9612mg/day.
Figure 3-19 shows the model behaviour under these conditions using all other model param-
eters from table 3.2.

























Figure 3-19: Numerical solution of the single compartment systemic model with food intake
for patients with classic and no PKU.
Whilst a patient without PKU maintains stable phenylalanine concentrations within a small
window, [0.069, 0.182]mM, the PKU suffering patient has an unbounded increase in phenylalanine
concentration under these conditions.
This behaviour is supported by considering food intake at an average rate over time, 0.0558mMh-1
under the current diet, and evaluating equation (3.12) with the food intake term replaced
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+ vNPD + ac, (3.13)





= −V Pm − V Tm + vNPD + ac,
= −0− 0.063 + 0.012 + 0.0558 > 0,
indicating unbound growth. Unbound growth is unlikely to be observed in a realistic scenario
and this level of overdosing would lead to serious medical complications such as nerve damage
and seizures [68].
Recommendations propose that classic PKU sufferers should maintain intake below 20mgkg-1day-1,
equivalent to 8.12µMh-1. This intake gives rise to a positive steady state of 0.6428mM, and
is still far higher than that for fasting state patient behaviour. The difference between the
reduced diet behaviour and the normal diet behaviour in a PKU suffering patient is shown
in Figure 3-20.
3.5.3 Food intake model - Two compartment
Incorporating food intake into the two compartment model gives rise to the system:
dPs
dt


























The two-compartment system is also represented diagrammatically in Figure 3-21. VS repre-
sents the volume of distribution in serum, ie total body water volume, V , minus the volume
of blood in the liver, Vl. Figure 3-22 shows the time profile for phenylalanine concentration
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Figure 3-20: Effect of phenylalanine concentration on a rate of change of phenylalanine
concentration in a patient with PKU with normal and reduced phenylalanine intake. This
model uses equation (3.13).
Figure 3-21: Diagrammatic model of food intake in a two compartment model.
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using parameters given in table 3.1






























Figure 3-22: Numerical solution of the two compartment systemic model with food intake
for patients with classic and no PKU.
Using the two compartment model for food intake results in non-PKU suffering patients hav-
ing an phenylalanine concentration in the blood in the range [0.075mM, 0.255mM] with liver
concentration being just below this. Patients suffering from classic PKU have phenylalanine
concentration in both the blood and liver increasing unbounded, much like the single com-
partment model for food intake in section 3.5.2. Using the recommended dosage for a PKU
patient, the steady state for PKU suffering patients was found to be 0.598mM for the blood
and slightly lower for the liver.
The minima and maxima for the two compartment model for non-PKU patients is higher
than for the single compartment model and the steady state lower for patients suffering from
PKU under recommended food intake, although both show similar behaviour.
3.5.4 Varying food intake
Up until this point, food intake was considered based on a trial man at average height and
ideal bodyweight with a balanced diet resulting in a total body water volume of 40L and a
daily intake of 9658mg/day. This corresponds to an intake of 241 mg/L of total body water.
Figure 3-23 considers a range of intakes per L of total body water, namely 50, 150, 250 and
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350 mg/L, using the single compartment food intake model. This demonstrates that a greater
intake of phenylalanine per litre of total body water causes larger oscillations, as would be
expected. Figure 3-23 also demonstrates that lower phenylalanine intakes in patients with
PKU leads to a steady state being reached but this takes a very long time. Additionally, it
is worth noting that 50mg/L of bodyweight corresponds to 28mg/kg of bodyweight which is
just above the recommended maximum intake of 20mg/kg for a severe PKU suffering patient.
Figure 3-23: Numerical solution of the single compartment model for both PKU suffering
and non-PKU suffering patients under a variety of food intakes.
3.6 Chapter Summary
The objective of this chapter was to model the systemic distribution of phenylalanine in
the body for later input into a model for distribution of phenylalanine in the skin. Fasting
state and food intake models for both PKU suffering and non-PKU suffering patients were
considered as well as single compartment and multiple compartment approaches to the body.
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For the fasting state model, in line with prior work [10], phenylalanine was considered to
be generated via natural protein degradation at a constant rate and metabolised via two
pathways, transamination and hydroxylation. Hydroxylation is catalysed by phenylalanine
hydroxylase, the enzyme altered by PKU, and transamination is catalysed by phenylalanine
transaminase, which is unaffected by PKU. Prior work [10] considered the hydroxylation
pathway to operate via a two site ordered binding model in order to model the activation of
phenylalanine hydroxylase. We considered the effect of the activation term on the model and
found that it was significant when considering the dynamics of phenylalanine. Having done
this, we also considered the effect of the transamination route and showed that it was not
significant for normal patients, but became more significant with increasing severity of PKU.
Having investigated the terms in the fasting state model, the existence and behaviour of
steady states were considered. For a physiologically realistic stable steady state to exist the
creation of phenylalanine must be less than its removal, vNPD < V Pm +V
T
m , which, considering
realistic parameters, is true for all normal and PKU suffering patients and again demonstrates
the importance of the transamination term for severe PKU patients where V Pm → 0.
As we intended to add food intake into the model, resilience and reactivity of the fasting
state model was considered. This showed that a perturbation to the system at steady state
did not initially increase in magnitude, but returned monotonically to the steady state. The
rate of return was approximately linearly dependent on V Pm with higher V
P
m causing a faster
rate of return.
The final consideration for the fasting state model was to consider the effect of liver-only
metabolism on the system as phenylalanine hydroxylase is only active in the liver [67]. This
was modelled using a time dependent two-compartment approach. Both the one and two
compartment approach had almost identical behaviour in the fasting state under a loading
test and identical steady state conditions. Neither model demonstrated reactive behaviour.
Both the one and two compartment approach were considered when adding food intake. Food
intake was considered by adding a Bateman function to the systemic compartment in order
to compensate for movement of phenylalanine from the stomach to the blood [11]. For test
purposes, phenylalanine intake was initially based upon a UK male at average height and
bodyweight with a balanced diet [58, 61, 62] having 3 evenly spaced meals with equal doses
of phenylalanine. In this case, Figures 3-19 and 3-22 both show an unbounded increase in
serum phenylalanine concentration for PKU patients with food intake of 137mg/kg of body
weight per meal and oscillatory behaviour for non-PKU suffering patients.
Figure 3-23 considers a range of food intakes and, critically, shows that a controlled diet in
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patients with PKU does not cause an unbounded increase in serum phenylalanine concentra-
tions.
There is currently no experimental work measuring systemic phenylalanine concentration in
non-fasting patients to compare the results of either model to, hence it is difficult to say
which is most appropriate for use. The only visible difference between the one and two
compartment approach for the trial patient is the magnitude of oscillation under food intake.
The magnitude change is small, changing from 0.133mM to 0.188mM in the case of a normal
patient, hence we decide to use the one compartment model to model blood phenylalanine
concentration in later chapters as adding the additional complexity of the two compartment
does not make it much more accurate.
The model could be improved by investigating the effect of food intake on protein degra-
dation and synthesis, as this could change the value of vNPD. Previous work on modelling
phenylalanine in a non-fasting state [11] suggested that protein synthesis outweighed degra-
dation and caused an overall drop in systemic phenylalanine levels, rather than an increase in
the fasting state [10]. However, the non-fasting model selected parameters to fit a very spe-
cific set of data, so in order to get a better parameter prediction, consideration of background
theory into protein formation and catabolism is required.
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Chapter 4
Stratum Corneum Profile of
Phenylalanine
4.1 Chapter Objective
Based on the work into systemic concentration of amino acids, specifically phenylalanine, we
now consider the distribution of phenylalanine in the skin. The objective of this section will
be to produce a time and spatially dependent profile of phenylalanine in the skin based on
systemic concentration in a non-fasting state. We consider the effect that different systemic
levels have on phenylalanine concentration in the skin and if variation from food intake has
a noticeable effect on the skin reservoir.
In this chapter, we also investigate the effect of considering the stratum corneum to be
split into the stratum corneum and stratum disjunctum. The stratum disjunctum represents
layers of the stratum corneum that have started to separate from the lipid matrix. We test
the validity of the model by comparing the predictions to in vivo and in vitro data. We also
use the model to consider another, similar amino acid, tyrosine.
4.2 Parameter Summary
Table 4.1 summarises all the parameters and variables used in this chapter with their defi-
nitions and, where appropriate, values and ranges found in the literature. Where possible,
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standard deviations are used however this is not given for many parameters. Parameters listed






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Prior work has shown that the rate limiting step for movement of all but small, highly
lipophilic compounds through the skin is the stratum corneum [1, 2, 52]. Amino acids are
not small, highly lipophilic compounds hence the stratum corneum is the rate limiting barrier
to transport. In this section, we split the epidermis, described in section 1.4.2, into the viable
epidermis, stratum corneum and stratum disjunctum and investigate the structure of each
compartment including its unit cell, the packing fraction - the volume fraction occupied by
corneocytes - and the velocity of cell movement. As discussed in section 1.4.2, there is no
blood flow through the epidermis.
We also consider prior in vivo work into amino acid profiles through the stratum corneum.
4.3.1 Stratum Corneum
The stratum corneum is the outermost layer of the skin and is 10-40µm thick [18]. Figure
4-1 shows the stratum corneum in a brick and mortar type arrangement of corneocytes,
forming the bricks, and an extended lipid bilayer structure, or lipid matrix, forming the
mortar [18, 73].
Figure 4-1: Brick and mortar arrangement of the stratum corneum. The measurements shown
are: corneocyte length, lx, corneocyte depth, lz and intercellular space channel size, lps. We
consider corneocytes to have equal length and width, lx = ly.
Corneocytes are keratinocyte cells in their final stage of cell differentiation. In the corneocyte
stage, the cell has no nucleus or cytoplasmic organelles and are considered to be biologically
’dead’ [22]. Corneocytes have a rigid outer layer and are interlocked via protein chains
called corneodesmosomes. The permeability of corneocytes within intact stratum corneum is
unknown with opinions varying between completely impermeable to highly permeable [73].
The lipid matrix between corneocytes is composed primarily of fatty acids, cholesterol and
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sphingolipids [73]. These lipids form the skin natural moisturising factor which is important
in maintaining the barrier properties of the skin and is key in the skin healing process [2].
The Unit Cell
Packing fraction in the stratum corneum was calculated by considering the dimensions of
corneocytes and intercellular channels in a unit cell of the stratum corneum, shown in Figure
4-1, found in the literature [71]:
< lx >=< ly > = 40µm, σlx,ly = 10%
< lz > = 0.8µm, σlz = 10%
lps = 0.07µm.
Using these values, stratum corneum corneocyte volume, V3, is 1280±221.7µm3 and the
corresponding intercellular space volume around that corneocyte, V4, is 117±457x10µm3.
Using Figure 4-1, we obtained the packing fraction of cells in the intercellular space by
dividing the volume of a single corneocyte by the volume of a unit cell in this structure given
by (lx + lps)(ly + lps)(lz + lps). The packing fraction of cells is hence 0.92±0.23.
Cell Velocity
The stratum corneum is known to fully replenish every two weeks [69] with cells being pushed
towards the surface of the skin by the formation of new cells. Using this replenishment rate
and knowing stratum corneum depth is between 10-40µm, the velocity of the movement of
skin towards the surface through the stratum corneum, v, can be calculated to be in the
range 0.83-8.27x10−11ms-1.
4.3.2 Stratum Disjunctum
Cells are removed from the surface of the skin via a process called desquamation [74]. This
process is still poorly understood [74] and can be affected by pathogens in the skin. This
process occurs in the top few layers of the stratum corneum, known as the stratum disjunctum
[75].
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The stratum disjunctum has a similar structure to the stratum corneum. The main difference
is that corneodesmosomes break down in this layer, resulting in whole cells being removed
from this layer non-uniformly.
4.3.3 Viable Epidermis
The viable epidermis consists of the stratum basale, stratum spinosum and stratum granulo-
sum. Although this is not the rate limiting band for transport through the viable epidermis
for amino acids - the concentration in this compartment is still important to consider as it
governs flow of compounds into the stratum corneum. These layers are described in more
detail in section 1.4.2.
The Unit Cell
The structure of the viable epidermis varies through the skin. As the majority of the viable
epidermis is the stratum spinosum, with the exact fraction depending on the area of the body
considered, we consider this layer as a basis for the viable epidermis unit cell. In the stratum
spinosum, keratinocytes are idealised as hexagonal prisms arranged in a hexagonal lattice





Using these dimensions, it is clear that the volume of the unit cell, V2, is 1.19x10-14m3.
As each viable epidermis cell transitions into a single stratum corneum cell, the change from
hexagonal structure to a brick and mortar type array is not considered to have any additional
effects.
Velocity of Cells
As the volume of the stratum corneum is considered to be constant, the number of cells
leaving the stratum corneum must be equal to the number of cells entering. It is known that
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Figure 4-2: Viable epidermis unit cells organised in a lattice of hexagonal prisms, left, and a
single unit cell consisting of one cell surrounded by intercellular space, right. The intercellular
space is of thickness lp/2 on all sides.
the number of cells pushed into the stratum disjunctum from the stratum corneum over a








where ASC and hSC are, respectively, the cross sectional area and height of the stratum








where AV E and hV E are, respectively, the cross sectional area and height of the viable
epidermis unit cell. Equating gain and loss and rearranging, we obtain the velocity of cells









4.3.4 Potts and Guy Model
The Potts and Guy correlation presents a method of determining the diffusion coefficient, D,
of compounds through the stratum corneum [34]
log10(kpcms
−1) = −6.36(±0.18)− 6.0(±0.6)x10−3MW + 0.74(±0.07)log10kOW , (4.1)
where MW is the molecular weight of the compound considered, kOW is the octanol/water
partition coefficient of the compound. kp is the permeability coefficient based on the path





The path length through the stratum corneum intercellular space, δ, is known to be in the
range [500,880]µm [76] and the the stratum corneum/water partition coefficient, km, was
approximated using the octanol/water partition coefficient.
Phenylalanine The molecular weight of phenylalanine is 165.18 [70] and log10kOW = −1.43
[77]. Using the Potts and Guy correlation, the diffusion coefficient of phenylalanine in the
stratum corneum intercellular space, D1, is in the range [1.29,14.5]x10-15m2s-1.
Tyrosine The molecular weight of tyrosine is 181.19 [70] and log10kOW = −2.26 [77]. Using
the Potts and Guy correlation, the diffusion coefficient of tyrosine in the stratum corneum
intercellular space, D2, is in the range [3.55,23.6]x10-13m2s-1.
4.3.5 In Vivo Results
Previous work in vivo into transdermal extraction of amino acids using reverse iontophoresis
and passive diffusion [2] has shown that there is a large reservoir of amino acids in the stratum
corneum. This reservoir can take over 4 hours to clear and it is suggested that there is limited
transport of amino acids from the viable epidermis to the stratum corneum over this time
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period [1]. This makes it impractical to directly assess systemic concentrations of amino acids
via transdermal extraction.
In vitro [1] and in vivo [2] experiments used tape stripping to assess reservoirs of amino
acids in the skin. Tape stripping involves applying a length of tape to a fixed area of skin to
remove exterior layers of the stratum corneum. The depth of the stratum corneum removed
is calculated by weighing the amount extracted, using the area considered and the density of
skin, 1gcm-3 [2]. The content of the sample is then assessed via a variety of methods. The
results of tape stripping through the stratum corneum in vivo [2], shown in Figure 4-3, also
suggested that amino acid levels through the stratum corneum have a non-constant spatial
distribution. There appear to be concentration peaks within the stratum corneum rather
than on its boundaries.
Figure 4-3: Experimental results for the spatial distribution of amino acids through human
stratum corneum in vivo [2]. These results consider the top 75% of the stratum corneum
which determined by measuring transepidermal water loss (TEWL) starting at the surface of
the skin corresponding to SC depth = 0. Each different symbol represents a different patient.
Taken from [2].
Reservoirs of amino acids obtained in [2] were larger than anticipated due to the production of
amino acids, such as phenylalanine, in the skin [2]. This production is due to the irreversible
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breakdown of proteins, such as filaggrin, to form the natural moisturising factor (NMF) in
the skin [2]. NMF is important for maintaining the barrier properties of the skin and is key
in the skin’s healing process [78]. Due to the importance of NMF and future transdermal
extraction methods, mathematically modelling amino acid distribution through the stratum
corneum would be very useful.
Prior mathematical modelling work into amino acids is largely focussed on systemic distribu-
tions considering dosing via vectors such as food intake [15] and IV bolus [10]. Metabolism
is considered using a variety of enzyme kinetic techniques [64] such as Michaelis-Menten and
two site ordered binding models [10] depending on the enzyme considered. There are also
mathematical models of amino acids in other organs in the body such as the brain [15]. This
particular example uses a three compartment approach with one compartment modelling
sytemic levels and the other two focussed on bound and unbound amino acid in the brain.
However, prior mathematical modelling work into concentrations of amino acids through the
skin is limited. Chapter 3 addresses previous approaches to modelling phenylalanine concen-
trations in blood serum as well as new approaches to modelling blood serum phenylalanine
concentrations with food intake.
Mathematical modelling of compounds within the stratum corneum is primarily concerned
with transdermal delivery of various drugs [52, 73, 33] rather than establishing the formation
of the chemical reservoir. Changes in the architecture of the skin are generally considered
negligible over the time period considered for extraction experiments. Passive delivery and
extraction through the stratum corneum has hence been considered using diffusion models
based on Fick’s first and second laws [52].
Fick’s first law states that the diffusive flux, J(x, t), of concentration, C(x, t), is proportional
to the concentration gradient in the spatial domain, x, going from areas of high concentration
to areas of low concentration [52]:
J(x, t) = −D∇C(x, t).
Fick’s second law applies Fick’s first law to the mass conservation equation to obtain:
∂C(x, t)
∂x
−∇.(D∇C(x, t)) = 0. (4.2)
Fick’s law has been utilised directly by considering a uniform membrane in one spatial di-
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mension in order to model diffusion of drugs through the stratum corneum [79, 80].
Movement of compounds in the stratum corneum has also been modelled using discrete
methods [81]. In this, the stratum corneum lipid matrix is modelled via nodes. Transport
between nodes was modelled to be either linearly dependent on the concentration difference
between adjacent nodes or to have diffusivity increased in areas of high concentration to
represent membrane damage [81]. Both mechanisms showed Fick-like diffusion and came up
with various drug delivery theories which are not discussed here.
More complex mathematical models consider the architecture of the brick and mortar struc-
ture demonstrated in Figure 4-1. [73] considers a uniform brick and mortar structure with the
compound of interest allowed to move between corneocytes and the intercellular space with
the aim of assessing how permeable corneocytes are in relation to the lipid matrix. This work
suggested that corneocytes are 1000 times less permeable than the lipid matrix and hence
most transport occurs along the intercellular route. Other work into the effect of the brick
and mortar structure has also suggested that the change in path length and tortousity of the
lipid route has a significant effect on the diffusion coefficient through the stratum corneum
[52].
In contrast, recent work by Wang et al. has considered movement of compounds through the
skin with varying levels of permeability of stratum corneum cells, ranging from impermeable
to transparent [82]. The approach presented compares a diffusion based model in two spatial
dimensions at steady state to measured extraction fluxes through human skin for water,
ethanol, nicotinamide and testosterone. Based on these results, it is suggested that there is
significant transport through the intracellular route straight through the stratum corneum
and that corneocytes are highly permeable to these compounds [82]. However, experimental
work into extraction flux using mercuric chloride through porcine skin has suggested that
stratum corneum cells are highly impermeable [83]. This discrepancy could potentially be due
to the theoretical work by Wang et al. neglecting appendageal pathways through the stratum
corneum [82] which have been shown to be very important during extraction experiments [32]
and could explain the straight through pathway theorised by Wang et al. Permeability and
extraction of compounds through the stratum corneum is discussed further in chapters 5 and
6.
The effect of movement and desquamation of corneocytes and production of compounds in the
stratum corneum layer on skin reservoirs have, to date, not been considered. Additionally,
peaks in concentration within the skin reservoir have not been predicted in prior models.
The Potts and Guy model, discussed in section 4.3.4 also suggests that the the effective
diffusion coefficient of large molecules through the stratum corneum is less than that for
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small molecules. Hence, for large compounds, such as amino acids, movement through the
stratum corneum will be slow and movement processes in the skin may have a significant
impact on the stratum corneum distribution.
4.4 Model Formation
In order to model skin reservoirs of amino acids, we begin by setting up a linked model
structure for systemic and skin concentrations of amino acids and parameters for our case
study compound, phenylalanine. We first address assumptions that hold throughout the
model then address specific assumptions for corneocytes and the intercellular space. In order
to form the linked model, it is assumed that:
1. Amino acids in the blood are instantaneously evenly distributed through the whole
compartment, hence systemic concentration only varies in time. This follows the model
presented in chapter 3.
2. Phenylalanine gets into the skin both from the blood and production in the skin. Pro-
duction of amino acids in the stratum corneum has been suggested in prior experimental
work [1, 2].
3. As there is limited experimental work into amino acids the viable epidermis and this
layer is not the rate limiting barrier to transport through the skin, we consider the viable
epidermis to be spatially uniform and in dynamic equilibrium with the systemic com-
partment. This assumption also means that the viable epidermis cells and intercellular
cells are considered to have equal concentrations of phenylalanine.
4. The skin is considered to be replenished at the same rate as it is removed, hence the
volume of each compartment is constant.
5. The stratum corneum is considered to vary with time and one spatial dimension, depth
through the skin x.
6. The stratum corneum is considered to be at a constant depth L and split into the
stratum corneum (SC), x ∈ (d, L], and stratum disjunctum (SD) x ∈ [0, d]. x = 0
represents the surface of the skin.
7. Corneocytes in the stratum corneum and stratum disjunctum are completely imperme-
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able to amino acids because amino acids are large and mostly hydrophilic and has been
suggested in prior work [73].
8. Corneocytes moving through the stratum corneum are in the final stages in terminal
differentiation. Hence breakdown of filaggrin and other proteins to form amino acids
will occur in the deeper layers of the stratum corneum and be at a far reduced rate at
the surface of the skin as filaggrin becomes depleted. In order to simplify the model,
we initially assume that this production rate of amino acids is constant in the stratum
corneum and zero in the stratum disjunction.
9. Removal of cells and compounds from the skin only occurs in the stratum disjunctum,
being the layers closest to the skin surface. Although it is possible that removal occurs in
deeper layers of the stratum corneum, this is considered to be negligible. The stratum
disjunctum occupies the top few cell layers of the stratum corneum [75], distance d,
based on where amino acid concentrations in skin begin to decrease in prior experimental
work [1, 2].
10. The outer layer of the skin is considered to be completely replenished every 2 weeks
[69].
11. Cell packing fraction is considered to be constant in the stratum corneum and viable
epidermis. As whole cells are lost from the SD, the volume fraction occupied by cells
is considered to be non-constant in this layer, altering the packing fraction.
Given this, concentration of amino acid in each compartment is denoted:
Systemic C1(t), ∀t ≥ 0.
Viable epidermis C2(t) = C1(t), ∀t ≥ 0.
Stratum corneum corneocytes C3(x, t), x ∈ (d, L] ∀t ≥ 0.
Stratum corneum intercellular space C4(x, t), x ∈ (d, L] ∀t ≥ 0.
Stratum disjunctum intercellular space C5(x, t), x ∈ [0, d] ∀t ≥ 0.
Stratum disjunctum corneocytes C6(t), ∀t ≥ 0.
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Each compartment has corresponding volume Vi, i ∈ [1, 6] which is considered to be constant.
Using these assumptions and definitions results in the schematic diagram given in Figure 4-4.
Figure 4-4: Schematic diagram of the overall model. The viable epidermis and systemic
compartments are considered to be in dynamic equilibrium. x is a spatial variable where
x = 0 represents the surface of the skin and t is time.
Parameters in the system, using phenylalanine as a trial compound, are given in table 4.1.
These parameters are derived from published sources where possible and discussed in more
detail in section 4.3. Unknown parameters were calculated using least square regression
analysis on in vivo data. The Gauss-Newton method for numerically solving least squares
regression problems is detailed in section 2.2.
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Having established a linked model, governing equations are now formed for concentration in
the blood serum and stratum corneum. The viable epidermis is considered to be in dynamic
equilibrium with the blood serum at all times.
4.4.1 Phenylalanine in the Blood
For phenylalanine in the blood, we use the single compartment model presented in chapter 3
in a non-fasting state. Food intake is considered via a Bateman function. It is assumed that
the viable epidermis rapidly reaches a dynamic equilibrium with the systemic compartment
and that the volume of the viable epidermis in comparison to the blood is small. Hence we
do not consider there to be a significant drop in blood serum concentration due to movement
into the viable epidermis.
As cells and intercellular space are considered separately in the outer layers of the skin, it
is important to mention that, as the viable epidermis is considered to be spatially invariant
at constant unit cell volume, V2, the volume occupied by cells is equal to peV2, where pe
is the packing fraction in the viable epidermis, and intercellular space volume in the viable
epidermis is (1− pe)V2.
4.4.2 Corneocyte Model
Figure 4-5 gives a graphical representation of the corneocyte model. As whole cells are
removed from the stratum disjunctum, we consider the concentration in corneocytes in this
compartment to be spatially invariant. For cells, we additionally assume that:
1. As corneocytes are considered to be impermeable to amino acids and fixed in the lipid
matrix, movement of amino acids in corneocytes is only due to movement of the cells
towards the surface of the skin at velocity v > 0.
2. Corneocytes are removed from the stratum disjunctum at a constant rate λ.





(x, t) = k2, x ∈ (d, L], ∀t ≥ 0, (4.3)
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Figure 4-5: Graphical representation of the model for amino acid concentration in corneocytes
in the skin. In this the SC compartment is considered as a spatially dependent model and
the SD as a compartment with flux in based on flux out of the SC.
and for C5(t) is:
dC5
dt
(t) = −λC5(t) + vC3(d, t)
d
, x ∈ [0, d], ∀t ≥ 0. (4.4)
As the volume of the SD is constant, the influx of cells into this compartment per unit time,






(C3(d, t)− C5(t)), x ∈ [0, d] , ∀t ≥ 0. (4.5)
Flux out of the viable epidermis must be equal to the flux into the SC on the boundary
between these two layers, x = L. As movement across this boundary on both sides is solely
due to advection, this results in the boundary condition:
vC3(L, t) = veC2(t). ∀t ≥ 0. (4.6)
As we consider there to be a constant number of cells in the stratum cornem, we can relate






v = αv, (4.7)
with the derivation shown in detail in section 4.3.3. Equation (4.6) and (4.7) hence yield the
boundary condition:
C3(L, t) = αC2(t).
The problem is fully specified by introducing arbitrary constant initial conditions:
C3(x, 0) = C3s, x ∈ (d, L],
C5(0) = C5s.
4.4.3 Intercellular Space Model
Figure 4-6 gives a graphical representation of the proposed intercellular space model. For
intercellular space, we additionally assume that:
1. As amino acids are not fixed in corneocytes in the intercellular space, amino acids can
move through diffusion, with diffusion coefficient D1, as well as with overall movement
of the skin towards the surface at velocity v > 0.
2. Diffusion in the SD is complex due to non-uniform removal of intercellular space which
tape stripping does not take into consideration. Hence, diffusion in the stratum corneum
is grouped with removal into a single, linear term.
The flux in the SC is due to diffusion, with diffusion coefficient D1 and advection at velocity








(x, t) = k3, x ∈ (d, L], ∀t ≥ 0, (4.8)
and for C6(x, t) is given
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Figure 4-6: Graphical representation of the model for amino acid concentration in the in-






(x, t) = −γ(x)C6(x, t), x ∈ [0, d], ∀t ≥ 0, (4.9)
where γ(x) is a spatially dependent removal rate from the stratum disjunctum. We consider
γ(x) to be spatially dependent as layers of the SD closer to the surface are removed with
greater frequency than the deeper layers. For simplicity, we consider a linear function
γ(x) = σ(d− x), x ∈ [0, d],
where σ > 0.





(L, t) + vC4(L, t) = veC2(t), ∀t ≥ 0,

















As we consider the structure of the skin to remain unchanged over the SC-SD boundary, the
concentration of amino acid on this boundary is considered to be equal in the SC and SD:
C4(d, t) = C6(d, t), ∀t ≥ 0. (4.11)
In order to conserve the amount of amino acid in the system, the flux must be equal from
both sides of the boundary between the SC and SD giving the final boundary condition:
∂C4
∂x
(d, t) = 0, ∀t ≥ 0. (4.12)
We consider an arbitrary constant initial condition in the SC
C4(x, 0) = C4s, x ∈ (d, L] ∀t ≥ 0, (4.13)
and a decaying initial condition based on γ in the SD:








(x2−2dx+d2), x ∈ [0, d], ∀t ≥ 0. (4.14)
In order to fulfil the boundary condition in equation (4.11) C6s = C4s.
4.4.4 Total Concentration Model
In vivo [2] and in vitro [1] experiments give the concentration of amino acid through a tape
stripped layer of the skin at n discrete intervals xi, i ∈ [1, n], from the surface of the skin to
75% of the way through the stratum corneum, hence 0 < xi ≤ 0.75L. The point at which 75%
of the outer layer of the skin had been extracted was determined by TEWL measurements
[10].
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To compare the model results at steady state to in vivo and in vitro data, we first changed
the experimental results to show average concentration in each layer, rather than amount
through the layer, by dividing the amount obtained per unit area by the thickness of the
layer and considering these discrete points to occur in the middle of the layer considered. The
model results were compared to this using a continuous concentration curve, T (x,Ω), which
incorporates both corneocytes and the intercellular space based on the unknown parameter




pC∗5 (x,Ω) + (1− p)C∗6 (x,Ω), x ∈ [0, d],
pC∗3 (x,Ω) + (1− p)C∗4 (x,Ω), x ∈ (d, L],
(4.15)
where p is the packing fraction of the stratum corneum.
The Gauss-Newton algorithm for minimising the least squares approximation [48], detailed in
section 2.2, was employed to obtain estimates for unknown parameters in Ω based on results
obtained in vivo for phenylalanine [2].




Taking the Laplace transform, discussed in section 2.7, of equation (4.3)





























is found by consideration of the boundary condition in equation (4.6). Inverse transforming
using standard transforms yields the solution
C3(x, t) =












, if t ≥ L− x
v
,
x ∈ (d, L]. (4.17)
For x ∈ [0, d], we consider the solution to equation (4.5):
C5(t) =









) − e−λt) + k2(L− d)
v














As C2(t) is not yet defined, solutions presented in equations (4.17) and (4.18) are presented
graphically in section 4.9 when considering variable concentrations in the viable epidermis.
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Steady State
As replenishment of the outer layers of the skin occur continuously from birth, it’s important
to explore steady state solutions at a constant concentration in the viable epidermis, C∗2 :












A typical steady state profile is shown in Figure 4-7 and shows that there is a linear increase
in concentration through the stratum corneum with the stratum disjunctum levelling off at
a constant concentration. Equations (4.19) and (4.20) demonstrate that the steady state is
linearly dependent on the selection of k2 with k2 = 0 giving a constant profile based on viable
epidermis concentration.
Figure 4-7: Demonstration of the steady state behaviour of concentration of phenylalanine
in corneocytes using k2 = 0.14mmolm-3s-1 as a trial value with all other parameters given in
table 4.1.
As all parameters must be greater than or equal to 0, considering equations (4.17) and (4.19)
parameters shifts change where the viable epidermis concentration starts to influence the SC
and the position of the steady state but not the general behaviour of the model.
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4.5.2 Intercellular Space Model
Time Dependent
This is determined using the GITT method, detailed in section 2.6.1, by making the substi-
tution
M(x, t) = C4(x, t) + f(x), (4.21)





















(x, t) = −ψ∂C2
∂t
(t),
with homogeneous boundary conditions formed from equations (4.11) and (4.12)
∂M
∂x
(L, t) + βM(L, t) =
∂M
∂t
(d, t) = 0,
and initial condition from equation (4.13):
M(x, 0) = αC2(0)− f(x).
Using the substitution
M(x, t) = θ(x, t) exp(px+ qt),
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with p = −v2D1 and q =
−v2
4D1











, ∀t ≥ 0, x ∈ (d, L],


















, x ∈ (d, L].
To solve the diffusion equation, we apply the GITT by considering an eigenvalue problem
with the same kind of boundary conditions specified for θ(x, t)
d2φ
dx2














which only has non-trivial solutions for certain values of µ = µi, i ∈ [1,∞], eigenvalues, with
the corresponding solutions, φi(x), being eigenfunctions with the orthogonality property
∫ L
d
φi(x)φj(x)dx = Niδij ,
where Ni is the normalisation integral and δij is the Kronecker delta function. Solving the
diffusion equation results in
φi(x) = Ai sin(µix) +Bi cos(µix),
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where Ai and Bi are determined by the boundary conditions. For ease, µi is set to pii/d,
i ∈ [1,∞). This results in the normalised eigenfunctions, φ˜i
φ˜i(x) =






































































































which can be used to find C4(x, t) exactly:


















+ αC2(t), x ∈ (d, L], ∀t ≥ 0.
(4.22)
In order to obtain an exact solution to the concentration of amino acids in the SD intercellular





dx which reduces the
governing equation, given in (4.9), to
Qt − vQx = 0,
with initial condition
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Q(x, 0) = C6s, x ∈ [0, d],
and boundary condition:
Q(d, t) = C6(d, t) = C4(d, t).



















cˆb = L{C4(d, t)}(s)− C6s
s
. (4.23)
Hence applying the inverse Laplace transform where H(t) is the unit step function
Q(x, t) = C6sH(t) + C4
(







































dx, x ∈ [0, d], ∀t ≥ 0,
(4.24)
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which is based on the solution to the SC intercellular space, C4(x, t). Again due to C2(t)
not being defined yet, equations (4.22) and (4.24) are demonstrated graphically in section 4.9
when dealing with variable concentrations in the viable epidermis.
Steady State







(1− e−v(x−d)D ) + ψC∗2 , x ∈ (d, L], (4.25)
and:





(x2−2dx+d2), x ∈ [0, d). (4.26)
A typical profile is shown in Figure 4-8. This shows that, similarly to the corneocyte model,
the stratum corneum concentration is linear with respect to production through the skin with
k2 = 0 giving a constant profile. The concentration decays non-linearly in the stratum dis-
junctum and is equal to the concentration in the stratum corneum on the boundary between
the two layers, x = d. It noticeable that the decay never results in zero concentration at the
skin surface.
4.6 Model Analysis - Parameter estimation
Having obtained exact solutions for each compartment, we now look to establish unknown
parameters from in vivo data in human skin [2]. Many parameters in the model can be
derived from published literature sources as shown in table 4.1. The unknown parameters
are the production rate of phenylalanine in the stratum corneum cells, k2, intercellular space,
k3, and the removal rate in the stratum disjunctum, σ. The goodness of fit of the predicted
results is then assessed using standard error of the estimate, S, detailed in section 2.2.1
It is currently unknown if tape stripping analyses the contents of the intercellular space or
the whole outer layer of the skin. We propose that if cells in the stratum corneum are
almost impermeable to amino acids [73], then tape stripping only samples the intercellular
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Figure 4-8: Demonstration of the steady state behaviour of concentration of phenylalanine
in the intercellular space using k3 = 0.14mmolm-3s-1 and σ = 1.54m-1s-1 as trial values with
all other parameters given in table 4.1.
space. Experimental work sampling amino acid concentrations through the skin works by
weighing the amount of skin stripped and then converting this into a depth through the skin
by considering the skin to be at a constant density of 1gcm-3 and comparing this to the
surface area sampled [1, 2]. This method ignores such effects as partially desquamated layers
of skin which can lead to thinner depths measured than have actually been extracted.
As cells take up 90% of the skin, the majority of the sample obtained from the tape strip will
consist of cells which, if impermeable, should have a consistent behaviour from the start of
the stratum corneum, at x = L, to the surface of the skin, at x = 0. For example, if an amino
acid is produced by breakdown of proteins inside a cell and not broken down further within
the cell each individual cell would be expected to have more of that particular amino acid
inside it at the surface of the skin than at the boundary between the stratum corneum and
viable epidermis. Due to depth calculated being linearly dependent on weight extracted, this
increase would be expected to be reflected in the tape stripping results with minor variation
due to 10% of the layer being occupied by intercellular space.
A least square regression analysis, more specifically using the Gauss-Newton method detailed
in section 2.2, was used to approximate the unknown parameters based on in vivo data [2] and
the steady state equations given in equations (4.19), (4.20), (4.25) and (4.26). We consider
tape stripping results from 8 patients from the top 75% of the stratum corneum/stratum
disjunctum. Due to the limited data available for each patient, k2 and k3 were initially con-
sidered to be equal, reducing the number of parameters that required estimation. The results
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Table 4.2: Parameters used with equal production in corneocytes and the intercellular space,
k2 = k3 = k.
Patient L(µm) d(µm) k(mmolm-3s-1) σ(m-1s-1) v(x10-11ms-1) S(x103mmolm-3)
1 9.3 4.0 0.018 2.21x1018 0.77 5.96
2 11.0 2.5 0.010 1.93x1020 0.91 4.05
3 11.3 3.5 0.010 6.95x1018 0.93 3.89
4 10.0 3.5 0.009 132.61 0.83 3.08
5 10.0 3.2 0.014 507.53 0.83 5.41
6 10.0 5.0 0.023 23.28 0.83 6.34
7 14.7 4.5 0.017 556.22 1.22 6.11
8 16.0 7.0 0.022 28.68 1.32 6.38
of the regression analysis are shown in Figure 4-9 with the specific parameters calculated for
each patient given in table 4.2. It is noticeable that the range of values predicted for σ is
quite large as is the standard error of the estimate.
Considering Figure 4-3, which shows the results of in vivo experiments in human skin, there
is a clear increase in all the amino acids from the viable epidermis, reaching a peak and then
decay towards zero at the surface of the skin [2] which is also reflected in in vitro experiments
[1]. Considering Figure 4-9, it is clear that this peak is not reflected when considering
significant production in the corneocytes. Significant production in corneocytes results in a
very small concentration drop towards the surface of the skin. The behaviour observed in
Figure 4-9 closely resembles that observed for the steady state for cells in Figure 4-7 which
is expected as corneocytes comprise over 90% of the stratum corneum.
Production in cells causing unrealistic behaviour near the surface of the skin suggests that
either:
1. The production of amino acids in cells is eclipsed by production in the intercellular
space.
2. Concentration of amino acids is not assessed in cells during tape stripping.
We consider both approaches in the following two subsections. In both cases, due to the
parameters being patient specific, each patient was considered separately and the resulting
estimates used to establish a range.
The thickness of the stratum corneum, L, and stratum disjunctum, d, varied between patients.
L was calculated using that the deepest point considered in each patient was 75% of the way
through the SC [2] and d was approximated by considering the location of the ’peak’ result
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Figure 4-9: The results of regression analysed σ, k2 and k3 with k2 = k3 for each patient
entered into the phenylalanine concentration model, red line, compared to in vivo data,
blue dots. The dotted line represents the estimated final depth through the skin, L, for
each patient. Based on in vivo results, shown in Figure 4-3, concentration should decrease
significantly through the stratum disjunctum. The parameters used to generate this figure
are given in table 4.1.
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Table 4.3: Parameters used with zero production in corneocytes.
Patient L(µm) d(µm) k3(mmolm-3s-1) σ(m-1s-1) v(x10-11ms-1) S (x103mmolm-3)
1 9.3 4.0 0.166 0.631 0.77 3.08
2 11.0 2.5 0.076 3.621 0.91 1.68
3 11.3 3.5 0.087 1.781 0.93 1.33
4 10.0 3.5 0.071 0.588 0.83 1.97
5 10.0 3.2 0.125 3.402 0.83 1.19
6 10.0 5.0 0.244 0.962 0.83 1.99
7 14.7 4.5 0.139 1.238 1.22 2.08
8 16.0 7.0 0.221 0.766 1.32 2.34
in each case.
4.6.1 Zero Cell Production
If we consider production in corneocytes, k2, to be equal to zero and production in the
intercellular space, k3, to be variable then performing regression analysis results in the plots
given in Figure 4-10 and the k3 values given in table 4.3.
At zero production, the corneocytes have a very limited effect on the model - this does open
the possibility for very limited production in cells which could be approximated from the
concentration gradient in in vivo data. In some cases, such as patient 1 and 4, the decline
in amino acid concentration observed experimentally is greater than predicted close to the
boundary of the skin, x = 0.
Comparing the standard error of the estimate given in tables 4.2 and 4.3, it is clear that
regression analysis using a model with zero production in cells better fits the observed data
than using equal production in cells and the intercellular space for all 8 patients considered.
4.6.2 Tape Stripping only Assesses the Intercellular Space
The parameters found for each patient using the intercellular space only are given in table 4.4
with the resulting distributions given in Figure 4-11. Additionally, comparing the k3 values
in table 4.3 and table 4.4 the difference between the values obtained is negligible. Indeed,
figures 4-10 and 4-11 are also very similar. Comparing the standard error of the estimate
between the two models, it is clear that not including cells results in a model that fits the
experimental results slightly better. Hence, we do not consider cells to contribute to tape
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Figure 4-10: The results of regression analysed k3 and σ for each patient entered into the
phenylalanine concentration model, red line, compared to in vivo data, blue dots. The dotted
line represents the estimated final depth through the skin, L, for each patient.
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Table 4.4: Table of parameters for individual patients considering intercellular space only.
Patient L(µm) d(µm) k3(mmolm-3s-1) σ(m-1s-1) v(x10-11ms-1) S(x103mmolm-3)
1 9.3 4.0 0.163 0.633 0.77 2.95
2 11.0 2.5 0.080 3.289 0.91 1.51
3 11.3 3.5 0.091 1.688 0.93 1.15
4 10.0 3.5 0.076 0.578 0.83 1.79
5 10.0 3.2 0.129 3.246 0.83 1.04
6 10.0 5.0 0.249 0.954 0.83 1.91
7 14.7 4.5 0.143 1.197 1.22 1.94
8 16.0 7.0 0.225 0.756 1.32 2.28
stripping results for the remainder of this chapter.
The standard error of the estimate in table 4.4 is of a similar magnitude for each patient and
represents some scatter around the model prediction and those observed experimentally.
Using this data, we obtain a value of -0.43 for the Pearson coefficient between k and σ, which
suggests low negative correlation [84] between the two parameters with the exact distribution
shown in Figure 4-12. Production and decay in the stratum corneum should be completely
independent. However, it is difficult to draw any firm conclusions on correlation from a
dataset of 8 patients, so more experimental data would be useful to draw a full conclusion
from.
The depth of the stratum disjunctum is affected by the amount/thoroughness of washing the
skin. It is also likely that the decay rate, σ, is based on the amount of washing of the skin,
hence we consider the correlation between σ and d/L for each patient. Figure 4-13 and the
Pearson coefficient of -0.694 suggests that there is a moderate to strong negative correlation
between σ and d/L. This supports the implication that more skin washing, and hence a
smaller stratum disjunctum, leads to a lower decay rate.
4.7 Comparison without the Stratum Disjunctum
Motivation for the inclusion of the stratum disjunctum came from consideration of experi-
mental data [1, 2]. To determine the effect of this additional compartment, we now consider
a model system where this compartment is not included. For the intercellular space the
governing equation is
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Figure 4-11: The results of regression analysed k3 and σ for each patient entered into the
phenylalanine concentration model, red line, compared to in vivo data, blue dots. The dotted
line represents the estimated final depth through the skin, L, for each patient.
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Figure 4-12: Plot of production rate against decay rate for each patient with corresponding
SD depth labelled on each point.









(x, t) = k2, x ∈ [0, L], ∀t ≥ 0.
with initial condition:
C4(x, 0) = C4s(x).
The boundary condition at the stratum corneum, viable epidermis boundary, x = L, remains
as a flux conservation condition
∂C4
∂x
(L, t) = β(αC2(t)− C4(L, t)), ∀t ≥ 0,
and we consider the boundary condition on the surface of the skin, x = 0, to be a sink:
C4(0, t) = 0, ∀t ≥ 0. (4.27)
The corresponding steady state








, x ∈ [0, L], (4.28)
where c1 is a positive constant:








































which, using parameters given in table 4.1, results in xs ≈ L as demonstrated in Figure 4-14.
Clearly not including removal effects in stratum disjunctum does not reflect the behaviour
observed in vivo as shown by Figure 4-3 as, using physiological parameters, the peak occurs
close to the viable epidermis boundary.
Figure 4-14: Demonstration of the concentration profile through the stratum corneum with
a zero concentration initial condition on the surface of the skin.
4.8 Comparison with Tyrosine
If we expect our model to describe amino acid distribution in the skin in general terms,
then we might expect γ(x) to be independent of a particular amino acid. To explore this,
we consider in vivo data for tyrosine [2] from the same patients using the same model for
the SC and SD and a constant concentration C2 = 0.075mmoldm−3 in the viable epidermis
compartment. We fix σ, v d and L to the parameters given in table 4.4 for each patient and
the diffusion coefficient for tyrosine, D2, is set to 3.71x10-13m2s-1 using the Potts and Guy
correlation [34], described in section 4.3.4. All other parameters are independent of molecule
and hence given in table 4.1 with regression analysis performed to find the production rate
of tyrosine in the intercellular space, k4.
Figure 4-15 shows the resulting total plots for tyrosine with the corresponding production
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Table 4.6: List of ranges and trial parameters.






rates given in table 4.5. These plots match the experimental data well, suggesting that the
model formation is valid for a variety of amino acids.
4.9 Effect of Parameter Variation on Total Amount in the
Skin
For most of the previous sections, we have used trial parameters based on ranges found in the
literature. Here we investigate the effect of varying some key parameters on the total amount
of phenylalanine in the stratum corneum in a fasting state. We consider the depth of the
stratum corneum, L, the depth of the stratum disjunctum, d, the production of phenylalanine
in cells, k2, in the intercellular space, k3 and the decay rate in the stratum disjunctum, σ.
To do this, we fix all other variables to the values given in table 4.6 and alter the parameter
considered over the range given in table 4.6.
Total amount in the skin is found by considering the integral of equation (4.15) with respect
to x at steady state given in equations (4.19), (4.20), (4.25) and (4.26). Due to the exp(x2)
term in equation (4.26), the integral is found numerically.
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Figure 4-15: The results of regression analysed k for each patient inputted into the tyrosine
concentration model, red line, with fixed σ based on the phenylalanine regression analysis
compared to in vivo data, blue dots. The dotted line represents the estimated final depth
through the skin, L, for each patient.
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4.9.1 Varying Stratum Corneum Depth
Figure 4-16 indicates that the relationship between L and the total amount in the stratum
corneum is approximately linear. This is to be expected as increasing the depth of the stratum
corneum effectively increases the depth which phenylalanine is sampled over.
Figure 4-16: Effect of varying stratum corneum depth, L, on the total amount of
phenylalanine in the stratum corneum per unit area.
4.9.2 Varying Stratum Disjunctum Depth
Varying stratum disjunctum depth has a non-linear effect on total amount of amino acid in
the stratum corneum. As demonstrated by Figure 4-17, the thinner the stratum disjunctum,
the more amino acid is in the stratum corneum. This is because removal effects are considered
to not start until the stratum disjunctum has been reached.
4.9.3 Varying Production in Corneocytes and the Intercellular Space
Figures 4-18 and 4-19 demonstrate, respectively, that production in cells and intercellular
space has a linear effect on amount of phenylalanine in the stratum corneum. As cells occupy
90% of the stratum corneum - it is unsurprising that changes in k2 have a much larger effect
than changing k3.
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Figure 4-17: Effect of varying the stratum disjunctum depth, d, on the total amount of
phenylalanine in the stratum corneum per unit area. L is fixed at 20µm. The dotted line
indicates the value of d given in table 4.6.
Figure 4-18: Effect of varying production of phenylalanine in stratum corneum cells, k2, on
the total amount of phenylalanine in the stratum corneum per unit area. k2 = 0 in table 4.6.
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Figure 4-19: Effect of varying production of phenylalanine in stratum corneum intercellular
space, k3, on the total amount of phenylalanine in the stratum corneum per unit area. The
dotted line indicates the value of d given in table 4.6.
4.9.4 Varying Stratum Disjunctum Decay Rate in the Intercellular Space
Figure 4-20 demonstrates that varying the decay rate of phenylalanine in the stratum disjunc-
tum intercellular space has a non-linear effect on the amount of phenylalanine in the stratum
corneum. Increasing decay rates causes a smaller total amount in the stratum corneum with
changes having less effect at high rates than low rates. The change to total concentration is
relatively small as the decay rate only affects the concentration in the stratum disjunctum
intercellular space.
Figure 4-20: Effect of varying decay rate of phenylalanine in stratum disjunctum intercellular
space, k3, on the total amount of phenylalanine in the stratum corneum per unit area. The
dotted line indicates the value of d given in table 4.6.
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4.10 Model analysis - Non-fasting state
Having obtained estimates for the unknown parameters in human skin, the concentration
of phenylalanine through corneocytes and intercellular space was considered in a non-fasting
state. Using the trial parameters listed in table 4.1, the plot given in Figure 4-21 was produced
for phenylalanine concentration within stratum corneum corneocytes with k2 = 0. This plot
is very similar to that produced in the systemic compartment in a non-fasting state as shown
in chapter 3 when scaled by the volume ratio α.
Figure 4-21: Amino acid concentration profiles in SD (left) and SC (right) corneocytes under
a variable viable epidermis concentration.
Figure 4-22 shows the non-fasting state behaviour for the intercellular space over a period of
one month, 672 hours, as this is double the time taken to fully replenish the stratum corneum
[69]. Variation in the viable epidermis concentration has an unnoticeable effect on skin
concentrations. Hence, we conclude that production dominates the amount of phenylalanine
in the SC and SD intercellular space. Comparing Figures 4-21 and 4-22, and remembering
that cells occupy nine times more volume than the intercellular space, it is clear that there
is significantly more phenylalanine in the intercellular space than in corneocytes. This also
suggests that phenylalanine concentration in the stratum corneum and stratum disjunctum
is dominated by production.
As the impact of systemic concentration of phenylalanine is almost unnoticeable under re-
alistic concentration ranges, this also means that changes in systemic concentration due to
phenylketonuria are unlikely to have a large impact on the skin reservoir.
It is also noticeable that the concentration profile is almost flat through the stratum corneum
intercellular space. This is not due to the movement of amino acids from the viable epidermis,
but is instead due to phenylalanine being allowed to spread through the compartment via dif-
fusion. Additionally, by construction of removal in the stratum disjunctum, the concentration
will never hit zero at x = 0.
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Figure 4-22: Amino acid concentration through the intercellular space in a non-fasting state.
The effect of varying viable epidermis concentration on the concentration of amino acids in
the intercellular space is unnoticeable.
Table 4.7: Parameters used when performing regression analysis on porcine skin.
Parameter Definition Range Value used
L Depth of the stratum corneum [21, 26]µm 24µm
d Depth of the stratum disjunctum [3, 6.25]µm -
v Velocity of advection [1.74, 2.15]x10-11ms-1 1.98x10-11 ms-1
C∗2 Steady state plasma concentration [0.066, 0.074]mM 0.070mM
4.11 Model Analysis - In Vitro Porcine Skin
Having considered in vivo data for human skin, we consider in vitro data for pig skin. Pig
skin is different from human skin and will, hence, have different parameters, such as the
depth of the stratum corneum. We consider the structure of the stratum corneum to remain
the same with the new model parameters given in table 4.7.
Performing least squares regression analysis on the 6 sets of pig data results in the plots
given in Figure 4-23 with corresponding k2 and σ for each pig given in table 4.8. Pigs do not
wash as much as humans, which results in much less removal of amino acids from the outer
layer of the skin. The model seems to predict in vitro data well with some scatter, which is
measured using standard error of the estimate, S, in table 4.8, in all but pig 2 where there is
a significant drop in amino acids concentration deep within the stratum corneum.
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Table 4.8: Parameters obtained from regression analysis for each pig.
Patient k3 (mmolm-3s-1) σ (m-1s-1) S(mmolm-3)
1 0.027 2.78 616
2 0.024 6.71 817
3 0.050 3.79 325
4 0.024 1.76 400
5 0.027 0.36 606
6 0.021 0.65 319
Figure 4-23: Individual regression analysis on each pig.
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4.12 Chapter Summary
A simple, generic model for amino acid concentration through the SC and SD has been
developed. This model builds on prior in vitro and in vivo [1, 2] experimental work into the
formation of reservoirs of amino acids in the skin. The model results are directly compared to
in vivo [1] and in vitro [2] work and matches well for intercellular space amounts of the amino
acids phenylalanine and tyrosine. The model suggests that the production of phenylalanine
in the stratum corneum is in the range [0.08,0.25]mmolm-3s-1 for humans and that the decay
in the stratum disjunctum can be modelled using a linear profile with decay constant in the
range [0.58,3.25]m-1s-1. The ranges on these parameters are large and an improvement to the
results would involve considering a larger sample size in order to get an accurate mean and
standard deviation for these parameters.
The results of the model were also strengthened by considering in vivo tyrosine data from
the same patients as the phenylalanine data was obtained from [1]. Regression analysis on
tyrosine produced similar decay rates.
The model presented suggests that analysis of historic systemic concentrations of amino acids
via consideration of the skin reservoir alone is not possible as production of amino acids in the
skin significantly eclipses movement from deeper in the body. However, it may be possible to
find systemic concentrations by considering extraction of the stratum corneum reservoir and
the viable epidermis simultaneously. This is investigated in later chapters.
In order to check the validity of this model for specific amino acids, parameters such as
production rate in the skin and the decay constant need to be verified experimentally. The
same decay rate seems to produce reasonable results for both phenylalanine and tyrosine
decay in the stratum disjunctum, which makes the parameter selection more valid. However,
there is significant variation between patients which is likely due to some patients experiencing
a much more rapid drop on the surface of the skin than others.
Varying the removal rate of the amino acid from the stratum disjunctum intercellular space, σ,
is a possible way of modelling different levels of washing with larger removal rates representing
more washing. Indeed pigs, who wash less than humans, experience a less steep decay rate
through the stratum corneum and a definitive non-zero concentration on the surface of the
skin. Unfortunately, due to the large range and small number of patients and pigs observed
it is not possible to draw any firm conclusions from these results.
Considering the steady state concentrations and exact solution for the stratum corneum in-
tercellular space, equations (4.22) and (4.25), a reduced amount of diffusion in the stratum
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corneum intercellular space would significantly increase the spatial variation of amino acid
in the stratum corneum. By extension this would also increase the spatial variation in the
stratum disjunctum and increase the time taken to reach the steady state. This is impor-
tant as it suggests that viable epidermis variations will be more obvious when considering
compounds with limited diffusion in the stratum corneum.
Opinions vary on whether cells in the stratum corneum are permeable or impermeable [73].
In this chapter we assumed that the cells were completely impermeable. Prior work into drug
diffusivity into SC corneocytes has suggested that this movement, if it exists, is very small,
even for lipophilic compounds [73]. Hence having impermeable cells is a reasonable assump-
tion, especially as considering permeable cells would introduce more unknown parameters
into the system which would need to be estimated experimentally.
Prior work [73] has suggested that the diffusion coefficient may vary through the skin, however
incorporating this increases the complexity of the model. It is reasonable to assume the






In this chapter, we consider the movement of uncharged compounds through channels under
an applied electric field. As the compounds considered, like phenylalanine, are uncharged
[70], the primary mechanisms of transport are passive diffusion and electro-osmotic flow. The
objective of this chapter is to combine prior work into surface chemistry and electro-osmosis
in order to fully describe solvent flows through a channel in the skin.
This chapter uses known theory from micro-fluids to find electro-osmotic velocity in terms
of known constants, properties of the fluid, applied field and zeta potential on the channel
walls. We then use surface chemistry in order to express the zeta potential in terms of the
surface charge density and compare several approaches for finding the surface charge density
including consideration of the ionic charge density in the fluid through the channel and using
streaming potential.
The novelty of this chapter is combining theory from different disciplines, namely classical
Navier-Stokes from fluid dynamics, electric potential theory and surface chemistry theory, to
obtain the electro-osmotic flow velocity through skin in terms of measurable quantities. We
present the general theory and apply it to different geometries. Following unrealistically high
predicted velocities, the theory is then further modified using surface chemistry.
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5.2 Parameters
This section lists the parameters used in this chapter for reference. As this chapter mostly
develops theory into electro-osmotic flow, most of the parameters are either unspecified or
are dependent upon values such as the bulk concentration of the ionic salt, c0, which varies
between cases. For these parameters, values are dealt with in the text.
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































5.3 Introduction to Electro-Osmotic Flow
Electro-osmotic flow is an electrokinetic phenomenon where an externally applied electric field
interacts with an electric double layer to cause bulk flow of a liquid [88]. Electro-osmotic flow
was first observed by Reuss in 1809 who observed water migration through porous clay under
an externally applied field [89]. Since this time, electro-osmotic flow has become a critical
technology in a variety of fields ranging from transdermal delivery [21, 33, 87] to integrated
micro- and nanofluidic systems [88, 89, 90].
An electric double layer is a layer of non-zero net charge that forms near the interface between
two mediums [88] - for cases of interest in this thesis, this is a solid-liquid interface. In this
case, the electric double layer is formed by the adsorption or desorption of ions by the
surface which causes ions in the fluid to re-arrange to compensate for the charge imbalance
and maintain overall electro-neutrality [88]. The effect caused by the double layer exhibits
approximately exponentially decay in potential with distance from the interface.
When an electric field, with electric potential φ, is applied parallel to the surface, the surplus
of positive or negative charges in the fluid, depending on the charge on the surface, results in
a net body force on the fluid towards the oppositely charged diode [89]. For example, Figure
5-1 represents an excess of negative charges in the fluid moving towards the positively charged
cathode. The electro-osmotic flow velocity generated is directly proportional to the electric
field applied [33] based on some mobility constant µeo that can be found experimentally or
derived from theory. The mobility constant is a property of the system considered and is
based on the electric potential generated by the charge on the surface, ψ. Here we focus on
direct current (DC) electro-osmotic flow.
Far away from the double layer, the velocity of electro-osmotic flow is considered to be con-
stant and is largely independent of channel size [88]. This behaviour, combined with the ease
of application and the ability to perform precise, nano-scale fluid handling via manipulation
of external voltages, has made electro-osmotic flow key in micro-fluid and nano-fluid systems
[88, 89].
Transdermal iontophoresis and reverse iontophoresis utilises electro-osmotic effects in order
to enhance extraction of compounds through the skin. There has been significant research
into this field using in vitro experiments [1], in vivo experiments [2] as well as mathemati-
cal modelling [21, 33]. Approaches to transdermal iontophoresis are very varied and, when
considering the flow of charged species, electro-osmotic effects are frequently ignored [36, 91].
The amino acid phenylalanine is uncharged, hence the primary movement mechanism through
the skin under reverse iontophoresis is electro-osmotic flow.
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Figure 5-1: Depiction of the electric double layer created by a single surface. In this Ex
represents the electric field applied between the anode and cathode, veo the electro-osmotic
velocity with mobility µeo. The thickness of the electric double layer (EDL) is quantified
using the Debye length, λD. The shear plane measures the point where charged particles
can start to move with the potential, ψ, at this point defined as the zeta potential, ζ. The
potential on the shear plane, psi, is different to the potential applied across the membrane,
φ.
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When considering electro-osmotic flow through skin, consistent with fluid dynamics, flux is
considered to be proportional to the electric field applied [33, 87] with the proportionality
constant determined experimentally. In pharmacy, a common approach is to consider that
all flows are linear combinations of all the forces involved in the system [33]. That is that
the volume flux, Jv, and current density, i, in a system under an applied potential, ∇φ, and
pressure, ∇P , gradient are
Jv = L11∇P + L12(−∇φ),
i = L21∇P + L22(−∇φ),
where Lij are properties of the system considered called Onsager coefficients. The Onsager
coefficient associated with electro-osmotic flow is L12 with the electro-osmotic flow velocity
determined by Jv|∇P=0. L12 is determined either experimentally or by using mathematical
models.
One example of mathematical modelling is called the limiting law theory. This theory con-
siders the force balance between viscous fluid forces and the electrical volume force [33] in the









where F is the Faraday constant, r0 the pore radius, zm is the sign of the charge on the
pore, Cm is the concentration of the compound of interest, η is the dynamic viscosity of the
solvent, L is the membrane thickness and λD = κ−1 is the Debye length. As the Debye
length is inversely proportional to the root of the ionic salt concentration, the limiting law
suggests that electro-osmotic flow velocity will decrease with a greater concentration of ionic
salt, which is not observed experimentally [33].
There have been several expansions to limiting law theory which produce more realistic results
such as the Manning ‘lattice’ model. In this model, the pore is considered to be a single
channel between two rectangular planes which are separated by r0 [92]. These rectangles
are lattices containing evenly distributed fixed point charges which are considered not to
have electrostatic interactions with mobile ions flowing through the pore. This leads to the
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where A is an experimentally derived constant and C is the concentration of co-ions in the
membrane. Other, more complex expansions, such as the Hildreth ‘plate’ model [94], exist but
are not considered in this chapter. None of these approaches consider fluid dynamics concepts,
such as the Navier-Stokes equations, and make large assumptions about the system, although
the proposed end result can give good approximations when based on experimentally derived
constants [33].
In this chapter, we attempt to model electro-osmotic flow from base micro-fluid, surface chem-
istry and electromagnetic concepts for use in a reverse iontophoresis model for amino acids
in the next chapter. We begin by introducing key background concepts, such as the Navier-
Stokes equations and the Poisson-Boltzmann equation, before developing electro-osmotic flow
models.
5.4 Navier-Stoke Equations
The Navier-Stoke equations describe the motion of a viscous fluid based on pressure, density
and temperature [95]. The full Navier-Stokes equation is, as yet, unsolved analytically and
is an area of significant interest in fluid dynamics [95]. Generally, several assumptions are
applied to the Navier-Stokes equation to make the system analytically solvable, or numerical
methods are used. In this chapter, we consider fluid in the skin to be at a constant viscosity, η





(x, t) + v(x, t).∇v(x, t)) = −∇P (x, t) + η∇2v(x, t) + f(x, t),
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where v is the fluid velocity, P (x, t) is the pressure and f(x, t) represents an applied body
force to the fluid at spatial location x and time t. For electro-osmotic flow the applied body
force is created by the applied electric field.
In order to find the electro-osmotic flow velocity, we reduce the full Navier-Stokes equation
into a more manageable form by assuming that:
1. The solvent is incompressible.
2. The fluid has a low Reynolds number [96] - hence inertia forces are negligible compared
to viscous forces.
3. The fluid velocity reaches steady state quickly.
4. In line with prior work, we consider the induced electro-osmotic pressure to be negligible
[97].
5. There is no pressure gradient in the system.
Under these assumptions, and noting that the body force under an applied electric field is
equal to the local electric charge density, ρe(x) multiplied by the applied field, E(x), the
Navier-Stokes equation reduces to:
η∇2v(x) + ρe(x)E(x) = 0. (5.1)
5.5 Poisson-Boltzmann Equation
The Poisson-Boltzmann equation is a mean field theory that aims to describe the distribution
of electrochemical potential, the total chemical and electrical potential, in a solution next to
a charged surface under the assumptions [88, 98]:
1. Ions are point charges, hence ion size effects are ignored. Although valid far away from
the surface, this theory breaks down close to the surface.
2. The surface is uniformly charged.
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3. Non-Coulombic interactions, being any interaction not between static electric charges
such as the interaction between hydrogen shells in water, are ignored.
4. Each ion only interacts with the average electrostatic field of all its neighbours rather
than its individual neighbours. This is called a mean field approximation.
5. The ions in solution are considered as a continuous charge distribution which ignores
the discrete nature of ions.
6. The permittivity of the medium, ² = ²w²0, is constant.





based on the local electric charge density, ρe(x), the permittivity of free space, ²0, and the
relative permittivity of the fluid, ²w. The local electric charge density is found by considering
the sum of charges at each point - which is found by summing the concentration, ci, of each





where zi is the corresponding valence of ionic species i and n is 1 for negatively charged species
and 2 for positively charged species. The Boltzmann equation can be used to calculate the
local ion concentration [88]





based on the temperature, T , the Boltzmann constant, kB, and the work required to move
an ion closer to the surface from an infinitely far distance, Wi(x). It is assumed that the only
forces acting are electrical in nature, hence [88]:
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Wi(x) = (−1)nzieψ(x). (5.5)
Combining equations (5.2)-(5.5) with the specific surface geometry and ionic species present
in the fluid gives the Poisson-Boltzmann equation. Despite the large number of assump-
tions associated with Poisson-Boltzmann theory, the behaviour of the electric double layer
is described well [88]. For aqueous solutions, predictions are good for monovalent salt con-
centrations below 0.2M and potentials below 50-80mV [88] where monovalent salts are salts
consisting of ions with a valency of 1 such as NaCl.
5.6 Boundary Behaviour
Key to understanding electro-osmotic flow is the boundary effects caused on the interface
between the fluid flowing through a channel and the channel walls. This section details key
concepts in defining the behaviour at this interface.
5.6.1 Zeta Potential
When considering fluid flow along charged surfaces, ions binding to the surface can cause the
shear plane, where ions begin to move in the fluid - shown in Figure 5-1, to be away from
the interface between the surface and the fluid. The potential exerted by the surface at a
distance from the surface interface where ions start to move is called the zeta potential, ζ
[88]. The zeta potential plays a very important role in electro-kinetic phenomena such as
electro-osmotic flow.
5.6.2 Surface Charge Density
Surface charge density, σ, measures the electric charge per unit area on a surface. Gauss’ law
states that net electric flux through a closed surface is equal to the net electric charge within
that surface multiplied by 1/² [98]. Hence, if there is a overall charge on a surface, an electric
field will be generated away from that surface. This electric field drives electro-osmotic flow.
If the system is electro-neutral, the charge density on the surface will be mirrored by a net
charge density in the fluid. The region away from the charged surface in which a charge
143
imbalance, and hence an electric field, exists is called the electric double layer with the
properties of this double layer affecting the velocity of electro-osmotic flow.
5.6.3 Debye Length
The Debye length is the characteristic length of the electric double layer [33, 88, 89] . The
Debye length measures how far an electrostatic effect persists into a solution with the electric
potential decreasing by a factor of 1/ exp(1) every Debye length. Generally, it is assumed
that if the channel in question is much wider than the Debye length, then effects that take
place in the double layer can be considered to be negligible. The Debye length, λ is given by





with why this expression comes about derived through section 5.7.
5.6.4 Streaming Potential
A common method in characterising zeta potential in a system with a well defined geometry
involves measuring the streaming potential. When a pressure difference, ∇P , is applied to
fluid flowing through a channel, the liquid drags some of the charge attached to the double
layer with it. This process causes accumulation of ions at the ends of the channel - resulting
in a potential difference called the streaming potential, ∇U [88].
Streaming potential has been previously considered when dealing with microfluids and porous








where In(κr0) are modified Bessel functions of order n, described in section 2.8, and κe is the
pore conductivity. In a binary 1-1 electrolyte, one ion to one cation in the salt such as NaCl,






























D+ and D− are, respectively, the ionic diffusion coefficients for the cation and anion, R is the
ideal gas constant, T is temperature and r0 is the channel radius. If the channel radius, r0,
is much greater than the Debye length, then κe → κb [90]. Additionally, considering section








As shown in section 5.5, Poisson-Boltzmann theory has several strong assumptions which can
introduce inaccuracies when describing the electric double layer. However, the inaccuracies
introduced tend to cancel each other out, for example including non-Coloumbic forces leads
to an increased ionic concentration at the surface and a corresponding decrease in surface
potential whereas taking the finite ion size into account reduces the ionic concentration and
the surface and causes an increased surface potential [88].
One extension to Poisson-Boltzmann theory is called Stern theory. In this theory, the electric
double layer is divided into two parts, the Stern layer, close to the surface, and an outer part
where Poisson-Boltzmann theory holds [88]. The Stern layer is considered to end when the
potential is equal to the zeta potential.
The simplest way to consider the Stern Layer involves considering ions to have a finite size
with the layer of ions closest to the surface being fixed. The distance between the surface
and the center of the ion, δ, marks the boundary between the Stern Layer and the outer
layer, called the outer Helmholtz plane. By definition, at δ the potential is equal to the zeta
potential and is demonstrated graphically in figure 5-2. More complex versions of the Stern
Layer exist [88], but we do not consider them as it is currently not possible to get a greater
level of detail in the skin.
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Figure 5-2: Demonstration of the Stern Layer on a positively charged surface. Modified from
[88].
5.7 Application
Having established the base theory behind electro-osmotic flow, we now apply this theory
to different channel geometries to calculate the electro-osmotic flow velocity. We consider
the electro-osmotic flow velocity in both the parallel plate (one-dimensional) and cylindrical
(two-dimensional) case. The goal in both cases is to express the electro-osmotic flow velocity
in terms of known properties of the system and the surface charge density which can then
be calculated using experimental work into streaming potential. The theory for streaming
potential is detailed in section 5.6.4 and it’s application to find electro-osmotic flow velocity
in shown in section 5.8.
In both the parallel plate and cylindrical geometries, the derivation of the velocity in terms
of surface charge density is split into three distinct stages, namely:
1. Starting from the incompressible Navier-Stokes equations, detailed in section 5.4, ex-
press electro-osmotic flow velocity in terms of double layer potential.
2. Express the double layer potential, and hence velocity, in terms of the zeta potential.
3. Express the zeta potential in terms of surface charge density, leading to an expression
for velocity in terms of surface charge density and known parameters for the system.
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How these steps were achieved for the parallel plate and cylindrical cases under the assump-
tions given in section 5.7.1 are expanded on in sections 5.7.2 and 5.7.3 respectively.
5.7.1 Assumptions
In both the parallel plate and cylindrical case, there are consistent assumptions. In the
channel, we assume that:
1. Channel walls are identical with constant surface charge density at all points.
2. Charge density and channel dimensions are constant along the channel, the x direction.
3. There are either no or negligible effects created at each end of the channel.
In order to calculate the velocity of electro-osmotic flow, we first consider the Navier-Stokes
equation for fluid flow in an electric field, given in equation (5.1), and the Poisson equation,
given in equation 5.8, under the additional assumptions:
1. The electric field applied is constant.
2. The concentration of ions with respect to time is constant throughout the system and
uniformly distributed in x.
3. The channel walls have a no-slip boundary condition.
4. The electric current is primarily carried by the salt NaCl - the most prevalent electrolyte
in skin as demonstrated by the composition of PBS buffer solutions [18].
5. Ions are point charges, hence we consider the Stern layer to have zero size and the
surface potential on the channel walls to be equal to the zeta potential.
Under these assumptions, the velocity can be expressed as a function of the potential created
in the double layer. We then express the potential created in the double layer in terms of the
zeta potential under the assumptions:
1. The system is electro-neutral - this makes the overall system stable and means we don’t
have a net overall charge created. This is in line with prior research [33].
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2. The potential created by the electric double layer, ψ, is small (≤ 25mV).
This results in an expression for electro-osmotic velocity where the only unknown is the
zeta potential. We then move on to express the zeta potential in terms of the surface charge
density. There are several approaches for modelling surface charge density based on streaming
potential which we address later in the chapter.
Additional assumptions in each case are given in the appropriate section.
5.7.2 Parallel Plate Approach
The parallel plate approach considers two parallel plates separated by distance 2r0 as demon-
strated in Figure 5-3. In order to model electro-osmosis in this case, we consider the effect
of one plate in y ∈ [0, r0], i.e. between the surface and the center of the channel, and assume
the behaviour is mirrored by the second plate.
Figure 5-3: Graphical representation of electro-osmotic flow between two parallel plates. Like
skin at physiological pH, the channel walls are considered to be negatively charged. In order
to maintain electro-neutrality, this is reflected by more positively charged ions in the channel,
hence the predominant flow direction is towards the cathode. If the membrane was positively
charged the flow direction would be reversed. L represents the length of the channel.
For the parallel plate case, the steps given in section 5.7 are achieved as follows:
1. Express electro-osmotic flow velocity in terms of double layer potential:
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(a) This section was started by considering the incompressible Navier-Stokes equations
with body force due to an applied electric field, as detailed in section 5.4.
(b) Using the Poisson equation, detailed in section 5.5, charge density was then linked
to double layer potential.
(c) The expression for charge density in terms of double layer potential was then
substituted into the body force term in the incompressible Navier-Stokes equation.
Solving the resulting ODE gave an expression for electro-osmotic flow velocity in
terms of double layer potential.
2. Express the double layer potential in terms of zeta potential:
(a) Using the Poisson-Boltzmann equation, detailed in section 5.5, an ODE for double
layer potential was found.
(b) Solving the ODE for double layer potential using boundary conditions on the par-
allel plate case, an expression for double layer potential in terms of zeta potential
was found.
(c) Combining the expression obtained for double layer potential in terms of zeta
potential with the results from step 1 expressed the electro-osmotic flow velocity
in terms of zeta potential.
3. Express the zeta potential in terms of surface charge density:
(a) Assuming that the system was electro-neutral, it was possible to link the charge
density in the fluid to the surface charge density.
(b) Using the Poisson equation, detailed in section 5.5, an expression was found for
surface charge density in terms of the double layer potential which, using the
results of step 2, could be expressed in terms of zeta potential.
(c) It was then possible to combine the relation between surface charge density and
zeta potential with the result of step 2 in order to express the electro-osmotic flow
velocity in terms of known properties of the system and the surface charge density.
We now move on to expand these steps in the following sections.
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Expressing velocity in terms of the double layer potential
In order to find the velocity of electro-osmotic flow in terms of double layer potential, we
consider the fluid flow through the channel given in figure 5-3 using the incompressible Navier-
Stokes equations [96] discussed in section 5.4:
η∇2v(x) + ρe(x)E(x) = 0.
As discussed in section 5.5, the Poisson [96] equation links the net charge density to the
dielectric permittivity of the fluid, ² = ²w²0, and the double layer potential, ψ(x), which,





As the only non-zero component of velocity occurs in the x-direction and only varies in the
y direction, vx(y), the applied field is considered to be constant and to only act in the x







(y)Ex = 0, (5.9)
which is an ODE with boundary conditions given by:
1. The no slip assumption on the channel wall (shear plane) means that vx(0) = 0 and,
as we consider ions to be point charges, potential on the shear boundary, ψ(0), is equal
to the zeta potential, ζ.
2. As demonstrated by figure 5-3, the velocity in the middle of the channel is maximal,
hence dvx/dy(r0) = 0. The potential is also at a minimum in the center of the channel,
hence dψ/dy(r0) = 0.







which is the electro-osmotic flow velocity in terms of the zeta potential and electric potential
caused by the double layer.
Expressing the double layer potential in terms of the zeta potential
The next stage in expressing the electro-osmotic velocity in terms of known constants is to
express ψ(y) in terms of ζ. This was done by constructing an ordinary differential equation
for ψ(y) using the Poisson equation, given in equation (5.8) and explained in section 5.5. To
express ρe(y) in terms of ψ(y), we use the Boltzmann equation given in equation (5.4) in
section 5.5 [88]. Using the Boltzmann equation, the local ion concentration for ionic species
i, ci, in one spatial dimension y is given by





where c0i is the bulk concentration of ion i in the solvent, i.e. where the work done by the
field is equal to zero, kB is the Boltzmann constant, T is temperature and Wi(y) is the work
exerted by the field on ion i at distance y.
As we have assumed that the predominant ions are sodium, i = 1 charge +e, and chlorine,
i = 2 charge -e, the work exerted by the field on these ions is Wi(y) = ∓eψ(y) where e is the
elementary charge. In order to calculate charge density at a point, we take the sum of the
charge on each ionic species at that point, hence in this system:
ρe(y) = Nae(c2(y)− c1(y)). (5.12)
It is assumed that concentration of ions is measured in moles, hence to obtain charge we
multiply concentration by the number of ions in 1 mol, Avogadro’s number, Na, and the














and, as the bulk concentration of ions is equal to the bulk concentration of the salt due to






























Assuming that the potential created by the electric double layer is small, the sinh(eψ(y)kBT ) term
can be considered to be approximately equal to eψ(y)kBT we obtain the ODE
d2ψ
dy2







and κ−1 = λD is the Debye length described in section 5.6.3 [88]. Solving equation (5.14)
results in the expression for the potential through the double layer
ψ(y) = αexp(−κy) + βexp(κy), (5.16)
where α and β are constants determined by the boundary conditions. Using that ψ(0) = ζ
and that solution is bounded as y → ∞, we get that α = ζ and β = 0 and therefore can





and results in the velocity profile given in figure 5-4 which shows that far away from the




which is in-line with prior theory [96]. Permittivity of free space, ²0, is a known constant, the
relative permittivity ²w, and dynamic viscosity, η, are based on the fluid considered, which
can be found in the literature for many types of fluids and the electric field, Ex, is a property
of the field applied to the skin. The zeta potential, ζ, is unknown, but can be found in terms
of known parameters using results from surface chemistry [88] and the electro-neutrality
assumption, which is addressed in the next section.
Figure 5-4: Demonstration velocity profile formed in the electric double layer in the one
dimensional case.
Finding the zeta potential
Equation (5.17) gives the velocity due to electro-osmosis based on known constants, the
permittivity of free space, ²0, properties of the solvent, ²w and η, properties of the field
applied across the membrane, Ex, and the zeta potential, ζ, on the channel walls. This
section considers how to find the zeta potential in terms of surface charge which is then
investigated later in the chapter.
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As the system is assumed to be electro-neutral and the charge considered to be split evenly
between the two plates, the surface charge density on the channel walls, σ, can be related to

























As we have assumed that the velocity in the center of the channel, y = r0, is maximised and
that the channel is symmetric around the center, the electric potential of the double layer











Under the low potential assumption ψ(y) is given in equation (5.16). Differentiation of
equation (5.16) combined with equation (5.18) results in





since κ−1 = λD which matches prior theory into surface chemistry [88]. So, we have shown
that the zeta potential can be linked to the surface charge density in this case. Hence, we










where κ is given in equation (5.15). Equation 5.19 gives the electro-osmotic flow velocity
through the channel in terms of properties of the solvent, universal constants, properties of
the applied field and the surface charge density. The only current unknown is the surface
charge density. We discuss methods of finding surface charge density later in this chapter.
5.7.3 Cylindrical Approach
In the previous section, we calculated the velocity of electro-osmosis by considering the chan-
nel through the skin as being sandwiched between two parallel plates. This had several issues
when calculating ψ(y) and neglects the effects of curved walls. A more accurate scenario is
to consider channels through the skin as being cylindrical, as depicted in figure 5-5. In this
case, in addition to the assumptions listed in section 5.7.1, we also assume that the system
is radially and axially symmetric.
For the cylindrical case, the steps given in section 5.7 are achieved as follows:
1. Express electro-osmotic flow velocity in terms of double layer potential:
(a) This section was started by considering the incompressible Navier-Stokes equations
with body force due to an applied electric field, as detailed in section 5.4.
(b) The Poisson-Boltzmann equation, detailed in section 5.5, was used to find an
expression for the net charge density in terms of the double layer potential.
(c) The expression for net charge density in terms of double layer potential was com-
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Figure 5-5: Graphical representation of the cylindrical reverse iontophoresis model. This
model is considered to be radially symmetric and uniform in x. The length of the tube is L.
bined with the incompressible Navier-Stokes equation to form a differential equa-
tion for velocity of electro-osmotic flow in terms of the double layer potential.
As the double layer potential was an unknown function at this point it was not
possible to solve the differential equation formed at this stage.
2. Express the double layer potential in terms of zeta potential:
(a) Using the Poisson-Boltzmann equation, an ODE for the double layer potential was
found and solved using boundary conditions on the system to give an expression
for double layer potential in terms of zeta potential.
(b) The expression for the double layer potential in terms of zeta potential was com-
bined with the results of step 1 in order to obtain a differential equation for electro-
osmotic flow velocity in terms of zeta potential.
(c) The resulting differential equation for the electro-osmotic flow velocity was solved
in order to give the electro-osmotic flow velocity in terms of the zeta potential.
3. Express the zeta potential in terms of surface charge density:
(a) Assuming that the system was electro-neutral, it was possible to link the charge
density in the fluid to the surface charge density.
(b) Using the Poisson equation, detailed in section 5.5, an expression was found for
surface charge density in terms of the double layer potential which, using the
results of step 2, could be expressed in terms of zeta potential.
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(c) It was then possible to combine the relation between surface charge density and
zeta potential with the result of step 2 in order to express the electro-osmotic flow
velocity in terms of known properties of the system and the surface charge density.
We now move on to expand these steps in the following sections.
Expressing velocity in terms of the double layer potential
Electro-osmotic flow velocity is governed by the Navier-Stokes equation for an incompressible
flow under the assumptions of constant pressure, low Reynolds number and steady state
η∇2v(x) + ρe(x)E(x) = 0,













In order to express, ρe(r) in terms of ζ, we first need to express ρe(r) in terms of ψ(r). Using















If we now consider the definition of net charge density based on the ion concentration and
Boltzmann equation, as discussed in section 5.5, the resulting Poisson-Boltzman equation






























Expressing double layer potential in terms of the zeta potential
We now look to express ψ(r) in terms of ζ potential for substitution into equation (5.23).
Solving the resulting ODE will then give an expression of velocity in terms of zeta potential.


















(α)− α2ψ(α) = 0,
which is a zero order Bessel equation and hence, as there is no singularity in ψ(r) at r = 0, the
solution is given as a constant, β, multiplied by a zero order modified Bessel function of the
first kind, I0(κr). Bessel functions are detailed further in section 2.8. Using this definition,
the potential in the electric double layer is:
ψ(r) = βI0(κr).
Using the boundary condition displayed in figure 5-5 at the edge of the cylinder, ψ(r0) = ζ, it
is possible to calculate β which gives the distribution of electric potential in a cylinder based






which matches prior work [96]. Using the Navier-Stokes equation given in equation (5.20)
with velocity only acting in the x direction and only varying in the r direction, ρe in equation
(5.22) and the electric potential given in equation (5.25), we now find the ODE for velocity















with corresponding boundary conditions based the no-slip condition on the channel walls and







Using standard identities for integrating Bessel functions [100], namely
∫
uI0(u)du = uI1(u), (5.26)
and
∫
I1(u)du = −I0(u), (5.27)








which not only matches prior theory [96] but, in the case of a thin electric double layer, the
velocity reduces to be exactly the same as that found in the 1D case, in equation (5.17). In
the non-thin case, the velocity profile is shown in figure 5-6.
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Figure 5-6: Plot of how velocity varies with distance in a radial direction from the center of
the cylinder in the non-thin double layer case. Velocity reaches a maxima in the middle of
the channel.
Finding the zeta potential
Having found the velocity profile based on the zeta potential, we now attempt to find the zeta
potential based on the surface charge density. This starts in much the same way as in the
one dimensional case, where we use the electro-neutrality assumption to say that the surface







where A is the surface area and V the volume. Under the assumption that the charge is





















which can be combined with equation (5.25), which gives the electric potential in terms of a







Using the identities for the integrals of Bessel functions given in equations (5.26) and (5.27)














As demonstrated in section 2.8, modified Bessel functions of the first kind are monotonically
increasing with the ratio between two modified Bessel functions of the first kind tending to
one as κr0 → ∞. Hence, considering a thin double layer, in which r0 >> κ−1, and the





which is the same as the one-dimensional case. Hence, calculating electro-osmotic flow in a
cylinder and as a one dimensional channel only has a significant difference when considering
effects close to the double layer or in the case where the tube radius is close to the size of the
double layer. This is demonstrated in figure 5-7 for variation through the tube. Figure 5-8
shows the difference in velocity in the center of the tube as r0 increases and demonstrates
that the difference between the approaches tends to zero as the channel becomes much larger
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than the Debye length.
Figure 5-7: Comparison of the electro-osmotic velocity predicted in the 1D system (blue) and
cylindrical system (red) for a variety of tube sizes.
Figure 5-8: This figure demonstrates the difference between the cylindrical velocity and the
1D velocity in the center of a channel of radius r0. As is observed in figure 5-7, the 1D velocity
is greater than the cylindrical velocity when r0 is comparable to λ with this reversing as the
channel gets larger.
5.8 Surface Charge Density Calculation
Having established the electro-osmotic flow velocity in terms of known parameters and the
surface charge density for both the parallel plate and cylindrical channel geometries, we now
consider methods for finding the surface charge density.
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5.8.1 Average Charge Concentration in the Fluid
Surface charge in the channel is caused by a surface absorbing unequal charges of positive
and negative ions from the surrounding fluid. In order to maintain an electro-neutral system,
this surface charge must be exactly matched by an opposite charge within the fluid, the net
charge density. Hence we have that the sum of charge through the fluid volume, V , is equal







Prior work has investigated finding the average charge concentration in the fluid, δc, in the
channel based on the bulk concentration of the ionic solvent and experimentally derived














It is assumed that the surface charge density is uniform at the channel and tube walls, hence
σ = −Naer0δc,




for the cylindrical case. Using equations (5.19) and (5.30) we obtain the velocities of electro-














Having established expressions for velocity in terms of channel dimensions and ionic charge
concentration in the solvent for both the parallel plate and cylindrical channel cases, we now
consider how to calculate ionic concentration based on the bulk electrolyte concentration.
There are two approaches for this, the first, named the Donnan approach [87], considers
a low bulk electrolyte concentration and hence ignores saturation effects. The second, the
adsorption isotherm approach, considers the ionic concentration when saturation effects begin
to become significant.
Donnan Approach
The Donnan approach links the average charge concentration in the fluid to the bulk elec-
trolyte concentration [87] using the Nernst-Planck equation in a strong, 1-1 electrolyte solu-
tion where electro-migration dominates the flow of ions. The result of this was that
δc = c0
θ√
1− θ , (5.33)










where D+ and D− are the aqueous diffusion coefficient of the cation and anions respectively,
in this case Na+ and Cl-, and tM+ and t
w
+ are the transport numbers of the cation in the
membrane and water. All of these parameters can be found in the literature and are given
in tables 5.1 and 5.2.
Hence, δc at a bulk electrolyte concentration of 133mM is 39mM which corresponds to a
surface charge density of 18.78 mCm-3 at a channel radius of 20nm.
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Table 5.2: Table of parameters for calculating the ionic charge concentration using the Donan
approach.
Parameter Value Definition Reference
D+ 1.344x10-5cm2s-1 Aqueous diffusion coefficient of Na+ [85]
D− 2.032x10-5cm2s-1 Aqueous diffusion coefficient of Cl- [85]
tM+ 0.62 Transport number of Na
+ in the membrane [87]
tw+ 0.50 Transport number of Na
+ in water [87]
The calculated value for δc is 10 times larger than would be expected for a corresponding
KCl solution [87]. This is likely due to saturation of ions in the channel walls, especially for
a 133mM solution as saturation is achieved far before this in a corresponding KCl solution
[87], hence we consider the adsorption isotherm approach.
Adsorption Isotherm Approach
The Donnan approach is valid when saturation of ionic charge in the channel walls is not a
limiting factor. When this saturation does become a factor, the adsorption isotherm approach





based on the maximum charge concentration, δmax, and an adsorption constant, b. For the
salt KCl, δmax is predicted to be 2.8mM and b to be 0.17mM-1 by using electromotive force
measurements [87]. As this adsorption is based on the ability of the channel walls to absorb
Cl-, NaCl is likely to give a similar result. At low concentrations, equations (5.33) and (5.34)
should be equivalent. For low c0, 1 + bc0 → 1, hence comparing equations (5.33) and (5.34)
results in
δmaxb ≈ θ√
1− θ , (5.35)
which suggests that δmaxb = 0.294 for sodium chloride. Without specific experiments into
streaming potential through human skin with sodium chloride, as has been performed for
potassium chloride, it is not possible to separate δmax and b without experimental data.
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Analysis
If we consider the electro-osmotic velocity given in equation (5.32) with δc given by the
adsorption isotherm approach in equation (5.34) then the complete expression for electro-





















Estimates for intercellular pore radius in the literature vary from 0.5nm [101] to 20nm [87]
with hair follicles having a pore radii varying between 50µm and 200µm depending on body
location and inter-person variability [102]. Using parameters from the literature given in
table 5.1, the Debye length at human body temperature is approximately 0.8nm. Hence for
all but the smallest pore radii
v(r)→ Naeδmaxr0Ex
2ηκ
, r0 >> κ
−1, (5.37)
which is proportional to pore radii, r0, as demonstrated in figure 5-9, and is contrary to prior
work into electro-osmotic flow effects in nano- and micro- fluid systems [88]. The difference in
pore diameter will result in a minimum velocity difference of order 103 between hair follicles
and intercellular space. Considering an applied field of 1V through a hair follicle results in
an electro-osmotic flow velocity of order 10-2ms-1 - which, considering L is approximately
20µm [18], would mean that compounds would travel completely through hair follicles in the
stratum corneum in a fraction of a second.
Additionally, the zeta potential predicted in hair follicles becomes of the order of 5V which
is much greater than the 25mV and hence violates the small potential assumption on the
electric double layer.
This suggests that using δc to find surface charge density, and hence electro-osmotic flow
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Figure 5-9: Demonstrating the dependence of electro-osmotic flow velocity on pore diameter.
velocity, is unsuitable when moving from nano-scale pore radii to micro-scale pore radii as
the resulting velocity scales linearly with pore size. Due to this, we propose that the limiting
law on ionic concentration in the solvent should instead be a limiting law on the surface
charge density as the limit is due to saturation of charge within the pore walls.
5.8.2 Modifications to Surface Charge Modelling
As identified in the previous section, the velocity of electro-osmotic flow through hair follicles
is very large due to an extremely large surface charge resulting in a zeta potential of approx-
imately 5V, far above the limit of 25mV previously suggested in theory. We showed that,
in this case, v was dependant on pore size, contradicting prior nano- and micro-fluid work
[88]. This is unrealistic suggesting that the theory needs to be modified when considering
micro-channels.
We consider three different approaches to calculating surface charge density that will stop
the velocity scaling linearly with pore radius. We begin by considering the simplest case by
having surface charge density linearly dependent on the bulk concentration of the fluid
σ = Ac0, (5.38)
where A is a constant based on the system considered. The second approach, in line with
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other micro-fluid theory [90], extends this relation to impose a limit on charge absorbed by






where σmax is the maximum possible surface charge and bσ is the adsorption constant. Pre-
vious research into streaming potential in the skin has been used to identify ionic charge
concentration in the fluid under the assumption that this is limited rather than the surface
charge density [90] and additionally suggested that a more accurate approach would be to







in order to account for chloride ions adsorption into the pore wall with a quasi-normal dis-
tribution of binding energies [90]. For the purpose of estimating parameters, we consider the
double layer to be thin.




























Table 5.3: Table summarising streaming potential results from prior work [87]. We also







all of which, for r0 >> λ, are independent of pore size as would be expected.
Parameter Estimation
In order to estimate A, σmax, bσ and n for our three approaches, prior work into streaming
potential through human skin was considered [87]. Details of streaming potential are given
in section 5.6.4 and the experimental results summarised in table 5.3.
As a first approximation, we consider the pore size to be much larger than the Debye length




η²0²w(D+ −D−) , (5.44)
















in the Freundlich isotherm case, detailed in equation (5.40).
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We use equations (5.44), (5.45) and (5.46) in combination with the results in table 5.3 to ob-
tain estimates for A, bσ, σmax and n focusing around the results obtained at higher c0 values
due to the Debye length being smaller and compare the results. Figure 5-10 plots the pre-
dicted streaming potential using A = 4.16x10−8m3mol-1 for the linear case, σ = 2.97mCm-2
and b = 0.0016molm-3 for the adsorption isotherm approach and σmax = 14.2mCm-2, b =
0.0066molm-3 and n = 0.167 for the Freundlich isotherm.
Figure 5-10: Comparison of the three different approaches to modelling surface charge density
compared to experimental data. Due to the limited number of points and potentially high
variability it is difficult to say which approach is most suitable.
All three approaches predict similar surface charge densities at high concentrations, but differ
significantly at low concentrations with the Freundlich approach seeming to mirror the data
closest. It is worth noting that at low concentrations, the Debye length increases which could
make the thin double layer assumption invalid and the small sample size makes it difficult to
identify experimental error. To validate these predicted parameters, more experimental work
is required.
As the bulk salt concentration of the PBS buffer used in iontophoresis experiments for
phenylalanine is 133mM [1, 2], issues at low concentrations are not key to this research.
At 133mM, the streaming potentials, and corresponding surface charge predicted for each of
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Table 5.4: Comparison of the streaming potential and surface charge density predicted by
each of the three approaches at 133mM.
Approach Streaming Potential (nV/Pa) σ (µCm-2)
Linear -1.98 553
Adsorption Isotherm -1.87 521
Freundlich Isotherm -0.76 208
the three approaches are given in table 5.4.
The sample size used to predict these measurements is very small, hence doing a full statistical
analysis is not appropriate. We instead consider the surface charge density at bulk NaCl
concentration of 133mM to be in the range [208,521]µCm-2 with a mean of 427µCm-2.
5.9 Chapter Summary
In this chapter we have presented methods of predicting the electro-osmotic flow velocity in
both a 1D and cylindrical channel using a combination of surface chemistry, electromagnetism
and fluid dynamics in a thin and non-thin double layer. As the amino acids we are considering
are uncharged, we do not consider electro-migration. The overall objective of the chapter was
to present the electro-osmotic velocity in terms of parameters that could be found or derived
from the literature.
In both the 1D and cylindrical cases, the derivation of flow velocity started by considering the
incompressible Navier-Stokes equations under an applied body determined by the external
electric field. Doing this allows the velocity of electro-osmosis to be calculated in terms of
the double layer potential.
Considering the potential using a mean field approximation, the Poisson-Boltzmann equation
then links the double layer potential to the zeta potential which allows the electro-osmotic
flow velocity to be expressed in terms of the zeta potential and position in the tube.
Having obtained this, we then moved on to consider finding the zeta potential in terms of
surface charge by using the Poisson-Boltzmann equation and considering the system to be














which were compared in figure 5-7. Comparison suggests that velocity increases away from
the channel walls, reaching a maxima in the center of the channel and that the difference
between the two approaches decreases as the pore size becomes much greater than the Debye





which is the Helmholtz result [90]. Considering the case of a thin electric double layer, it is
possible to find all parameters except surface charge directly from the literature and consid-
eration of the field applied to the channel. In order to approximate surface charge density,
we considered several approaches starting with calculating the average charge concentration
in the fluid and using the electro-neutrality assumption, as has been considered in previous
work [87]. Average charge concentration in the fluid was considered to be based on the bulk
concentration of the ionic salt which saturates as bulk concentration tends to infinity. We
showed that this approach results in an electro-osmotic velocity that is directly proportional
to the pore radius, violating prior work into nano- and micro-fluids [88]. Hence this approach
is not appropriate for considering both nano-channels through the intercellular space and
micro-channels through the hair follicles.
It was then proposed, again in line with prior surface chemistry work [90], that this limiting
effect was instead on the surface charge density directly. This meant that velocity did not
scale directly with pore radius making this approach appropriate for both nano- and micro-
fluid systems. We considered three different approaches to the behaviour of surface charge
based on the bulk concentration of the ionic salt namely linear, adsorption isotherm and
Freundlich isotherm and compared these approaches to experimental results for streaming
potential in the case of a thin double layer [87]. Due to the limited data available, it was
not possible to say which was the best approach out of these three, although prior literature
favours the Freundlich approach [90]. At 133mM this lead to a range of [208,521]µCm-2 for
surface charge density. More experimental work into streaming potential through human skin
would help verify which of these approaches was most suitable and provide more data points
for better estimation of parameters, especially for the Freundlich isotherm approach which
attempts to estimate 3 unknown parameters from 5 data points.
Overall we have combined information from several fields in order to find a working theory
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and parameters for electro-osmotic flow velocity through human skin based on the applied
field and known properties of fluid. More experimental work would be required to validate
some of these parameters, especially those associated with surface charge density over a range
of ionic salts and concentrations.
In the next chapter, we will use the theories on electro-osmotic velocity to model and test





In the previous chapters we have established models for blood serum concentration and skin
distribution of amino acids, specifically phenylalanine. We have also presented electro-osmotic
flow in terms of known or derived parameters.
The objective of this chapter is to combine all of this work into an extraction model for
phenylalanine under both passive extraction and extraction via reverse iontophoresis. An
initial model is formed and compared to in vitro and in vivo prior work [1, 2, 42]. We also
consider in vivo extraction of phenylalanine from patients with phenylketonuria (PKU) to
assess the possibility of identifying higher systemic levels of phenylalanine via transdermal
extraction [103].
This chapter then considers extensions to the initial model and proposes future avenues of
theoretical and supporting experimental development.
6.2 Parameters
Table 6.1 lists the key parameters for extraction through the skin as a reference for this
chapter. As hair follicles have been previously identified as a potential extraction route,
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Iontophoresis is the enhanced delivery of compounds through the skin via the application of
a small electric current. This technique has been used since the early 20th century to treat
various disorders, as detailed in chapter 1 [36]. Reverse iontophoresis is iontophoresis applied
in reverse so instead of delivering compounds through the skin, the focus is extraction of
compounds already in the skin [21].
As we have detailed basic reverse iontophoresis principles and its application potential in
chapter 1, this section focusses on prior mathematical modelling techniques for reverse ion-
tophoresis. As the focus of this thesis is large, uncharged compounds, we tend to focus around
papers that consider electro-osmotic flow.
Prior work suggests that for small ions, electro-migration dominates flux through the skin
[33]. Hence, when modelling extraction of small ions through the skin, electro-osmotic flow
effects are frequently considered negligible [21, 36, 38, 107]. Interestingly, work into electro-
migration suggests that the electro-migration flux is proportional to the electric field applied
[36, 91]. As shown in chapter 5, electro-osmotic velocity is also proportional to the electric
field applied. By definition, electric field strength is equal to the potential gradient in the
system so fixing the voltage would make the system easier to model, especially considering
previous work has shown that skin resistance changes over time based on voltage applied
[91, 105]. However, due to the dangers of high currents to living creatures, current is fixed in
many in vivo and in vitro reverse iontophoresis experiments [1, 2]. Noticeably, it is rare that
voltage is measured in these experiments, which could contribute significantly to the error
observed in these experiments and the time taken to achieve steady state.
Considering electro-osmotic transport through skin, the most prevalent approaches appear
to be either experimentally considering permeability of individual compounds through the





where J(x) is the flux at spatial co-ordinate x, where x = 0 represents the skin surface, As is
the surface area of skin considered and Cs is the source concentration. J∗(x) represents the
steady state flux hence J∗(0) is the steady state flux at the skin surface. Another approach
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where Ni is the flux density, Di the diffusion coefficient, zi the valence of species i, F is the
Faraday constant, R is the gas constant, T is the temperature and v is the electro-osmotic
flow velocity. The electro-osmotic flow velocity is then calculated using Onsager coefficients,
as discussed in chapter 5.
The permeability approach is an empirically calculated value, whereas the Nernst-Plank
equation is based on theoretical work. There are advantages and disadvantages to both
approaches. The theoretical approach is based on validated theories and hence can model real
life with significant confidence, but generally requires a deep understanding of the mechanisms
driving the system which can be very complex or not fully known. An empirical approach
is must faster and allows complicated models to be simulated via a more simple mechanism
which can be especially useful if the simplified results are then used in another model.
6.3.2 Hair Follicles
One of the routes of extraction through skin samples is considered to be through appendages,
such as hair follicles, through the skin. Although appendage routes only cover approximately
0.1% of the skin surface it has been suggested that they play a critical role in extraction
[32, 102].
Figure 6-1 demonstrates a hair follicle penetrating through the epidermis and bypassing the
tortuous lipid matrix that is the stratum corneum. The body of the hair follicle in this case
is called the shaft and the pore containing it the orifice. The shaft and orifice have different
diameters in different sites as demonstrated in table 6.2 and it is considered that transport
through the hair follicle route will occur in the orifice space not occupied by the hair shaft.
Noticeably, in the pharmaceutical case, there is not much consideration of area fraction of
the skin utilised in transport or the split between intercellular, intracellular and hair follicle
extraction. Indeed, for the most part hair follicles seem to be ignored in theoretical treatment
of the skin with flow considered to occur through pores with sizes estimated between 0.675nm
and 20nm, which ignores micro-fluid flows that would occur through hair follicles through
the stratum corneum [33, 87, 91].
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Figure 6-1: Cross section of human skin showing a hair follicle through the stratum corneum.
As an initial approximation, the hair follicle is considered to be uniform through the epider-
mis. Taken from [19].
Prior experimental work using scanning electrochemical microscopy (SCEM) has identified
that there is significant flux of large, uncharged compounds - specifically acetaminophen
- through hair follicles through the stratum corneum with almost no transport observed
through the intercellular space over the time period considered [32]. As hair follicles occupy
a very small fraction of the skin surface area and are a much less tortuous pathway than
the intercellular route, it is important to consider this extraction route separately. Even
though the experiment considering acetaminophen extraction showed no flux through the
intercellular space, it is important to note that acetaminophen does not occur naturally
in the skin, steady state was considered to be reached after 30 minutes of extraction and
identified some penetration into the intercellular space [32]. This might mean that the time
considered was not sufficient for the acetaminophen to fully penetrate the intercellular space
route.
6.3.3 Hindrance Modelling
Hindered transport models have been previously utilised to characterise flows through cap-
illaries in channels through porous membranes [35]. Hindered transport theory includes
inter-particle and particle-wall interactions. These interactions become of concern in trans-
port systems where the channel is comparable to the size of the particle. Curvature effects
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are also considered which are of concern in both small and large channels. The general form












where τ is the tortuosity of the system, H and W represent the hindrance factors for dif-
fusion and advection respectively and are based on the radius of the channel. Tortuosity
characterises the curvature and interconnectedness of the pore space and is used to relate
transport properties of the porous structure to its microscopic structure [108]. Tortuosity is
often empirically measured and is commonly estimated to be the length of the curve divided
by the the distance between the ends of it [109]. Prior work has derived expressions for H
and W empirically [110]
H(λ∗) = (1− λ∗)2(1− 2.144λ∗ + 2.089λ3∗ − 0.0948λ5∗),







where rp is the radius of the pore and rpa is the radius of the particle of interest. Clearly
if rp >> rpa then λ∗ → 0 causing H and W to tend to 1. In the case of an uncharged


















when the pore size is much larger than the particle size. Along its largest axis, a molecule
of phenylalanine has length of order 10-10m hence can be considered small compared to the
pore size for all but the smallest estimates of pore size through the intercellular space.
6.4 Initial Model
In order to construct an initial model for reverse iontophoresis through the skin we consider
flow through both the interceullar space and hair follicles as demonstrated graphically in
Figure 6-2. In order to model the flow, we make several assumptions, namely:
1. All channels are perfectly cylindrical.
2. The electric field applied is constant and uniform in x.
3. The intercellular and hair follicle routes are completely separate.
4. In line with prior theory, we consider cells as highly impermeable at the voltages used
in reverse iontophoresis [73]. If the voltage were significantly higher, cells would begin
to become permeable due to electroporation.
5. The system is initially considered to only vary in one spatial dimension and time. To do
this, the intercellular space route is considered in one spatial dimension, x, with path
length equal to the path length of the torturous route through the skin. Although this
will not affect the initial concentrations, it will change the surface area considered by
the ratio of the path length to the actual distance travelled through the skin.
6. Tortuous path effects are initially considered to be negligible.
7. The electric double layer described in chapter 5 is considered to be thin.
8. We initially consider the skin to follow the circuit diagram given in figure 6-3 where
R1, R2 and R3 are constant. It has been previously shown that skin resistance changes
with time and voltage applied [105], but not the effect under constant current.
9. Electro-osmotic velocity and diffusion coefficients are constant through the skin.
10. Hair follicles are considered to be unchanged from the viable epidermis to the stratum
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corneum.
Figure 6-2: Schematic diagram of the initial model. Ci(x, t), i ∈ [1, 3] represents concentration
in each compartment with x = 0 representing the surface of the skin with depth through
the skin increasing with x. The hair follicle is considered to be unchanged through the
stratum corneum and viable epidermis whereas the intercellular route is split with boundary
conditions at x = L1 given later. Later in the chapter L1 is extended to the path length of
the intercellular route, hence L2 6= L3.
Figure 6-2 does not give a velocity of electro-osmotic flow through the intercellular viable
epidermis because the skin is initially modelled according to the circuit diagram given in
Figure 6-3. As the resistance through the stratum corneum, R1 is much larger than through
the intercellular space, R2, for low frequency AC or DC currents [106], the potential drop over
the viable epidermis will be negligible compared to that over the stratum corneum. Hence,
as velocity of electro-osmotic flow is proportional to the potential gradient, the velocity of
electro-osmosis in the viable epidermis intercellular pathway is considered to be negligible.
The resistivity of the stratum corneum has been previously found to be 8x104Sm-1. This
value, in combination with L1 and Ohm’s law [98], will be used to calculate the voltage
across the stratum corneum in the case of constant current density.
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Figure 6-3: Initial circuit diagram through the skin. Although there are much more complex
effects through the skin, this is sufficient to demonstrate why electro-osmotic flow does not
occur through the intercellular space in the viable epidermis. Resistance of each layer is
found by considering the resistivity of the layer multiplied by it’s length. As this is a parallel
circuit, the potential difference across each route will be the same.
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6.4.1 Model Formation
The model schematic shown in figure 6-2 results in the following system of governing equations






















(x, t) = 0, x ∈ [0, L3], ∀t ≥ 0, (6.4)
with corresponding cross sectional surface areas A1, A2 and A3 respectively. We consider the
intercellular pathway through the stratum corneum and viable epidermis to occupy the same
physical surface area, A, but are required to scale this due to the change in porosity between
the two compartments. Porosity measures the fraction of space not occupied by objects in
a material and can be calculated by multiplying the surface area occupied by pores by the
tortuosity of the path
A1 = τ1A, (6.5)
A2 = τ2A, (6.6)








L2 − L1 .
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The boundary conditions are based on the cathode compartment on the skin surface, x = 0,
being a sink
C1(0, t) = C3(0, t) = 0, ∀t ≥ 0, (6.7)
on the amount on the stratum corneum/viable epidermis boundary, x = L1, being equal
when scaled by partition coefficient, k, to represent the material changes between the stratum
corneum and viable epidermis
C1(L1, t) = kC2(L1, t) (6.8)















, ∀t ≥ 0.















, ∀t ≥ 0. (6.9)
The final boundary condition is found by considering the donor (anode) compartment as a
source, x = L2 or L3 for the intercellular and hair follicle routes respectively:
C2(L2, t) = C3(L3, t) = Cs, ∀t ≥ 0. (6.10)
We also consider initial conditions based on previously calculated steady state profiles, given
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+ ψCs, x ∈ (d, LSC ],







is a correction based on the path length as the initial conditions calculated previously are
based on the physical depth of the stratum corneum, LSC , and not adjusted for the length of
the intercellular pathway. kp is the production rate of amino acid in the stratum corneum, d
is the depth of the stratum disjunctum, vc is the velocity of cells towards the surface of the
skin, DSC is the diffusion coefficient in the stratum corneum using the Potts and Guy model
[34], ψ is the volume ratio between the stratum corneum and viable epidermis and γ is a
removal constant for amino acid in the stratum disjunctum. The values for these parameters
are given in table 6.1 and discussed in more detail in chapter 3.
From our previous work into electro-osmosis theory, given in chapter 5, we know that the
velocity of electro-osmosis, vi, i ∈ [1, 3], is based on the Debye length, λ = κ−1, dynamic




where the ± depends upon the definition of the flow direction. The electric field, Exi, is






where ∆φ is the potential difference applied and σ is considered to follow the adsorption





where σmax is the maximum surface charge density and b is the absorption coefficient.
6.4.2 Model Analysis
In order to analyse steady state behaviour, we consider the steady state solutions, Ci(x, t) =
C∗ip(x), i ∈ [1, 2, 3], of equations (6.2), (6.3) and (6.4) under the corresponding boundary
conditions in the passive case where v1 = v3 = 0
C∗1p(x) = Cs
kx
L1 + kδ(L2 − L1) , x ∈ [0, L1], (6.16)
C∗2p(x) = Cs
kδ(x− L1) + L1










In the reverse iontophoresis case at steady state, Ci(x, t) = C∗ir(x), i ∈ [1, 2, 3], where v1 6= 0










, x ∈ [0, L1], (6.19)
C∗2r(x) = Cs
kδv1(x− L1) +D(1− exp(−v1L1D ))
D(1− exp(−v1L1D )) + kδv1(L2 − L1)




, x ∈ [0, L3]. (6.21)
Consideration of equations (6.17) and (6.20) show that the profiles for C∗2p(x) and C∗2r(x)
are both linear with respect to x. At steady state, C1(x, t) and C3(x, t) are both linear
in the passive case and based on a constant multiplied by 1 − exp (−vix/D) in the reverse
iontophoresis case. This behaviour is demonstrated for the passive case and varying values
of vi in Figure 6-4.
When measuring experimental results of extraction through the stratum corneum, the mea-
sured quantity is usually based on flux at the skin surface, x = 0. In the passive case, the
flux is described by
Jip(x, t) = −D∂Cip(x, t)
∂x
, i ∈ [1, 2, 3],
hence using equations (6.16) and (6.18) we obtain the passive flux at steady state at the skin
surface for the intercellular stratum corneum
J∗1p(0) = −
DkCs
L1 + kδ(L2 − L1) , (6.22)





For iontophoretic extraction, the flux is described by
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Figure 6-4: Demonstration of the profile obtained for C1(x, t) and C3(x, t) at steady state
with no electro-osmosis and varying velocities. As velocity increases out of the skin, the
gradient at x = 0 increases which will increase flux out the skin.
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Jir(x, t) = −D∂Cir(x, t)
∂x
− viCir, i ∈ [1, 2, 3],










for the intercellular route and hair follicle route respectively at the skin surface.
In the time dependent case, numerical solutions, specifically the method of lines described
in section 2.6.2, are utilised as they offer greater insight into the extraction profile than the
analytical solution.
6.4.3 Application to Experimental Work
In order to analyse the results of this model, we compare the model predictions with real
data in the following scenarios:
• In vitro passive mannitol permeability at steady state in abdominal skin [111].
• In vitro iontophoretic mannitol permeability at steady state in mixed skin samples [42].
• In vivo passive and iontophoretic phenylalanine flux at steady state [2].
• In vivo passive and iontophoretic phenylalanine flux at non-steady state [2].
• In vivo iontophoretic extraction of phenylalanine in patients with PKU [103].
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Passive mannitol permeability in abdominal skin
The aim of this section is to consider in vitro passive diffusion of mannitol through abdominal
skin [43] which considers extraction for hair and intercellular extraction separately. Hence,
we use these results to check our predictions for hair follicle extraction predictions and obtain
estimates for intercellular surface area.
Using the definition of permeability in equation (6.1) in combination with equations (6.22)









A is currently unknown whereas A3 is known based on body site considered [102] as shown
in table 6.2.
In vitro [43] results for abdominal skin attempt to split the permeability of mannitol through
the hair follicle and intercellular route by considering extraction through two stacked skin
samples. Using the results for intercellular permeability in the passive case combined with
equation (6.26), we attempt to predict the area fraction, A, of the skin sample utilised by the
intercellular route. The in vitro results for hair follicles are then compared to the predictions
obtained using equation (6.27). The parameters values used are listed in table 6.1 with the
skin site considered being abdominal skin for hair follicle density in 6.2.
The results for area fraction occupied by the intercellular space in abdominal skin and the
comparison of predicted and in vitro hair follicle permeability are summarised in table 6.3.
These results initially suggests that the predicted permeability due to the hair follicles is far
higher than the permeability measured experimentally. It also suggests that the area fraction
used by the intercellular route is very small compared to the surface area of the skin exposed.
Comparing the permeability measured in this experiment with other in vitro data [42], the
permeability found in abdominal skin in this experiment is of order 102-104 lower compared to
other in vitro sources [42]. This may be due to the diffusion area considered being 0.126cm2
[43] and the hair follicle density in abdominal skin being 6cm-2 [102]. Hence it is entirely
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Table 6.3: Result summary for initial model applied to in vitro mannitol permeability through
abdominal skin [43]. Area fraction quoted is with respect to the whole skin surface.
In vitro Prediction Equation
Intercellular space permeability (ms-1) 3.13±1.76x10-11 - -
Area fraction used with IC route - 5.95±4.56x10-4 (6.26)
Hair follicle permeability (ms-1) 2.73±0.94x10-11 2.35±2.14x10-9 (6.27)
possible that hair follicles were not present in the 3 samples considered for this part of the
experiment and did not contribute to transport.
Due to this result, we consider the case where all of the extraction in this experiment occurred
through the intercellular space. Considering this case, the predicted area fraction occupied
by the intercellular pathway is 11.1±8.53x10-4, which is again very small compared to the
surface area of skin considered.
In vitro mannitol permeability under iontophoresis
There has been some work into mannitol extraction from the skin under a variety of con-
stant potential differences [42]. Here we compare the predicted extraction results with those
obtained experimentally. Similar to the previous section, extraction results are recorded by
considering permeability which is linked to flux in the passive case for intercellular space and
hair follicles via equations (6.26) and (6.27) respectively. When an electric field is applied,
the permeability of the intercellular space, P1r, and hair follicle, P3r, routes are determined
using flux through the skin under an applied field. At steady state at the skin surface, these
fluxes are given by equations (6.24) and (6.25) which, in combination with the definition of
permeability in equation (6.1), gives:
P1r =
kDv1A3






The location for the skin is obtained from is not stated for in vitro mannitol extraction, with
the acceptable range of starting permeabilities being between 3x10-9ms-1 and 3x10-7ms-1.
Hence, we consider the mean area fraction occupied by hair follicles for this experiment to
be the mean of all sites considered by prior work given in table 6.2 [102] which corresponds
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Table 6.4: Result summary for initial model applied to in vitro mannitol permeability under
iontophoresis[42]. Corresponding equations to calculate predicted values are also given in the
table.
Permeability In vitro Samples Prediction Equation
Passive (ms-1) 1.07±1.79x10-9 12 2.87±3.09x10-8 (6.26)(6.27)
125mV (ms-1) 2.55±4.32x10-9 4 2.97±3.09x10-8 (6.28)(6.29)
250mV (ms-1) 1.69±2.18x10-9 3 3.09±3.32x10-8 (6.28)(6.29)
1000mV (ms-1) 7.54±6.19x10-9 5 3.76±4.06x10-8 (6.28)(6.29)
to a skin surface area fraction of 2.7x10-3. Using this skin surface area in combination with
equation (6.27) and the parameters given in table 6.1 results in a passive permeability of
2.87±3.09x10-8ms-1.
Electro-osmotic flow velocity is calculated using equation (6.14) based on the potential dif-
ference across the skin.
The predicted results using the parameters given in table 6.1 are compared to in vitro man-
nitol extraction results under passive and iontophoretic extraction [42] in table 6.4. It is clear
that, similar to the passive case, the hair follicle route dominates the extraction profile with
the predicted results being 10 times higher than those predicted experimentally. This is again
likely due to the variability in hair follicle size between different sites. We also notice a drop
in average permeability between 125mV and 250mV which is likely an error due to different
pieces of skin and a low sample size.
Steady state phenylalanine extraction in vivo
Having established a prediction for the fraction of the skin surface utilised by the intercellular
route and having identified the need for skin site considered to be known to reduce hair follicle
variability, we now consider the extraction profile obtained for phenylalanine at steady state
and compare it to in vivo data [2]. Samples are taken from 4 subjects ventral forearm skin for
both passive extraction and under a constant applied current density of 0.3mAcm-2. Unlike
the previous cases, the area from which the skin is taken is known so the area utilised by the
hair follicle pathway can be estimated with a higher degree of accuracy from table 6.2.
Instead of considering permeability, these in vivo results directly consider flux at the surface
of the skin. Hence, equations (6.22) and (6.23) are used for the passive case and equations
(6.24) and (6.25) are used for the iontophoretic case. As the area the flux is considered over
in the experiment is the surface area of the skin exposed, it is necessary to multiply all fluxes
by the area fraction that route occupies.
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Table 6.5: Result summary for initial model applied to in vivo phenylalanine flux at steady
state [2].
Flux In vitro Prediction
Passive total (molm-2s-1) 8.3x10-10 5.93±5.40x10-10
Passive through hair (molm-2s-1) - 5.92±5.40x10-10
Passive through intercellular space (molm-2s-1) - 1.79±1.42x10-12
Reverse iontophoresis total (molm-2s-1) 2x10-9 1.58±1.71x10-9
Reverse iontophoresis hair (molm-2s-1) - 1.58±1.71x10-9
Reverse iontophoresis intercellular space (molm-2s-1) - 2.52±2.70x10-12
Electro-osmotic flow velocity is directly proportional to electric field strength which is, in
turn, directly proportional to the potential difference across the membrane. Considering the
resistance of the skin to remain constant throughout the experiment and using Ohm’s law
[98], V = IR, we obtain estimates for the voltage applied based on the parameters given
in table 6.1. Hence, using equation (6.14) we obtain predictions for the electro-osmotic flow
velocity, v1 = 3.18± 1.06x10−6ms-1 and v3 = 3.10± 1.03x10−5ms-1.
The results for the steady state are given in table 6.5. These results show that both passive
and iontophoretic phenylalanine extraction fluxes are comparable between the predicted and
experimentally obtained results. Additionally, transport in both cases is again dominated by
the hair follicle pathway.
Time dependent phenylalanine extraction in vivo
For non-steady state flux measurements, we use numerical solutions to the model system pre-
sented in section 6.4.1. Figure 6-5 compares the experimentally obtained flux of phenylalanine
in vivo [2] with that predicted by the model in 30 minute intervals under both passive and
iontophoretic extraction. The parameters used are those presented in table 6.1 with a fixed
current of 0.3mA/cm2. In both cases, the model results show the steady state is being
achieved far faster than is observed experimentally. The steady state displayed in Figure 6-5
is the same as predicted in table 6.5 with units changed to match in vivo extraction results
[2].




0, x ∈ [0, LSC ],
Cs, x ∈ (LSC , L3],
(6.30)
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Figure 6-5: Comparison between in vivo (yellow) and predicted (blue) extraction profiles in
the passive (left) and iontophoretic (right) case.
as the rapid transport through this route could mean that no phenylalanine is stored here
naturally. This again demonstrates a rapidly obtained steady state and suggests little inter-
ference from the intercellular route.
Phenylketonuria
Prior experimental work into phenylalanine extraction through human skin has suggested
that there is a measurable difference in observed extraction fluxes of phenylalanine with
higher systemic concentrations causing higher extraction fluxes as demonstrated in Figure
6-7 [103]. These fluxes were obtained through ventral forearm skin.
Considering the flux expressions in equations (6.22), (6.23), (6.24) and (6.25) the model
predicts the steady state extraction flux to be linear with respect to systemic concentration.
Figure 6-8 considers the extraction flux through forearm skin with systemic concentrations
corresponding to a non-PKU suffering patient, with Cs = 0.057mM, and a PKU suffering
patient, with Cs = 0.6mM. The parameters used are given in table 6.1 under an applied
current of 0.3mA/cm2 which is converted into a electro-osmotic velocity using Ohm’s law
and equation (6.14).
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Figure 6-6: Comparison between in vivo (yellow) and predicted (blue) extraction profiles
in the passive (left) and iontophoretic (right) case with a zero initial condition in the hair
follicles.
Comparing Figures 6-5 and 6-8 demonstrates that the initial model predicts a significant
difference in extracted phenylalanine concentrations between patients with and without PKU.
However, comparing Figures 6-7 and 6-8 it is suggested that the predicted flux reaches a
steady state faster than expected and that the steady state reached is higher than would be
expected.
6.4.4 Summary of Initial Model Findings
The initial model suggests that the hair follicle route is vitally important in determining
the permeability of skin, as has been demonstrated in prior experimental work [32]. Due
to the importance of hair follicle routes, and the variability in hair follicle density and size
over the body, we have demonstrated that predicting results from passive or iontophoretic
extraction without knowledge of the exact body site considered is very difficult. In the case
of phenylalanine extraction from ventral forearm skin, both the passive and iontophoretic
extraction cases are predicted well by the model at steady state, but appear to reach the
steady state faster than expected, as demonstrated by Figure 6-5. As a very small proportion
of the intercellular space it utilised in transport, this also means that only a fraction of the
skin reservoir is extracted.
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Figure 6-7: (A) - Plasma phenylalanine concentrations in the PKU suffering patients and
control patients over the 6 hour extraction period. (B) - Phenylalanine concentration ob-
tained in the extracted solution. As the extraction area was 1cm2, the units are equivalent
to nmolcm-2h-1. Taken from [103]. In both A and B, different symbols represent different
patients with PKU systemic concentrations ranging from 200-1000µM and the patients below
this representing the control group.
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Figure 6-8: Passive (left) and iontophoretic (right) extraction profiles of phenylalanine in
patients with phenylketonuria with a non-zero initial condition, given in equation (6.13) in
the hair follicle stratum corneum.
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Considering the initial model system, it should also be possible to tell significant differences
between systemic concentrations of phenylalanine after a relatively short period of time. This
is especially relevant when considering that prior work has shown that, at steady state, a pa-
tient suffering from PKU will have 10 times the systemic concentration of phenylalanine than
a patient not suffering from PKU. Considering equations (6.22)-(6.25), the model predicts
that the flux extracted at steady state is directly proportional to Cs, hence the 10-fold in-
crease in Cs in patients suffering from PKU is reflected by a 10-fold increase in extraction
profile.
For iontophoresis, prior in vitro work into extraction with zero concentration of phenylalanine
in the subdermal compartment suggests that porcine stratum corneum is fully analysed within
the first two hours of extraction [1]. If this behaviour holds true for human skin, then we
would expect the model to predict a greater amount of the skin reservoir to be extracted at
a slower rate than it suggests.
In order to tackle this discrepancy, hindered transport theory, explained in section 6.3.3, is
considered for flux through the porous intercellular space.
6.5 Model Adaptation Including Hindrance Effects
The previous section, and prior work into acetaminophen extraction [32], has suggested that
the majority of transdermal extraction occurs through hair follicles. However, the extraction
of the skin reservoir still proves complex with the initial model predicting the skin reservoir
emptying far faster than would be expected.
This section applies hindrance modelling techniques that have been used previously in capil-
lary flow through porous membranes to model flow through the stratum corneum intercellular
space as described in section 6.3.3 [110, 112].
6.5.1 Model Alterations
As the hair follicle route is considered to be directly through the skin, we do not consider hin-
drance modelling for flows through this route. The stratum corneum and the viable epidermis
however, as demonstrated in chapter 4, have torturous pathways. Hindered transport has
been described in section 6.3.3 and, under the assumption that the radius of the phenylalanine
molecule is not comparable to the pore size which, considering the size of phenylalanine is of
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the order of 10-10m [5], holds for all but the smallest estimates of pore size, results in scaling
the flux by the tortuosity of the pathway. Applying this to the governing equations for the





















= 0, x ∈ (L1, L2], ∀t ≥ 0.
The sink, source and concentration boundary conditions, given in equations (6.7), (6.10) and
(6.8) respectively, for the initial model still hold for the hindered model. However, due to the











(L1, t), ∀t ≥ 0.
with the initial conditions for the intercellular space remaining unchanged from the initial
model system, given in equations (6.11) and (6.12). For the hair follicles, we consider both
the zero initial condition, given in equation (6.30), and a non-zero initial condition, given in
equation (6.13).
6.5.2 Steady State Solution
The steady state for the hair follicle route remains unchanged in both the passive and ion-




L1 + kδ2(L2 − L1)x, x ∈ [0, L1],
C∗2p(x) = Cs
δ2k(x− L1) + L1
L1 + kδ2(L2 − L1) , x ∈ (L1, L2],
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are the passive steady state concentrations with corresponding steady state flux
J∗1p(0) = −
kDτ1Cs
L1 + kδ2(L2 − L1) ,
at the surface of the skin. In the iontophoretic case
C∗1r(x) =
CskD






, x ∈ [0, L1],
C∗2r(x) = Cs
kδ2v1(x− L1) +D(1− exp(−v1L1D ))
D(1− exp(−v1L1D )) + kδ2v1(L2 − L1)
, x ∈ (L1, L2],
with corresponding steady state flux
J∗1r(0) = −
CskDτ1v1
D(1− exp(−v1L1D )) + kv1δ2(L2 − L1)
,
at the surface of the skin.
6.5.3 In Vivo time dependent
The initial model, and prior experimental work into acetaminophen extraction through human
skin [32], suggest that the majority of extraction, especially at steady state, is through hair
follicles. Thus we focus on the non-steady state in vivo case [2] as the skin site used in this
experiment is known and the modifications will not affect the steady state position of hair
follicle extraction. In the same manner as the initial model, we consider numerical solutions
for non-steady state behaviour using the method of lines detailed in section 2.6.2.
Figures 6-9, 6-10, 6-11 and 6-12 consider the extraction profiles generated when using the
initial condition for hair given in equation (6.13) over a range of fractions of the intercellular
space utilised. The range considered is between 0 and the volume fraction of the skin occupied
by the intercellular space, p = 0.084. From these results, it is clear that the model predicts
that a very small fraction of the intercellular space is utilised in extraction - approximately
10% of the intercellular area available which translates to 0.84% of the total skin surface area.
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Figure 6-9: Hindrance model with the whole of the intercellular space fraction utilised in
transport. These show both model (blue) and in vivo experimental data [2] (yellow) in the
passive (left) and iontophoretic (right) case. The hair follicle is considered to have the same
initial concentration as the stratum corneum intercellular space given in equation (6.13).
Parameters are calculated using table 6.1.
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Figure 6-10: Hindrance model with 50% of the intercellular space fraction utilised in trans-
port. These show both model (blue) and in vivo experimental data [2] (yellow) in the passive
(left) and iontophoretic (right) case. The hair follicle is considered to have the same initial
concentration as the stratum corneum intercellular space given in equation (6.13). Parame-
ters are calculated using table 6.1.
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Figure 6-11: Hindrance model with 25% of the intercellular space fraction utilised in trans-
port. These show both model (blue) and in vivo experimental data [2] (yellow) in the passive
(left) and iontophoretic (right) case. The hair follicle is considered to have the same initial
concentration as the stratum corneum intercellular space given in equation (6.13). Parame-
ters are calculated using table 6.1.
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Figure 6-12: Hindrance model with 10% of the intercellular space fraction utilised in trans-
port. These show both model (blue) and in vivo experimental data [2] (yellow) in the passive
(left) and iontophoretic (right) case. The hair follicle is considered to have the same initial
concentration as the stratum corneum intercellular space given in equation (6.13). Parame-
ters are calculated using table 6.1.
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Figures 6-13, 6-14, 6-15 and 6-16 consider the extraction profile generated when using a zero
initial condition in hair follicles, as given in equation (6.30). Both passive and iontophoretic
extraction are considered for a range of intercellular space utilised. Similarly to using a non-
zero initial condition in the hair follicle, the model predicts a small fraction of the intercellular
space is used in extraction - approximately 10-25% of the area available.
Figure 6-13: Hindrance model with the whole of the intercellular space fraction utilised in
transport. These show both model (blue) and in vivo experimental data [2] (yellow) in the
passive (left) and iontophoretic (right) case. The hair follicleis considered to initially have
no phenylalanine in the stratum corneum part, given in equation (6.30). Parameters are
calculated using table 6.1.
Considering the PKU case for the non-zero initial condition in hair follicles, demonstrated
in Figure 6-17 for a utilised volume fraction of 0.1p of the SC, and zero initial condition for
hair follicles, demonstrated in Figure 6-18 for a utilised surface area of 0.25p, it is clear that
higher concentrations of systemic phenylalanine cause an observable difference in extraction
profiles. Similarly to the initial model, however, the steady state predicted is still higher than
expected from Figure 6-7 [103].
As shown in chapter 3, the skin reservoir is not noticeably affected by PKU. Hence the change
in amount extracted from the reservoir is small compared to the change in amount extracted
from deeper levels of the skin.
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Figure 6-14: Hindrance model with 50% of the intercellular space fraction utilised in trans-
port. These show both model (blue) and in vivo experimental data [2] (yellow) in the pas-
sive (left) and iontophoretic (right) case. The hair follicle is considered to initially have
no phenylalanine in the stratum corneum part, given in equation (6.30). Parameters are
calculated using table 6.1.
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Figure 6-15: Hindrance model with 25% of the intercellular space fraction utilised in trans-
port. These show both model (blue) and in vivo experimental data [2] (yellow) in the pas-
sive (left) and iontophoretic (right) case. The hair follicle is considered to initially have
no phenylalanine in the stratum corneum part, given in equation (6.30). Parameters are
calculated using table 6.1.
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Figure 6-16: Hindrance model with 10% of the intercellular space fraction utilised in trans-
port. These show both model (blue) and in vivo experimental data [2] (yellow) in the pas-
sive (left) and iontophoretic (right) case. The hair follicle is considered to initially have
no phenylalanine in the stratum corneum part, given in equation (6.30). Parameters are
calculated using table 6.1.
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Figure 6-17: Hindrance model with 10% of the intercellular space fraction utilised in trans-
port. The hair follicle is considered to have the same initial concentration as the stratum
corneum intercellular space given in equation (6.13). Parameters are calculated using table
6.1. The concentration of systemic phenylalanine corresponds to a patient with PKU at
Cs = 0.6mM. Both passive, left, and iontophoretic, right, cases are considered.
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Figure 6-18: Hindrance model with 25% the intercellular space fraction utilised in transport.
The hair follicle is considered to initially have no phenylalanine in the stratum corneum part,
given in equation (6.30). Parameters are calculated using table 6.1. The concentration of
systemic phenylalanine corresponds to a patient with PKU at Cs = 0.6mM. Both passive,
left, and iontophoretic, right, cases are considered.
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6.5.4 Summary for Hindrance Model
Similarly to the initial model system, the hindered transport approach again suggests that the
majority of steady state extraction occurs through the appendageal route. The incorporation
of hindrance transport methods to the intercellular route increases the time taken for the
initial amount in the stratum corneum to be extracted in both the iontophoretic and passive
case and agrees well with previous experimental results when the fraction of the intercellular
space utilised is considered to be 10-25% of the total volume occupied by the intercellular
space.
Additionally, utilising the hindered transport does not significantly affect the steady state
profile obtained for PKU patients in the initial model. As suggested by chapter 4, PKU does
not significantly affect the skin reservoir of amino acid. Hence, it should still be possible to
get indicators of PKU from a short sample time.
There are still several issues with the model however. Firstly, due to the formation of the
model, it is never possible to fully assess the skin reservoir of amino acid unless the whole
volume fraction is considered to contribute towards extraction which, in turn, results in an
extremely high initial profile. Secondly, as the hair follicle route dominates transport at
steady state and similarly to the initial model, the steady state flux for PKU patients is
higher than that observed experimentally - albeit in a very small sample size. Finally, and
perhaps most critically, the error bars associated with the model are very large - especially
in iontophoresis due to the variability in skin resistance and hence voltage applied.
As mentioned previously, the reverse iontophoresis experiments considered are at a constant
current of 0.3mAcm-2 [1, 2, 103] which, combined with skin resistivity [106], results in an
applied potential of 3.54±1.14V. The resistivity of skin has been shown to change under
applied fields of greater than 250mV with the amount of change dependent upon the voltage
applied [105]. This voltage drop would affect the electro-osmotic velocity and could explain
the differences observed in iontophoretic extraction profiles.
Due to the large error bars and the absence of data as to how the resistance of the skin behaves
under a constant current, it is impractical to attempt to further extend the model before more




In this chapter, we started by constructing an initial model for the extraction of large, un-
charged compounds via passive diffusion and reverse iontophoresis. In the initial model, the
intercellular and hair follicle pathways are split and modelled separately using partial differ-
ential equations. Initial conditions are based on the profiles obtained in chapter 4 and the
electro-osmotic velocity on the results of chapter 5. Comparing the predictions of the model
to prior in vitro [43, 42] and in vivo [1] experimental data for mannitol and phenylalanine sug-
gests that the hair follicle route dominates transport of large, uncharged compounds through
the skin. Considering the difference in hair follicle density in different sites in the body
[102], this makes it critically important to record the area of skin considered in extraction
experiments.
Hair follicles in prior work have been considered to negligibly contribute to flux through the
stratum corneum [33, 87, 91]. Hence the suggestion, using the mathematical model presented
here and prior work into identifying pathways through the skin under an applied electric field
using scanning electrochemical microscopy [32], is a key result. As the hair follicle pathway
rapidly obtains steady state, this result suggests that it is possible to detect systemic concen-
trations of large, uncharged compounds, like phenylalanine, directly via reverse iontophoresis.
When considering extraction in the non-steady state case, Figures 6-5 and 6-6 demonstrate
that the initial model predicts the steady state flux to be achieved quicker than has been
observed experimentally and, due to the very small fraction of the intercellular route utilised,
not assess much of the reservoir in the skin.
Having identified this issue, we move on to modify the initial model by considering hindered
transport methods through the stratum corneum. As the hair follicle pathway is considered to
have a radius that is large in comparison to the phenylalanine molecule and is straight through
the stratum corneum, hindrance modelling has no effect on this pathway. The intercellular
route, however, is tortuous and hence affected by hindrance effects.
Applying hindrance effects to the model significantly slows down the transport of compounds
through the intercellular pathway and, considering Figures 6-9 to 6-16 which compare model
predictions to in vivo data [2], suggests that 10-25% of the intercellular route is utilised during
extraction. This results in more of the skin reservoir being extracted and a greater time to
achieve steady state.
In both the initial model and the hindered model, the effect of increased systemic concen-
trations of phenylalanine, corresponding to a patient with PKU, is investigated. Figures 6-8,
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6-17 and 6-18 show that both models predict a noticeably increased flux of phenylalanine
from patients with higher systemic concentrations of phenylalanine. This result has also
been suggested in prior in vivo work [103]. However the predicted flux at steady state in the
case of a patient with phenylketonuria is higher than has been observed experimentally in the
reverse iontophoresis case. There currently does not exist any data on passive phenylalanine
extraction in PKU patients.
Although the hindered model approach gives a good prediction for passive and iontophoretic
extraction there are still several issues with this approach. Firstly, we assume that the pore
radius of the intercellular space route is large compared to both the Debye length and the
radius of the phenylalanine molecule. This assumption is not valid for the smallest pore
radius predicted by prior work, being 0.5nm [101] compared to a Debye length of 0.83nm
and a molecule radius of order 10-1nm. Additionally, prior work into skin resistance under a
constant voltage has suggested that skin resistance changes over time when a voltage of over
250mV is applied [105]. Due to the dangers of high current in the body, reverse iontophoresis
experiments tend to fix current rather than voltage with the current selected resulting in an
initial voltage of over 250mV. To date, there has not been any experimental work into skin
resistance changes under a constant current.
6.6.1 Variable Resistance
Prior in vitro work has identified that skin resistance decreases when exposed to a constant
voltage of over 250mV [105]. This work has also suggested that the change in skin resistance
is based on voltage applied with greater voltages causing a lower final resistance. Ohm’s law
means that a drop in resistance at fixed voltage results in a proportional increase in current.
Equations (6.14) and (6.15) show that electro-osmotic flow velocity is directly proportional to
the potential difference over the membrane, hence at a fixed voltage changes in skin resistance
should have no effect on electro-osmotic flow velocity.
In the case of in vivo phenylalanine extraction under reverse iontophoresis, the current den-
sity applied across the skin is constant at 0.3mAcm-2 rather than the voltage [2]. Using
the resistivity given in table 6.1 the resistance of the stratum corneum is calculated to be
11.8±3.8kΩcm2 which corresponds to a starting voltage of 3.54±1.14V. This means that the
voltage applied across the stratum corneum is greater than 250mV hence prior work has
suggested that there will be a change in skin resistance over the course of experiments using
this constant current density [105]. As the current density is fixed, a drop in resistance will
cause a corresponding drop in voltage, leading to a decrease in electro-osmotic flow velocity.
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Currently, there are no experiments that have looked at skin resistance changes under a
constant current. Producing a circuit diagram to model the decreasing resistance under a
constant current is very complex and requires the introduction of many unknown variables.
Considering a constant voltage, as has been done in prior in vitro work into resistance changes
through the skin [103], we propose that resistance, R, decays exponentially at rate, τ0 from
it’s start point, R0, and finishes at a non-zero fraction, pf , of this initial value:
R(t) = pfR0 + (1− pf )R0 exp(−τ0t). (6.31)
Figure 6-19 takes the results from prior in vivo resistance work under a constant voltage
[103] and compares them to the results of equation (6.31) with τ0 considering to correspond
to a half life of 10 minutes hence τ0 = 1/10x60 = 6.67x10-3s-1. This seems to be a good fit for
resistance behaviour under a constant voltage.
More experimental work would be required to ascertain if this relation holds for a constant
current and to find estimates for corresponding decay rates and end resistance. Alternatively
recording voltage during iontophoretic experiments would be very useful.
Due to the large error bars present in the hindered model and the uncertainty surrounding
both pore size in the intercellular space and resistance changes in the skin under a constant
current, further changes are not made to the hindered model at this stage. However, this
section and chapter 5 set up theory that can be used in the case of a pore radius comparable to
the molecule size and Debye length respectively. The model proposed for resistance changes
in the skin under a constant voltage using prior in vitro work [105] might be used as a basis
when considering skin resistance changes under a constant applied current.
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Figure 6-19: Comparing the resistance changes predicted by equation (6.31) with in vivo
data [105]. Filled in, yellow circles represent an applied constant voltage of 250mV, clear,
pink triangles 500mV, clear, blue squares 750mV, filled, red triangles 1000mV, filled, green
squares 1500mV and clear, purple circles 2000mV.
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Chapter 7
Summary and Future Work
The aim of this thesis was to investigate the formation and extraction of reservoirs of amino
acids in the stratum corneum, using phenylalanine as a case study, to assess the potential for
non-invasive monitoring of amino acid concentrations in blood serum. The clinical applica-
tion of this would be to allow monitoring of amino acid disorders, such as phenylketonuria,
via non-invasive methods. Non-invasive methods are preferred to invasive methods as they
avoid several issues such as risk of infection and the need for trained personnel to administer
[18]. The non-invasive method focussed on was transdermal extraction which utilises passive
diffusion through the skin and can be enhanced by the application of an electric field, called
reverse iontophoresis. Extraction of amino acids via this method has been considered exper-
imentally both in vitro [1] and in vivo [2]. We use this data to test the mathematical models
proposed and predict unknown parameters.
In order to investigate this topic, the thesis addresses 3 distinct components namely:
1. Blood serum concentrations of amino acids, specially phenylalanine, under food intake.
2. Skin reservoir formation based on blood serum concentrations.
3. Extraction of phenylalanine via reverse iontophoresis.
Having addressed background biological theory and mathematical techniques required to pur-
sue these goals in chapters 1 and 2, chapter 3 addresses blood serum concentrations. The
aim of chapter 3 was to extend previous fasting state models of phenylalanine concentration
in blood serum to include the effect of metabolism only occurring in the liver and adding
food intake effects. This chapter suggested that there were only minor differences between
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including liver only metabolism and having metabolism occur throughout the body. One of
the differences highlighted was that the resilience of a two-compartment system was much
less than the single-compartment system meaning that the single-compartment system would
return to a steady state faster after a perturbation. However, this did seem to have a signif-
icant effect when considering perturbations due to food intake. Clinically, this means that,
although including a second compartment is more physiologically realistic, it does not change
the dynamics of the system enough to warrant the additional model complexity and error
that this introduces.
Considering food intake into the system was done via a Bateman function. This suggested
that fluctuations due to food intake into the body caused visible changes in both PKU
suffering and non-PKU suffering patients. As would be expected from discrete doses, food
intake causes periodic oscillations in blood serum concentration. These fluctuations reinforce
the need for phenylalanine tolerance tests via blood sample to be performed in a fasting state.
If systemic concentrations have a noticeable impact on the skin reservoir, these fluctuations
should also have a noticeable effect on the reservoir.
Having established a baseline model for blood serum concentrations of phenylalanine, chapter
4 moved on to consider the skin reservoir of amino acids based on the blood serum concentra-
tion profile established in chapter 3. To date, mathematical models have not considered the
formation of reservoirs of amino acids in the skin, primarily focussing on extraction methods.
Considering prior work has suggested that corneocytes are impermeable [73], we proposed a
model for the stratum corneum that splits corneocytes and the intercellular space into two
compartments, further stratified into the stratum corneum and stratum disjunctum.
Modelling the skin reservoir highlighted several interesting results. Firstly, when tape strip-
ping, the depth each strip is considered to analyse is based on the mass of skin removed
[1, 2]. Hence, a similar number of corneocytes should be present for the same depth assessed
through the stratum corneum. If corneocytes are impermeable and contribute significantly to
amino acid levels in the stratum corneum, then the decrease observed in vitro [1] and in vivo
[2] in amino acid concentration near the surface of the skin, namely the stratum disjunctum,
should not occur. Based on this, our model suggests that most of the amino acid found in
the stratum corneum is in the intercellular space.
We also suggest that modelling removal of compounds from the stratum disjunctum intercellu-
lar space can be modelled using a linear removal term and verify this approach by considering
in vivo phenylalanine and tyrosine data [2]. However, chapter 4 also suggests that the sys-
temic concentration has an unnoticeable effect on phenylalanine and tyrosine concentrations
in the stratum corneum, with production eclipsing movement from the blood serum.
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Production in the stratum corneum dominating the formation of the skin reservoir sug-
gests that assessing historic phenylalanine concentrations via direct consideration of the skin
reservoir is not possible. However, recent in vivo work suggests that variations in serum
phenylalanine levels are detectable via reverse iontophoresis [103]. Combined with the re-
sults of chapter 4, this suggests that there is significant flux of phenylalanine from the sys-
temic compartment through the stratum corneum during reverse iontophoresis. Chapter 5
and 6 investigate this experimental result mathematically by considering electro-osmotic flow
through the stratum corneum.
As phenylalanine is an uncharged compound, flux through the stratum corneum under an
applied field is governed by electro-osmotic flow and passive diffusion. The main objec-
tive of chapter 5 was to combine previous work into fluid dynamics, surface chemistry and
electromagnetism to form an expression for electro-osmotic flow velocity in terms of known
parameters in different system geometries. Although the theories proposed in the chapter
are not new, they have not been previously utilised in skin models and are combined in a
novel way to determine electro-osmotic flow velocity in the skin. Using streaming poten-
tial data [87] we obtain predictions for surface charge density based on the concentration of
ionic solvent in the fluid, allowing us to predict electro-osmotic flow velocity based on known
properties of the skin, applied field and fluid.
Chapter 6 then aimed to use the results of chapter 5 to form a model for extraction of un-
charged compounds through reverse iontophoresis. The initial reservoir in the skin was based
on the model results from chapter 4. Prior modelling work through the stratum corneum
tends to ignore the effect of appendageal transport [33, 87, 91]. However, experimental work
using scanning electrochemical microscopy has suggested that appendageal transport is the
primary extraction route for compounds through the skin [32]. This was investigated by
considering intercellular and hair follicle routes separately.
The main result of chapter 6 is to suggest, using mathematical models, that hair follicles are
indeed critical to extraction of compounds through the skin with this route becoming fully
established very quickly. It is further suggested that the contribution to flux through the
stratum corneum from the intercellular space at steady state is completely eclipsed by hair
follicles. However, consideration of the intercellular route is still important when looking at
reservoir extraction.
The results presented by chapters 5 and 6 develop the field of transdermal monitoring sig-
nificantly. The formulation of electro-osmotic flow velocity from fundamental principles of
electromagnetism, fluid dynamics and surface chemistry predicts that hair follicles are the
primary extraction route through the skin. This explains the large variation observed in
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experiments where the origin of skin samples is often not stated. Clinically, this result also
suggests that direct monitoring of amino acid disorders via transdermal extraction is possible,
particularly in areas of the skin where there are lots of hair follicles.
7.1 Future Work
One of the biggest limitations encountered in this thesis was the amount of experimental
data available. Small sample sizes and human variability lead to large standard deviations,
making it difficult to draw solid conclusions from the model results. The first instance of this
occurs in chapter 3 where it is not possible to compare non-fasting state model results to real
data. Experiments measuring these properties would validate model predictions.
The quantity of experimental data becomes a more pressing issue when considering extraction
through the skin. In this case, the small data set and the variability in parameters such as
voltage causes the standard deviation to be comparable to the size of the result measured.
Although human variability is always going to be an issue, there are several experiments that
can be done to decrease the error measured. Firstly, it has been established by this thesis,
and prior work in both reverse iontophoresis [33] and micro-fluids [89], that electro-osmotic
flow velocity is directly proportional to the electric field applied. By definition, in a uniform
electric field the field strength is equal to the voltage applied across the membrane divided by
the path length and voltage is equal to current multiplied by resistance, Ohm’s law [98]. Due
to the harmful effect of high currents on the human body most experimental work into reverse
iontophoresis uses a constant current of 0.3mA/cm2 [1, 2, 103]. Skin resistance is highly
variable which means that this constant current can result in an applied voltage of anywhere
between 2-5V, resulting in a large range of electro-osmotic flow velocities. Measuring voltage
throughout the experiment would allow a better prediction of electro-osmotic flow velocity
and significantly reduce modelling error.
On this note, prior research has also shown that voltages of over 250mV cause changes
in skin resistance with the change observed based on voltage applied [105]. To date, this
phenomenon has not been investigated under a constant current. Doing so would allow
models to be developed of this voltage change to be applied to electro-osmotic flow rates and
could contribute to the decrease in flux over time.
Recording the site from which skin is taken would also help to reduce error as hair follicle
density varies between different locations in the body [102]. Chapter 6 and [32] also suggest
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that hair follicles are the primary extraction route through the skin making this differentiation
critical.
Having performed these experiments and compared the results to the model structure pre-
sented in this thesis, there are several modifications that could potentially improve the model
presented. Firstly, having a time varying velocity based on the time varying voltage would
result in a reduction in flux over time. This could be similar to the structure presented in
section 6.6.1 or different depending on the experimental results.
One of the other limitations is that the pores through the stratum corneum are considered
to be large, with respect to both the Debye length and molecule size, resulting in a con-
stant electro-osmotic flow velocity. For the 133mM NaCl solution used in the extraction
experiments considered, the Debye length is 0.83nm. Hence, this assumption is valid for hair
follicles which are micro-channels, but predictions for pore sizes in the intercellular space
vary between 0.5nm [101] and 20nm [87]. Hence this assumption will not be valid if pore
sizes are on the lower end of this spectrum. We have presented theory for modifying the
electro-osmotic flow velocity accordingly in chapter 5 and empirical relations for hindrance
based on a pore size comparable to molecule size in chapter 6. These modifications will slow
down flow through the intercellular space and, thus, also slow reservoir extraction.
Applying these modifications may also mean that more of the skin reservoir is predicted to
be extracted during reverse iontophoresis. In the current model proposal, the whole reservoir
is not analysed as the results predicted using the full reservoir have a far too high initial
extraction flux. The other potential reason for this could also be due to some of the compound
being trapped in the skin.
Overall, the models proposed by this thesis identify significant changes to the field of math-
ematically modelling transdermal extraction which reflect recent experimental developments
[32, 103]. Clinically, this also identifies the potential for non-invasive monitoring of amino
acids, specifically phenylalanine, via reverse iontophoresis. The next stage in this research
is to perform experiments to validate predicted parameters and reduce the error associated
with several parameters, such as voltage, by direct measurement.
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